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Radionuclide therapy is an innovative treatment in nuclear medicine that uses unsealed sources 
to treat some specific tumours in the human body. With an increasing interest in this modality, 
some efforts have been done to improve this field in nuclear medicine, such as the 
radiopharmaceuticals administered or the components of the imaging equipment. 
Pure beta emitters are the radionuclides most used in radionuclide therapy. They are described 
to have extremely high potential in the treatment of malignant and non-malignant disorders. The 
energy of these radionuclides is absorbed close to the target site due to its low range (few mm in 
tissue). The problem is the impossibility of imaging their uptake in the interest places since 
there are no gamma rays emissions and the beta radiation is impossible to detect externally. As a 
result, the only radiation capable to be perceived by the gamma camera is the bremsstrahlung 
photons produced when an accelerate beta particle passes close to the atomic nucleus and is 
deflected towards it. The detection of these photons is relevant for dosimetric purposes, in order 
to detect the real uptake of the radionuclide and hence to know the absorbed dose in the patient. 
Thus, the current dissertation reports a study about bremsstrahlung characteristics by using a 
Monte Carlo simulation. The study attempts to realise in what way the bremsstrahlung photons 
are produced in different types of biological materials, using different beta particles energies. 
The simulator used was the EGSnrc (Electron Gamma Shower) system (V4 2.3.2), a package 
for Monte Carlo simulations. The programs were written in Mortran language and compiled to 
Fortran. With this study, an additional aim was to obtain a strong knowledge on EGSnrc system 
and to be able to modify and produce a wide range of different simulations in different physical 
conditions. In order to understand the bremsstrahlung photons several simulations were 
performed, in different media and with different energies of beta particles emissions. 
Future work should be necessary in order to relate the bremsstrahlung photons understanding 
with the gamma camera components. The aim will be to improve the bremsstrahlung imaging 
and hence gathering realistic dosimetric data for the pure beta emitters. 
 
 







A terapia com radionuclídeos é um tratamento inovador em medicina nuclear, o qual utiliza 
fontes não seladas para tratar tumores específicos no corpo humano. Com o crescente interesse 
por esta especialidade terapêutica, alguns esforços têm sido feitos para melhorar este campo da 
medicine nuclear, nomeadamente através dos radiofármacos administrados ou na tecnologia dos 
equipamentos de imagiologia. 
Os emissores beta puros (electrões) são os radionuclídeos mais utlizados nesta terapia. São 
descritos na literatura como os que apresentam um elevado potencial no tratamento de doenças 
malignas e benignas, uma vez que a energia destes radionuclídeos é absorvida perto do local 
alvo (poucos mm de alcance nos tecidos). O problema da utilização de beta puros reside na 
impossibilidade de se formar uma imagem médica, uma vez que estes radionuclídeos não 
emitem qualquer radiação gama. Como resultado, a única radiação capaz de ser detectada pela 
câmara gama são os fotões bremsstrahlung (radiação de travagem), produzidos quando ocorre 
uma desaceleração e deflexão dos electrões acelerados quando estes passam perto dos núcleos 
atómicos. A detecção de bremsstrahlung é muito importante para fins dosimétricos, dado que 
permite conhecer a verdadeira dose absorvida pelo paciente. 
A presente dissertação tem como principal objectivo estudar as características dos fotões 
bremsstrahlung, através da utilização de um simulador Monte Carlo - EGSnrc (Electron Gamma 
Shower). Pretende-se compreender de que forma os fotões bremsstrahlung são produzidos no 
interior de diferentes tipos de materiais biológicos, utilizando partículas beta de diferentes 
energias. Os códigos foram programados em linguagem Mortran e compilados para Fortran. 
Pretende-se também obter um forte conhecimento sobre o sistema usado, de forma a ser 
possível produzir qualquer tipo de simulação para diferentes condições físicas.  
Torna-se necessário prosseguir este trabalho, a fim de se relacionar as características dos fotões 
bremsstrahlung com os componentes da câmara gama. O objectivo será melhorar as imagens 
criadas por fotões bremsstrahlung e, portanto, reunir dados dosimétricos realistas para os 
emissores beta puros. 
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The present dissertation encompasses a research work developed at the Institute of Nuclear 
Medicine (INM) of the University College London Hospital (UCLH), with a contribution of the 
Institute of Cancer Research (ICR) and the Department of Nuclear Medicine in Cambridge 
Biomedical Campus (Addenbrooke's Hospital). The work developed in UCLH was undertaken 
from February to November 2012, within the framework of an Erasmus exchange program. 
 
The Institute of Nuclear Medicine (INM), actually included within the new UCL Hospital NHS 
Foundation Trust building, was founded in 1961 by Professor E.S. Williams (director of the 
institute 1963-1985) and by Professor P.J. Ell (currently consultant physician). This institute is 
the only academic department of nuclear medicine in the UK and its physics research group is 
internationally recognised. The INM is responsible for the nuclear medicine service of UCL 
Hospitals NHS Trust. In addition, the institute also offers the full range of nuclear medicine 
diagnostic, laboratory based and therapy procedures, which currently performs approximately 
15,000 patient studies every year. The INM has a unique technology platform in the UK and it 
comprises an extensive range of state-of-the-art imaging equipment, image processing, IT 
systems and radiopharmacy/radiochemistry facilities. The institute is equipped with two PET-
CT systems (a 16-slice system and a 64-slice system), two SPECT-CT systems, two SPECT 
gamma camera systems, a cardiac camera (D-SPECT) and DEXA (dual-energy x-ray 
absorptiometry) bone densitometry. Currently, it possesses the first fully integrated 3T PET/MR 
in the UK, as well as a full range of supporting nuclear medicine instrumentation. Particular 
areas of expertise include nuclear cardiology, PET-CT and SPECT-CT imaging in oncology and 
radiotherapy, the sentinel lymph node technique - the application of nuclear medicine to 
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1.1. Dissertation Context 
Nuclear medicine is one of the most dynamic fields in medicine. It is defined by the British 
Nuclear Medicine Society (BNMS) and the Society of Nuclear Medicine and Molecular 
Imaging (SNMMI) as “a medical specialty that embracing all applications that leads with 
unsealed radioactive materials for diagnosis, therapy and research purposes”. This scientific 
and clinical discipline is a painless and cost-effective technique. It uses a radiopharmaceutical, a 
chemical or molecular agent labelled with a small amount of a radioactive material (called 
radionuclide, radioisotope or unsealed source), to image the patient’s body or treat diseases. 
Nuclear medicine is used by many medical specialties, such as paediatry, cardiology, 
psychiatry, angiology, and so forth, which resort to this field both to diagnostic and therapeutic 
purposes (Britton, 1995; SNMMI, 2004; BNMS, 2010) 
The origins of nuclear medicine stem from many scientific discoveries, as the discovery of 
radioactivity from uranium, in 1896 by Henri Bequerel, and the finding, in 1898, of other 
natural radioactive compounds, as radium and polonium, by Marie Curie. But it was in 1913 
that was born the real biological fundamentals to this speciality, when Georg de Hevesy 
developed the principles of the tracer approach, forming the first radiopharmaceutical. This 
event, amongst the fact of Alexander Graham Bell, in 1903, having suggested to place sources 
containing radium in or near tumours, which became to be the pioneering activities for the birth 
of radionuclide therapy (Wheat et al., 2011). 
After these, the growth of the nuclear medicine history was astonishing. The “artificial 
radioactivity” was found with the invention of cyclotron; Lawrence made the first clinical 
therapeutic application to treat leukaemia with phosphorus-32 (32P) and the radioactive iodine-
131 (131I) was firstly applied in the treatment of the thyroid cancer (News Medical, 2012a). 
The advent of technology has enabled further the progression of this multidisciplinary medical 
specialty. In 1958, the first gamma camera was developed by Hal Anger - an imaging device 
that detects photons (γ- and x-rays) from the isotope decay, creating images reflecting the 
distribution of the radiopharmaceutical in the human body. The development of a generator 
system to produce technetium-99m (99mTc) in the 1960s was a landmark event. Today, 99mTc is 
the most widely used radionuclide in the nuclear medicine (Cherry et al., 2003; Graham & 
Metter, 2007). 
The computational progress, together with the mathematics innovations to reconstruct 
tomographic images from a set of angular views around the patient, allowed the emergence of 
others image equipment, as the Single Photon Emission Computed Tomography (SPECT), 
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developed by David E. Kuhl, and the Positron Emission Tomography (PET), developed by 
Gordon (Graham & Metter, 2007). 
This revolutionized the whole field of medical imaging, as it replaced the two-dimensional 
representation by a true three-dimensional representation of the radioactivity distribution 
(Cherry et al., 2003), giving to the nuclear medicine a unique property to provide information 
about the function of an organ (SNMMI, 2004). All these events led to the nuclear medicine as 
we know it today. 
As previously stated, the 99mTc is the most used radionuclide in imaging diagnostic. 
Consequently, the actual gamma cameras are designed to image low activities of low-energy 
gamma emitters produced by 99mTc. Contrasting to diagnostic, therapeutic radionuclides have 
high activities and high energies since the objective is to destroy malignant cells. Thus, the ideal 
mode of decay for radioisotopes used in radionuclide therapy is the beta-minus emission (β--, 
also known as electrons). Beta emitters have a high linear energy transfer (LET) and just a few 
millimetres of tissue range enabling the tumour’s destruction and reducing the likelihood of 
damaging healthy tissue (Sprawls, 1993). 
The radionuclides used in diagnostic decay by emission of gamma rays. This radiation provides 
the ability to image the biodistribution in vivo of the radiopharmaceutical and consequently 
indicating the tumour localization and the non-target uptake and retention (Stanciu, 2012). 
There are some radionuclides used in the radionuclide therapy that emit both beta and gamma 
rays, as lutetium-177 (177Lu) or rhenium-188 (188Re) and therefore these ones enable 
simultaneously the treatment and uptake’s visualization of the radiopharmaceutical that delivers 
the treatment in vivo (Flux, 2006; Stanciu, 2012), giving them a “bifunctional” property. 
However, there are a few radioisotopes used in the radionuclide therapy that do not emit gamma 
rays. Those are the pure beta emitters, as yttrium-90 (90Y) and phosphorus-32 (32P), and their 
detection relies on the bremsstrahlung photons released when the electrons interact in the tissue 
(Heard, 2007). 90Y also does produce 511keV gamma rays by a very low probability of internal 
pair production followed by annihilation, so it can be imaged on a PET scanner. 
Imaging pure beta emitters, used in radionuclide therapy, are useful to assess the uptake and the 
distribution of the radiopharmaceutical for each tumour under treatment. However, the beta 
emissions are completely stopped inside the tissue (a few millimetres of range) and do not emit 
gamma rays. For this reason, it is not possible to detect them with gamma cameras. 
Nowadays, for dosimetry purposes, surrogate radionuclides with gamma rays emissions and 
similar chemical properties, as the radionuclides used in radionuclide therapy, are typically used 
for treatment planning (Minarik et al., 2009; Rong et al., 2012). In the case of 90Y, the pre-
therapy dosimetry is performed by imaging the indium-111 (111In) to predict the 90Y activity 
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required for the treatment (Minarik et al., 2010). However, imaging the therapeutic radionuclide 
biodistribution is essential to confirm its uptake and estimate the absorbed dose. Therefore, 
imaging pure beta emitters depends on the bremsstrahlung radiation produced in the patient 
(Walrand et al., 2011). Problems, such as the low bremsstrahlung production efficiency, 
particularly in the low atomic number (low-Z) areas, such as tissue, and the continuous 
bremsstrahlung spectrum, prevent the easy formation of the bremsstrahlung imaging. According 
to Martin (2006), when beta particles are absorbed in the tissue (with a low-Z), less than 2% of 
the interactions produce bremsstrahlung and many of those might escape from the tissue 
medium, since the probability of interaction in media with low-Z is also small.  
Problems related to bremsstrahlung imaging are a challenge to overcome, in order to allow a 
patient-specific dosimetry planning. There have been studies in this area to try to exceed the 
complexities and the challenges in detecting the bremsstrahlung photons, particularly in 
selection of the acquisition parameters of the gamma camera, such as the collimator or energy 
window. 
 
1.2. Dissertation Aim 
Since there is a great potential in imaging bremsstrahlung photons, created by pure beta emitters 
used in radionuclide therapy, and still is a challenge to do it because of all difficulties related to 
their emission and detection, the present investigation aims to study and understand the 
behaviour of the bremsstrahlung photons. 
This dissertation comprises an understanding of the physical principles involved in the 
therapeutic process with unsealed sources when pure beta emitters are injected. The study 
attempts to realise the characteristics of the bremsstrahlung photons, when they are produced in 
different types of biological materials using different energies, i.e., aims to recognize the 
relationship between bremsstrahlung photons, biological materials and different energies of beta 
particles. 
For this purpose, a Monte Carlo simulation was used to simulate realistic events. Among some 
coding systems that use Monte Carlo simulation, for the present work the simulation’s software 
called EGSnrc (Electron Gamma Shower) was chosen. EGSnrc was chosen due to its 
advantages with respect to electrons transport. The programs created in EGSnrc were written in 
Mortran language and compiled to Fortran. 
A Mortran code using a point source of photons was used to validate the code model developed. 
The photons behaviour can be easily understood, making easier the full understanding of the 
EGSnrc system. The accuracy of the code may be validated by comparison of the results 
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obtained with the theoretical and published data. Another Mortran code was created to simulate 
the pure beta particles emission and hence the production of bremsstrahlung in vivo. Realistic 
events using beta particles source in different homogeneous media and for different energies 
emitted were simulated and the bremsstrahlung photons formed were recorded and studied. Also 
with the present study, one intends to obtain a strong knowledge of the EGSnrc system in order 
to be able to modify and produce a wide range of different simulations in different physical 
conditions. 
Particular limitations in this study arise from the lack of published information in specific 
results, such as the bremsstrahlung spectra for different media, and the nonexistence of proved 
and validated evidences of imaging bremsstrahlung in patients treated with some pure beta 
emitters. 
The results obtained may be a support tool that could be useful in future works as experimental 
evidence, mostly for dosimetric purposes. Due to the fact that this is an emerging area and in 
great development, further studies are required in order to establish and confirm the benefits of 
the practice, namely in the dosimetry field, to understand the real uptake of radionuclides in the 
patients treated by radionuclide therapy. 
 
1.3. Dissertation Structure 
The present dissertation is comprised of 5 main chapters. The second chapter presents the 
physics behind the nuclear medicine and all the concepts that will be drawn on throughout this 
study. The chapter is then divided into 3 different sections: section 2.1. summarises the general 
concepts of nuclear physics; section 2.2. provides an overview of the gamma camera 
components, imaging techniques and performance characteristics, and the last section reviews 
the concepts and the current practice of radionuclide therapy, the dosimetry undertaken in the 
treatments, as well as, it explains the difficulty in imaging bremsstrahlung photons. In chapter 3 
it is clarified the methodology used in the investigation: section 3.1. summarises the general 
principles of Monte Carlo simulation, how EGSnrc works and likewise it described the models 
created in EGSnrc to achieve the proposed aim and in section 3.2. are presented the 
measurements undertaken. In chapter 4 all the results are described, as well as the discussion of 
one of them. Each simulation is properly explained in addition to the method used in each one 
of them. Section 4.1. refers to the validation of the Mortran code created, section 4.2. explains 
and discusses the bremsstrahlung results and section 4.3., mentions the validation of a program 
to decode the list mode data. Ultimately, the conclusions are referred in the followed chapters, 
along with the bibliography needed for the development of this study. The Mortran and Matlab 















2. GENERAL BACKGROUND 
 
Nuclear medicine is a medical speciality used both in diagnosis and therapy of a wide range of 
diseases. In each one of these situations, the goals are achieved throughout the energy release 
and uptake. This “energy in transit” or radiation (Cherry et al., 2003) is obtained by the 
radionuclide decay. The radionuclide is linked to a pharmaceutical, forming the 
radiopharmaceutical administered to the patients. For diagnosis, the pharmaceutical is labelled 
with a gamma ray-emitting radionuclide or positron-emitting radionuclide, whereas in therapy 
the radiopharmaceutical ideally has a pure negative beta-emitting radionuclide or an alpha-
emitting radionuclide. 
After the radionuclide decay, the radiation interacts with the body tissues by several 
mechanisms, being scattered and attenuated. However, a significant fraction of the photons 
(gamma and x-rays) that outcome from the decay and tissues interactions can be externally 
detected by a sensitive gamma camera, forming an image of the distribution of the 
radiopharmaceutical in the body. A single photon imaging (Gamma Camera or SPECT) is used 
when the radionuclide decay by gamma ray emission, whilst a positron imaging (PET scanner) 
is used when there is a positron emission. 
Due to the fact that the present study involves all the processes described above, a general 
physical approach will be summarised in this chapter as an introductory course of all physical 
mechanisms underlying in this project. 
 
2.1. General Concepts of Nuclear Physics 
All matter is composed of atoms. Each one of them contains a collection of protons and 
neutrons (nucleons) in the atomic nucleus and shells of electrons, with discrete energy levels, 
orbit the nucleus. An atom is completely identified by the formula X Z
A , where A stands for the 
mass number, i.e., number of nucleons, Z represents the atomic number, i.e., number of 
electrons, (equal to the number of protons for stable atomic species), and X is the symbol for a 
certain chemical element. The number of neutrons is usually represented by N (A-Z). 
Besides the number and organization of the orbital electrons, which defines the atomic specie or 
chemical element, the composition of the atomic nuclei also determines the properties of atoms 
(Khan, 2003). An atomic specie, characterized by a specific nuclear constitution, is called a 
nuclide (Turner, 2007). Nuclides with the same number of protons constitute a chemical 
element and each nuclide with a different number of neutrons is called an isotope of that 
element. A given element may have many isotopes and some of them have unstable nuclear 
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combinations, by excess of protons or neutrons, or even both. In the nuclei of the unstable 
isotopes, called radioisotopes or radionuclides, the Coulomb force (repulsive) starts to gain 
ground relatively to the nuclear force (attractive) and they tend to break apart, being 
transformed into a more stable nucleus throughout a process called radioactive disintegration or 
radioactive decay (Bushberg et al., 2002). 
Consequently, when the neutron-proton ratio is slightly above or below the ratio of nuclear 
stability, the radionuclides attempt to reach stability by emitting radiation. This emission can be 
in the form of particles (changing the number of protons or neutrons within the nucleus) and/or 
photons. 
The radioactive decay is a spontaneous process that continues until a stable nuclide is reached. 
This process results in the conversion of mass into energy and energy into mass, according to 
Einstein’s equation: 
𝐸 = 𝑚𝑐2     Eq. (2.1) 
Where m represents the nuclear rest mass (in atomic mass units, u, with an energy equivalent of 
931.5 MeV) and c stands for the speed of light. Therefore, the total mass-energy conversion, or 
the transition energy (Q) is equal to the net decrease in the rest mass of the stable atom, from the 
initial (or parent, which will be represent by X) to the final (or daughter, which will be represent 
by Y) atomic specie. Total energy, momentum and electric charge are conserved during the 
process (Cherry, et al., 2003; Attix, 2004). 
 
2.1.1. Radioactive Disintegration Processes 
The three main disintegration processes in nuclear medicine are: alpha decay (α), beta decay (β), 
which encompasses three beta decays (β-, β+ and electron capture, EC) and gamma (γ) decay, 
which incorporates two processes (isomeric transition (IT) and internal conversion(IC)). 
 
ALPHA DECAY (α) 
Usually α-decay occurs naturally in heavy nuclides with Z≥83 (Turner, 2007). In this process 
the unstable nucleus emits an α-particle consisting on two neutrons and two protons. This 
results in a decrease of A by four, due to a reduction of both Z and N by two. This disintegration 
is often followed by gamma and characteristic x-ray emission, since the α-particle captures two 
electrons from its surroundings to become a neutral He2
4  atom. The general equation of α-decay 






→  𝑌 + 𝑄𝛼𝑍−2
𝐴−4       Eq. (2.2) 
Where the Qα is the difference in mass-energy between the parent and formed products, 
daughter and α-particle, and shared between the α-particle and the daughter. However, since the 
nuclear rest mass of the daughter is much higher than that of the α-particle, the energy released 
in the decay is almost all transferred to the α-particle in the form of kinetic energy. 
Due to their considerable higher mass (four times heavier than the proton) and electrical charge 
(twice than a proton), α-particles are not used in diagnostic medical imaging. The reason is that 
their ranges are limited to approximately 1cm/MeV in the air and typically less than 100μm in 
tissue (Bushberg et al., 2002). However, they are used in radionuclide therapy or 
radioimmunotherapy (RIT) and the increasing of their effectiveness is being a subject of study 
by researchers (e.g. see Abbas et al., 2011 and Kratochwil et al., 2011). 
 
POSITIVE BETA DECAY (Β⁺) AND ELECTRON CAPTURE (EC) 
When the radionuclide has an excess of protons in the nucleus, i.e., neutron deficit (low N/Z 
ratio), there is a high probability to occur a beta plus emission where the radionuclide decays to 
a stable level. As a result, a proton is converted into a neutron, ejecting a positron (β⁺, which is 
the antiparticle of the electron) and a neutrino (ѵ) from the nucleus. The atomic number Z of the 
daughter nuclide decreases by one and N increases by one, whilst the mass number A remains 
constant since there is only a conversion of particles inside the nucleus. Schematically, the 
process of proton conversion and the positron emission equation could be represented, 
respectively, by: 




→  𝑌 + β+ +  ѵ + 𝑄β+𝑍−1
𝐴     Eq. (2.4) 
The energy released in the decay, Qβ⁺, is shared between the positron and neutrino, which could 
be calculated as follow (Eq. 2.5), neglecting the electron binding energy to the nucleus, 
assuming that the neutrino has essentially zero rest mass and no charge and the positron mass is 
equal to the electron mass (Attix, 2004). It is important to refer that the recoil kinetic energy 
given to the daughter is extremely small because of its relatively large mass, so it may be 
neglected (Turner, 2007; Podgorsak, 2010).  
𝑄𝛽+ = 𝑀𝑁,𝑋 − [𝑀𝑁,𝑌 + 𝑚𝛽+] = 𝑀𝑋 −𝑀𝑌 − 2𝑚𝑒   Eq. (2.5) 
Where MN is the nuclear mass, M the atomic mass and me the electron rest mass energy equal to 
0.511MeV. According to this equation, in order for β+ decay to occur, the atomic mass of the 
parent must exceed the atomic mass of the daughter in at least 2me=1.022MeV. 
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The radionuclides that emit a positron, such as fluorine-18 (18F) or nitrogen-13 (13N), are truly 
useful in diagnostic imaging. The positron, after losing its kinetic energy in collisions with the 
surrounding atoms, comes to rest and combines with its antiparticle, the electron, in an 
annihilation reaction. In this reaction, the masses of the two particles are converted into energy, 
which appears in form of two photons travelling in opposite directions (180° between them), 
each one with 0.511MeV. These two opposite photons are detected by PET scanners, enabling a 
spatial and functional imaging of the body (Podgorsak, 2010). 
However, if the parent-daughter atomic mass difference is less than two times the electron rest 
mass energy, 1.022MeV, the positron emission cannot take place. Instead, an Electron Capture 
(EC) can occur. This is a competitive or an alternative to the positron decay for neutron-
deficient radionuclides. 
In the EC decay, an orbital electron, usually from the K-shell, is captured by a proton in the 
nucleus, converting the proton into a neutron with the ejection of a neutrino. The net effect of 
the EC is the same as in the positron emission: the Z is decreased by one, N is increasing by one 
and A remains unchanged. The general equations of EC can be written as follows: 




→   𝑌 +  ѵ + 𝑄EC𝑍−1
𝐴     Eq. (2.7) 
𝑄𝐸𝐶 = 𝑀𝑁,𝑋 +𝑚𝑒– 𝑀𝑁,𝑌 − 𝐵𝑒 = 𝑀𝑋– 𝑀𝑁 − 𝐵𝑒   Eq. (2.8) 
In this case, the neutrino carries away some of the transaction energy that equals the difference 
in atomic rest mass between parent and daughter, less the electron binding energy, Be, of the 
electron captured. The remaining energy appears in the form of characteristic x-rays and/or 
Auger electrons emitted by the daughter nuclide. This is due to the fact that an electron of an 
outer shell will fill in the K or L-shell vacancy caused by the capture electron. Characteristic x-
ray energy is equal to the energy difference of the orbitals involved in the process, which can be 
transferred to another electron knocking it out of its shell (Cherry et al., 2003). 
Positron decay and EC decay may be accompanied by gamma emission if the daughter is not in 
a completely stable level and the EC is always accompanied by characteristic x-rays and/or 
Auger electrons by the daughter nuclide. Thus, the radionuclides with parent-to-daughter 
transition energies greater than 1.022MeV may decay by EC or β⁺ emission, or both, as it can be 
seen in figure 2.1., which represents the decay scheme of the 18F into oxygen-18 (18O) (Cherry 





Figure 2.1. Decay scheme for 18F into a stable 
nuclide 18O, which may decay by both EC or β⁺, 
with Emax,β⁺=0.638MeV. For the 18F, 3% of the 
nuclei decay by EC and 97% decay by beta plus 




NEGATIVE BETA DECAY (Β-) 
Contrary to the positron emission, negative beta decay occurs when the radionuclide nucleus 
has an excess of neutrons (high N/Z ratio), when compared with the number of protons. In this 
case, a neutron in the nucleus is transformed into a proton with a simultaneous ejection of a 
negative beta particle (β⁻, identical to electron, with the exception of their origin) and an 
antineutrino (ѵ̅). When a β⁻ particle is emitted, the N decreases by one, the Z increases by one, 
so that A remains unchanged. Schematically, the previous process and the negative beta 
emission equation may be written, respectively, as: 




→   𝑌 + β− + ѵ̅ + 𝑄β−𝑍+1
𝐴     Eq. (2.10) 
The energy released in the negative beta decay, Qβ
-, is the difference between the mass energies 
of the parent and daughter nuclides, considering the electron binding energy neglected and 
assuming the antineutrino, such as the neutrino, with zero rest mass and no charge (Turner, 
2007; Podgorsak, 2010). 
𝑄𝛽− = 𝑀𝑁,𝑋 − [𝑀𝑁,𝑌 + 𝑚𝛽−]  =  𝑀𝑋 −𝑀𝑌   Eq. (2.11) 
This energy is shared between the electron and the antineutrino. As explained before, the recoil 
nucleus (daughter), because of its relatively large mass, receives negligible energy. Therefore, if 
Eβ⁻ and 𝐸ѵ̅ are the initial kinetic energies of the electron and antineutrino is possible to write:  
𝑄𝛽− = 𝐸𝛽− + 𝐸ѵ̅     Eq. (2.12) 
Decay modes, such as the beta decays (β⁻, β+ and EC), in which the mass number do not 
change, are called isobaric transactions (Bushberg et al., 2002). A beta minus emission is shown 






































Figure 2.2. Decay scheme diagram for 14C into a 
stable nuclide 14N, which decay only by β- 
emission, with Emax,β-=0.156MeV (Adapted from 
Cherry et al., 2003; LNHB, 2012) 
 
 
In opposition to the β⁺ emitters, β⁻ are not useful in diagnostic medical imaging because they 
travel a short distance inside the tissue and do not produce any gamma photons capable of being 
detected externally. However, according to Joseph (2006), the pure beta-minus emitters 
demonstrate good results in clinical therapeutic purposes, being therefore used in radionuclide 
therapy, as seen in section 2.3. 
In contrast with α- and EC decays, where the energies of the decay products are uniquely 
defined by the production of a monoenergetic spectrum, β- and β+ decays emit the most of their 
particles with energies lower than the maximum of the particle decay energy (Tmax). These 
particles exhibit a continuous spectral kinetic energy distribution, resulting in a polyenergetic 
spectrum ranging from zero to Tmax, calculated according to the Fermi theory of the beta decay 
(Podgorsak, 2010). The average energy of the β particles emitted is approximately 1/3Tmax. 
Typical shapes of β− and β+ spectra are presented in figure 2.3.  
 
 
Figure 2.3. Typical spectrum of beta 
particle energy. Energy distributions of 
beta particles emitted (Adapted from 
Podgorsak, 2010) 
 
The differences at low kinetic energies are related to the particle charge. The electrons are 
attracted by the nucleus while the positrons are repelled, causing an energy shift to lower 
energies for electrons and to higher energies for positrons (Bushberg et al., 2002; Podgorsak, 
2010). 
























































ISOMERIC TRANSITION (IT) AND INTERNAL CONVERSION (IC) 
After an isobaric transition, the daughter nuclide could remain with an excess of energy and it 
will further decay until it achieves a stable level. In order to reach stability, the daughter nucleus 
may emit a nonparticulate radiation in form of gamma photon, with the Z and N remaining 
constant. This process, in which energy is given off as a gamma photon, without change of mass 
and atomic number, is called isomeric transition (IT) (Mettler & Guiberteau, 2006). 
The gamma rays are very useful in diagnosis imaging, since the nuclear medicine imaging 
equipment, as the gamma camera, are tuned to detect photons. The detected energy is 
determined by the difference between the intermediate and final states of the daughter nucleus 
and generally is in the range of 100keV to 500keV (Sprawls, 1993). It is noted that the 
intermediate state could emit more than one gamma ray, with different energies, until it reaches 
stability. 
The isomeric transitions occur quickly after the isobaric ones. However, if the nuclear excited 
state has a long lifetime, this intermediate state is called metastable, as in the case of the 99mTc. 
According to Sprawls (1993), metastable states are important in nuclear medicine due to the fact 
that in a metastable state the only energy emitted from the nucleus and detected from the 
external equipment are the gamma rays. This avoids, consequently, the electron emissions in the 
body, which do not contribute to the medical image formation but only to the radiation dose in 
the patient. 
Figure 2.4. represents the decay scheme of molybdenum-99 (99Mo) which undergoes an isobaric 
transition to technetium-99 in the metastable state, 99mTc. The 99mTc will later undergo an 
isomeric transition to 99Tc. 
 
 
Figure 2.4. Simplified decay 
scheme of isobaric nuclides: 
99Mo/99mTc/99Ru. The decay starts 
with a β- decay of 99Mo into 99mTc, 
followed by a gamma ray emission 
of 99mTc into 99Tc, and ending with 
a β- emission of 99Tc into a stable 











































β- decay (17.3%) 
Tmax=0.436MeV 
β- decay (82.7%) 
Tmax=1.217MeV 
 
γ decay  
Eγ=140.5keV 





In some cases, the excess of energy emitted by the intermediate nucleus in the form of gamma 
ray (hυ) may be transferred to an orbital electron within the atom. If the energy transferred to 
this electron is higher than its binding energy (Be), the electron escapes from the atom with a net 
kinetic energy of hυ-Be (Attix, 2004). 
This process is known as internal conversion (IC) and competes with the IT. However, IC just 
can occur when the energy transferred to the orbital electron exceeds its biding energy. After the 
electron being ejected, a vacancy is created. If the vacancy is replaced by an electron from a 
higher energy level, characteristic x-rays and/or an Auger electron are emitted (Sprawls, 1993). 
The ratio between the internal conversion electrons and internal transition is called by internal-
conversion coefficient (α). A low conversion ratio is preferable since it allows a greater number 
of gamma emissions used in medical imaging, avoiding the electrons production (Mettler & 
Guiberteau, 2006). 
 
2.1.2. Characteristics of Radioactive Decay 
According to the Advisory Committee on Human Radiation Experiments (ACHRE), the act of 
emitting radiation spontaneously by an unstable nuclide is called radioactivity. Radioactivity is 
“a physical, not a biological, phenomenon” from the radioactive nuclides (HSS, 1995). Hence, 
radioactive nuclei, either natural or artificially, decay by a spontaneous process in which is 
impossible to predict exactly the moment of its transformation into another stable nuclide. 
However, since nuclear medicine works, not with individual nuclei, but with a sample or 
collection of radioactive material, the radioactive decay could be described in terms of 
probabilities and average decay rates. The amount of radioactivity present in a sample is 
measured by its activity (A). The activity of a sample is the rate at which the nuclei, within the 
sample, undergo transformations. It can be measured by counting how many atoms are 
spontaneously decaying in each second and it is express in units of curie [Ci], or currently, in 
the SI unit, the Becquerel [Bq], which is defined as one disintegration per second 
(1Ci=3.7x1010Bq) (Sprawls, 1993; Barnes, 1996). 
The activity, independently of the nature of the decay mechanism, is described mathematically 
as the change (dN) of the total number of radioactive atoms in a sample (N) in a given period of 
time (dt), or simplified, is equal to the decay constant (λ) times the total number of unstable 
atoms in a sample in that time. Both methods are represented in equation 2.13. 
𝐴(𝑡) = −𝑑𝑁 𝑑𝑡⁄ =  𝜆𝑁(𝑡)    Eq. (2.13) 
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The minus sign indicates the decline of the radioactive nuclei during time. The decay constant is 
equal to the fraction of the number of radioactive atoms remaining in a sample, or alternatively, 
is the probability of any nucleus to undergo a decay per unit time. The decay constant has a 
characteristic value for each radionuclide and is measured in seconds-1. By integrating equation 
2.13., it is possible to define the exponential radioactive decay law (Eq. 2.14), which expresses 
the exponential decay of every kind of radioactive nucleus over time (Bushberg et al., 2002). 
𝑁 = 𝑁0𝑒
−𝜆𝑡 𝑜𝑟 𝐴 = 𝐴0𝑒
−𝜆𝑡    Eq. (2.14) 
This equation allows calculation of the number of unstable nuclei in the sample at any time t, 
knowing the initial amount of radionuclides, N0, at t=0sec. On the other hand, equation 2.14., 
permits to identify the remaining activity, A, in the sample after t time, assuming an initial 
activity equal to A0. Figure 2.5., plots equation 2.14 during successive times T, called the half-
life of the radionuclide in which the activity drops by factors of one-half, as shown. 
 
 
Figure 2.5. Exponential 
radioactivity decay law, 
showing the activity A of a 
sample as a function of time t. 
Linear scale is used (Adapted 
from Bushberg et al., 2002) 
 
 
The half-life (T1/2) is a parameter related to the decay constant. It is defined as the necessary 
time for the radioactive atoms to decrease to one half, in a given sample, which means that the 
sample will be reduced to half of its existing activity. So, if in the beginning a sample has No 
radiative atoms, after an half-life, particular for each radionuclide, the remaining number of 
radioactive atoms (N) will be No/2. The decay constant and the half-life are related as follows: 
𝜆 = 𝑙𝑛2 𝑇1/2⁄      Eq. (2.15) 
Both the decay constant and the half-life are unique parameters for each radionuclide (Turner, 
2007). Thus, it is possible to say that the half-life, together with the nature of the decay process 
(α, β and γ-decay) can be a signature for the identification of the isotope. The half-lives of the 
radioactive isotopes range from fractions of a second to billions to years (ISNAP, 2011). 































In nuclear medicine, the radioactive material is administered in a living organism. Therefore, the 
material might be removed from the organism by normal radioactive decay of the radionuclide 
but also by biological transport. The half-life used to designate the normal radioactive decay, 
such as nominated above, is generally called physical half-life (Tp). In addition to the physical 
half-life, two other half-life terms are commonly used: the biological half-life (Tb), which refers 
to the time that an organism takes to eliminate half of the radioactive material administered by 
biological ways, and the effective half-life (Te) which is associated with both physical and 
biological half-lives (Mettler & Guiberteau, 2006). When the biological transport or elimination 
occurs, the lifetime of the radioactive material in the body is reduced and it is generally 
expressed in terms of an effective half-life, by the follow equation: 
𝑇𝑒 = (𝑇𝑝𝑥 𝑇𝑏) (𝑇𝑝 + 𝑇𝑏)⁄     Eq. (2.16) 
It is important to highlight that when both physical and biological half-life exist, the effective 
half-life is always shorter than either one or other (Sprawls, 1993). 
Choosing a radiopharmaceutical with an effective half-life that agrees with the duration of the 
study is crucial for dosimetric purposes. If the radionuclide has a long life then the effective 
half-life can be reduced by choosing a chemical component with a short biological half-life 
(Podgorsak, 2010). 
Subsequently to the radionuclide disintegration into a stable state, the particles and/or photons 
emitted, with certain energy according to the radionuclide, will interact with the surrounding 
tissues. Sometimes, photons may eventually dissipate without transferring any energy to the 
surrounding medium. The transferred energy to the matter is truly important for dosimetric 
purposes. According to Stabin (2007), it has important implications for radiation biology, 
radiation shielding, radiation detection, and for every practical application of radiation 
protection. 
In the next section, the interaction mechanisms of the photons and particles with matter will be 
described. However, since the present work concerns, primarily, with the beta-emitting 
radionuclides, only the electron interactions will be discussed, as well as the photons interaction 
types which provide energy loss during the collision with matter, such as the photoelectric 
effect, Compton scattering and pair production. Photon interactions occur both in tissue and in 




2.1.3. Photons Interactions 
Photons (x-, γ-rays or bremsstrahlung) may transfer all of their energy to matter, being totally 
absorbed, or they may transfer part of their energy when they are scattered or deflected from 
their original direction. In this last case, the photons no longer carry useful imaging information. 
Photons, eventually, may also penetrate the matter without interacting, and consequently, 
without losing any of their energy (Joseph, 2006; Turner, 2007). Most of the time, when the 
photons energy is low to moderate, photons interact with the whole atom or with the orbital 
electrons, whereas those with high energy interact with the atomic nuclei (Stabin, 2007). 
One should emphasize that photons do not steadily lose energy via coulombic interactions with 
matter, as do charged particles (MIT NSE, 2005). This is due to the fact that photons are 
indirectly ionizing radiation, electromagnetic radiation with zero mass and electrically neutral. 
For that reason, photons travel a considerable distance before undergoing an interaction and 
when they do interact, the energy is transferred to the matter into two single steps (MIT OCW 
NSE, 2007a). The initial step involves the kinetic energy transfer to the medium, with 
subsequently ejection of electrons from the atoms involved in the interaction. The second phase 
comprises the energy transfer from these high-speed electrons (such as the beta particles) to the 
matter, by producing ionization and excitation of the atoms along their paths, causing biological 
effects (Khan, 2003). 
The consequences of those facts will be analysed in section 2.3. The types of photon 
interactions with matter will be described below, including pair production, an uncommon 
interaction in gamma camera imaging, but possible to occur since in the current work the beta 
particles energies, and hence the bremsstrahlung photons energies, may exceed 1.022MeV. 
 
PHOTOELECTRIC EFFECT 
In the photoelectric process, a photon with energy hѵ experiences an interaction with an atom of 
the absorbing medium. The photon energy is completely absorbed by an orbital electron. The 
orbital electron is ejected from its shell with kinetic energy T=hv-Be, where Be is the binding 
energy of the ejected electron, and it is called of photoelectron. Thus, the incident photon 
completely disappears and the photoelectron carries off the resultant energy by producing 
ionizations and excitations, along a path until its energy is dissipated.  
The photoelectron creates a vacancy in the orbital shell which is filled in by an electron from the 
previous shell with a lower biding energy. In turn, it creates another vacancy filled in by an 
electron from an even lower binding energy shell. This process keeps creating an electron 
cascade from outer to inner shells until the atom remains in a stable state. These electronic 
transitions are followed by simultaneous emission of characteristic x-rays (more frequent in 
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high Z-materials), with energy equal to the difference of the binding energies, or Auger 
electrons (more frequent in low Z-materials). Usually, the majority of photoelectric events 
involves interactions with the innermost orbital shell, the K-shell. The energy of the incident 
photon must be greater or equal than the biding energy of the K-shell, in order for the 
photoelectric effect occurs (Cherry et al., 2003; Khan, 2003; Attix, 2004; MIT NSE, 2005; 
Heard, 2007; Stabin, 2007; Tu rner, 2007). Figure 2.6., represents a photoelectric event with 
characteristic x-ray emission. 
 
Figure 2.6. Representation of the photoelectric effect with characteristic x-ray emission. Note that, 
although not shown on this diagram, Auger electrons can be emitted instead of the characteristic x-ray 
(Adapted from Alpen, 1990) 
 
According to Attix (2004), Stabin (2007) and Turner (2007), the probability of photoelectric 
effect occurrence depends strongly on the photon energy, E, as well as, on the atomic number Z 
of the absorbing medium. The probability of producing a photoelectron per atom or the atomic 
cross section, symbolized by aτ, varies accordingly Z
4/E3. This relationship is used for energies 
equal or below 0.1MeV, where the photoelectric effect becomes more important. Consequently, 
with base of the relation above, the photoelectric effect has a higher probability of occurring in 
high-Z materials and low-energy photons.  
The angular distribution of the photoelectron also depends on the photon energy. The 
photoelectron is emitted at 90° when low-energy photons interact and in a more forward 













The Compton scattering, also known as inelastic or incoherent scattering, is the most dominant 
interaction mechanism in the biological tissues, as well as, the predominant interaction 
mechanism for photons with energies typically in a range from 100keV to 10MeV (MIT OCW 
NSE, 2007a). 
In this process, an incident photon with energy hѵ, interacts with an orbital electron, which is 
assumed to be unbound, stationary, with total energy m0c
2 and usually in an outer atomic shell 
(Bushberg et al., 2002; Attix, 2004; Podgorsak, 2010). The incident photon, referred to as 
scattered photon, is deflected from its original path, losing some energy to the electron. The 
electron is ejected from the atom with kinetic energy T and referred to as Compton or recoil 
electron (Khan, 2003; Attix, 2004; Turner, 2007; Podgorsak, 2010). Just like in the 
photoelectric effect, this recoil electron loses its kinetic energy by producing ionizations and 
excitations along a path (MIT OCW NSE, 2007a). The incident photon is deflected with an 
angle θ, designated as photon scattering angle and the recoil electron is ejected with an angle φ, 
designated as electron scattering angle. A typical Compton scattering interaction is shown, 
schematically, in figure 2.7.  
 
Figure 2.7. Schematic representation of the Compton Scatteringm where hѵ is the incident photon 
energy, hѵ’ the scattered photon energy, θ photon scattering angle and φ electron scattering angle 
(Adapted from Alpen, 1990) 
 
According to Khan (2003) and Anderson (2007), the Compton process can be analysed 
according to quantum-mechanics (double nature of radiation), i.e., considering the interaction 
between two particles, photon and electron. The expressions that relate the energy transferred 
and the scattering angle for the resultant particles can be derived by applying the laws of 
conservation of energy and momentum, as shown below in equations 2.17., 2.18. and 2.19. 
(Templeman, 2000; Attix, 2004). Since the energy and momentum are conserved in this 
process, the energy of the incident photon, hv, is equal to the sum of the energy of the scattered 
Incident photon, E=hѵ 
Scattered photon, E’=hѵ’ 





photon, hv’, and the kinetic energy of the recoil electron, T (Bushberg et al., 2002; MIT OCW 
NSE, 2007a; NDT Resource Center, 2007). 
Scattered photon energy:                              ℎѵ′ =
ℎѵ
1 + 𝛼(1 − 𝑐𝑜𝑠 𝜃)
                               Eq. (2.17) 
Recoil electron energy:                                  T = ℎѵ − ℎѵ′                                                    Eq. (2.18) 




2 is the electron rest mass, 0.511MeV. 
Scattering angles between 0° and 180° are possible. Therefore, the energy transferred to the 
recoil electron may vary from zero to a value near to the maximum photon energy. This energy 
shift depends on the angle of scattering and not on the nature of the scattering medium (NDT 
Resource Center, 2007). 
The incident photon can be deflected from its original direction, with ranges from 0° (forward 
scattering) to 180° (back scattering), whereas the recoil electron may have a scattering angle 
with ranges from 0° to 90° (Podgorsak, 2010). When the incident photon interacts directly with 
the orbital electron, the electron is scattered in a forward direction and the scatter photon travels 
in a backward direction, resulting in a backscattering collision with φ=0° and θ=180°. In this 
case, the electron receives maximum energy Tmax, and the scattered photon is deflected with 
minimum energy hѵ’min. Consistent with Khan (2003), replacing φ=0° and θ=180° in equations 
2.17 and 2.18, one can obtain:  
Maximum recoil electron energy:                        𝑇𝑚𝑎𝑥 = ℎѵ
 2𝛼
1 + 2𝛼
                                 Eq. (2.20) 
Minimum scattered photon energy:                   ℎѵ′𝑚𝑖𝑛 = ℎѵ
 1
1 + 2𝛼
                              Eq. (2.21) 
 
On the contrary, if the incident photon makes a grazing hit with the orbital electron, this is 
scattered in the perpendicular direction of the incoming photon, φ=90°, whereas the scattered 
photon goes in the forward direction, θ=0°. In this situation, the recoil electron does not receive 
any energy and the scattered photon receive the maximum energy, T=0 and hѵ’=hѵ (Khan, 
2003; MIT OCW NSE, 2007a). This last type of interaction is of little significance in terms of 
biological consequences or shielding, since the recoil electron does not have any energy and 
therefore do not cause damage to the surrounding tissues (Stabin, 2007).  
However, the amount of energy transferred to the recoil electron varies with photon energy. 
Using the relativistic quantum mechanical Klein-Nishina formulation, which considers the 
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electron at rest and unbound, and is used for photons energies higher than 100keV, it is possible 
to determine the relative probability of each energy transfer. Consequently, one may also 
determine the average fraction of the incident energy given to the electron, which is relevant for 
dosimetric calculations since it contributes to the dose (Johns & Cunningham, 1983; Attix, 
2004; Stabin, 2007). The total Klein-Nishina cross section or the Compton collision cross 
section per electron gives the probability of a photon interact with a “free electron” of the 
medium by Compton scatter (Turner, 2007; Podgorsak, 2010). This Compton scattering 
probability, symbolized by eσ, is independent of atomic number Z considering that the electron 
binding energy is assumed to be zero (Khan, 2003; Attix, 2004; MIT OCW NSE, 2007a). 
In general, the probability of Compton scattering to occur, decreases with the increasing photon 
energy and with the increasing atomic number of the medium. As a result, the Compton 
scattering is a predominant mode of interaction in low atomic-number media (Stabin, 2007). If a 
Compton scattering interaction takes place for low-energy photons (10 to 100keV), just a small 
amount of energy is transferred to the medium and the main part of it is merely scattered. 
Whereas for high-energy photons, above 10MeV, almost all of the energy is transferred to the 
recoil electron and a fractional part is scattered (Johns & Cunningham, 1983; Cherry et al., 
2003; Khan, 2003; MIT OCW NSE, 2007a). As the energy of the incident photon increases, 
both scattered photon and recoil electron are dispersed more toward the forward direction 
(Bushberg et al., 2002). According to Heard (2007), the energy distribution of the recoil 
electrons forms a continuum spectrum from zero up to Tmax, which is also known as the 
Compton edge. 
 
PAIR PRODUCTION  
When a photon, with energy greater than twice of the electron rest mass energy (2moc
2), 
interacts strongly with the electromagnetic field of an atomic nucleus, a pair-production 
interaction may occur. In this interaction, the photon is completely absorbed and its energy is 
converted into matter, together with the production of a pair of particles, an electron and a 
positron. Both particles tend to be emitted in a forward direction relatively to the incident 
photon. The remaining energy (hv-1.022) is shared between the particles as kinetic energy. The 
inverse process, namely the conversion of mass into energy, takes place when the positron, at 
rest, quickly annihilates with another electron of the medium, producing two photons, each one 
with 0.511MeV, emitted in opposite direction by conservation of momentum, as seen in figure 
2.8. (Sprawls, 1993; Khan, 2003; Joseph, 2006). The probability of a pair production event to 
occur, increases with the increasing of the atomic number approximately as Z2, as well as with 








The relative importance of the photoelectric effect, Compton scattering and pair production, 
depends both on the incident photon energy, hѵ, as on the atomic number, Z, of the absorbing 
medium, as seen in figure 2.9. The curves delimit the regions in which each interaction 
predominates and where two kinds of interactions are equally probable. As previously stated, 
the photoelectric effect is dominant at lower energies and the pair production at higher energies. 
Compton Scattering takes over at medium energies but for low-Z media, such as soft tissue or 
water, the region of this interaction is very broad (dashed line), being this the main interaction 
in imaging diagnosis and therapy in nuclear medicine (Advanced Laboratory of Physics, 2001; 
Attix, 2004). 
 
Figure 2.9. Relative importance of Photoelectric effect, Compton scattering and Pair production over a 
wide range of energy, hѵ, of the incident photons and atomic numbers, Z, of the attenuating material 











































The incident photon interacts with the absorber medium by only one of the three (or more, not 
mentioned in this work) processes referred before. Each type of interaction has a probability to 
occur, proportional to the cross section of that process. Therefore, according to Johns and 
Cunningham (1983), the probability of an interaction is proportional to the sum of the individual 
cross sections of each type of process. This probability is represented by the macroscopic 
attenuation coefficient or total linear attenuation coefficient (μ), written as the sum of the 
individual linear attenuation coefficients for each type of interaction (Bushberg et al., 2002; 
Attix, 2004; Turner, 2007; Podgorsak, 2010) 
𝜇 = 𝜏 +  𝜎 +  𝜅     Eq. (2.22) 
Where τ, σ, and κ denote, respectively, the linear attenuation coefficients for the photoelectric 
effect, Compton scattering and pair production. 
It is the total linear attenuation coefficient that governs the distance penetrated by the incident 
photon in the matter (Turner, 2007). The term attenuation refers to the removal of photons from 
a beam, caused by the absorption and scattering of the primary photons (Bushberg et al., 2002). 
A collimated and monoenergetic beam, with initial intensity I0, is attenuated exponentially when 
it passes throughout a slab of material, as a function of the linear attenuation coefficient and 
depth of material, x, such that the intensity is reduced to I, according to the following 
exponential relationship: 
𝐼 =  𝐼0𝑒
−𝜇𝑥     Eq. (2.23) 
The linear attenuation coefficient varies according to the energy of the incident photon, hν, and 
to the atomic number, Z, of the absorber medium or its density. A photon beam is more 
attenuated with the decreasing of the energy photon, with the increasing of the atomic number 
as well as with the increasing thickness of the absorber (MIT NSE, 2005; Bushberg et al., 2002; 
Stabin, 2007). 
It is noted that, contrary to the charged particles, when I falls off exponentially, no specific 
range [cm] to photons may be described (MIT NSE, 2005). However, the distance travelled 
before an interaction may be predictable as the inverse to the attenuation coefficient (Sprawls, 




2.1.4. Electron Interactions and Bremsstrahlung Photons Production 
In this section only the electron interactions will be referred, since the present dissertation 
comprises the study of the radionuclide therapy with pure beta-minus emitters, i.e., electrons 
emitters. Contrary to the photons, electrons and positrons (described as light charged particles) 
are responsible for the dose in the patient. 
In case of electrons, produced either by decay of pure beta emitter’s radionuclides or produced 
by photons interactions, they release all their kinetic energy in the surrounding medium. For this 
reason, in radiation dosimetry the main concern regards to the energy absorbed per unit mass of 
the absorbing medium (Podgorsak, 2010). It is the parameter stopping power, the one used to 
describe the average rate of energy loss per unit of path length, x, by a charged particle of type Y 
with kinetic energy T, when it travels throughout a medium of atomic number Z. The stopping 
power is represented by the following equation (Attix, 2004). 
𝑆 = (𝑑𝑇 𝑑𝑥⁄ )𝑌,𝑇,𝑍      Eq. (2.24) 
The stopping power, S, may be also represented by taking into account the density, ρ, of the 
material penetrated by the charged particle. In this case the stopping power is divided by the 
density of the absorbing medium, resulting in a quantity called mass stopping power, which is 
represented by S/ρ [MeV.cm2/g] (Attix, 2004; SNMMI, 2012). 
An electron may interact with one or more orbital electrons or with the nucleus of practically 
every atom it encounters, as it penetrates into matter. These interactions are mediated by the 
Coulomb force between the electric field of the traveling particle and the electric field of the 
orbital electrons or atomic nuclei of the material (Khan, 2003). When an electron interacts with 
another orbital electron, a collisional loss occurs. Whereas, when an electron interacts with a 
nucleus of the absorber the result is a radiation loss. Those two mechanisms of energy transfer 
by the electron to the medium are shown in figure 2.10. (Podgorsak, 2010). 
 
Figure 2.10. Electrons depositing energy 
through collisional and radiative losses 
when interact with the surrounding matter 
(Adapted from MIT OCW NSE, 2007b) 
 
 
e- (high kinetic energy) 
e- (delta ray) 
 








As a result, the total mass stopping power ((S/ρ)tot) corresponds to the sum of two components: 
the mass collision stopping power ((S/ρ)col), resulting from electron–orbital electron interactions 
(atomic excitations and ionizations), and the mass radiative stopping power ((S/ρ)rad), resulting 
from electron–nucleus interactions (bremsstrahlung production) (Turner, 2007; Podgorsak, 
















    Eq. (2.25) 
 
COLLISIONAL LOSSES 
The collision stopping power theory is based on quantum mechanical and relativistic concepts. 
It is further subdivided into two components: the soft collision and the hard collision. 
A soft collision interaction occurs when the electron passes from a considerable distance from 
an atom. The influence of the electron Coulomb force field affects the atom as a whole and may 
cause atomic polarization (distorting), excitation (when an orbital electron absorbs energy and 
moves into a higher energy state), or even ionization (by ejecting a valence shell electron, which 
is less common). 
In the soft collisions, only a small fraction of energy (a few eV) is transferred to the bound 
electron. However, the number of these interactions is large and therefore half of the energy 
transferred to the medium occurs through the soft collisions (Attix, 2004; Podgorsak, 2010). On 
the other hand, a hard collision occurs when the electron interacts directly with a single orbital 
electron, which is ejected from the atom as a delta (δ) ray or as a secondary electron with 
significant amount of energy. It should be noted that characteristic x-rays and/or Auger 
electrons may be emitted as consequence of the fill in the vacancy by another electron from a 
higher energy shell. Although hard collisions are just a few compared to soft collisions, the 
fraction of energy transfer by these two processes are generally comparable. Since δ rays are 
energetic enough, they are able to undergo their own Coulomb interactions. These interactions 
occur along a considerable distance away from the primary particle track, forming, thus, 
secondary particles tracks (Attix, 2004; Stabin, 2007; Podgorsak, 2010). 
The energy transferred to the medium through ionizations and excitations by the primary 
electron or δ-rays is responsible for the absorbed dose on the patient. This fact implies that the 
calculus of the energy absorbed per unit mass (mass stopping power), necessary to dosimetric 
purposes, encompasses the collision losses of the primary electron along with the additional 
interactions caused by the δ-rays (Sprawls, 1993; Martin & Sutton, 2002; Khan, 2003; Stabin, 
2007; Turner, 2007; Podgorsak, 2010). 
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In this way, according to Evans (1955) and Kase and Nelson (1978) (quoted in Attix, 2004) the 
total mass collision stopping power for electrons (soft collision stopping power plus hard 
collision stopping power), derived from the Bethe’s soft collision formula with a hard-collision 
































+ 𝑙𝑛 (1 +
𝜏
2
) + 𝐹−(𝜏) − 𝛿]  Eq. (2.27) 
𝐹−(𝜏) = (1 − 𝛽2)[1 + 𝜏2 8 − (2𝜏 + 1)𝑙𝑛2⁄ ]  Eq. (2.28) 
Where Z and A are, respectively, the atomic and mass numbers of the material, τ=T/m0c
2 is the 
kinetic energy T normalized to the rest mass of the electron, re is the classical electron radius 
equals to 2.818x10-13cm, β=ѵ/c is the electron velocity normalized to the speed of light, I refers 
the mean ionization/excitation potential of an atom of the absorbing medium and δ is the 
density-effect correction or polarization correction, introduced by Ugo Fano (1960) (Attix, 
2004; Podgorsak, 2010). 
Equation 2.27, shows that collisional losses are dependent of the velocity of the particle, i.e., the 
collisional lose increases as the electron’s velocity decreases. Also, the factor Z/A, makes the 
mass collisional stopping power to be dependent of the number of electrons per unit mass of the 
absorber. Therefore, if Z increases, the number of electrons per gram declines, and 
consequently, the stopping power decreases (Heard, 2007; Podgorsak, 2010). 
Stopping powers calculated from the Bethe equation are available from a National Institute of 
Standards and Technology (NIST) database and ICRU Report 37 for electron energies from 
10keV to above (Berger et al, 2005; Heard, 2007). 
 
RADIATIVE LOSSES (BREMSSTRAHLUNG PRODUCTION) 
When the electron’s Coulomb force field interacts with the external nuclear field, elastic or 
inelastic scattering may occur, with a change in the electron’s direction. In almost 97-98% of 
the interactions, the electrons are deflected elastically by the nucleus, losing only an 
insignificant amount of kinetic energy to satisfy the conservation of momentum. In this case, 
there is no transfer of energy to the medium but just a defection of the electron, reason why the 
electrons follow very tortuous paths (Attix, 2004). 
According to Attix (2004) only 2-3% of the scattering interactions are inelastic. In this case, the 
electron, at high speed, passes close enough to the static external field nucleus and undergoes a 
change in acceleration. According to the classical theory, when the electron suffers a deflection 
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from its path with a change in its velocity, it emits electromagnetic radiation, called 
bremsstrahlung, from the German word for “braking radiation”, whose amplitude is 
proportional to the deceleration (Evans, 1955; Attix, 2004). The larger the change in 
acceleration is, the more energetic the bremsstrahlung photon becomes (MIT OCW NSE, 
2007b; Stabin, 2007). Therefore, the electron may radiates any amount of energy from zero up 
to its total kinetic energy, Tmax, obtaining, thus, a continuum spectrum of energies (similarity 
with figure 2.3. relative to the spectrum of beta particle) (Evans, 1955). The classical description 
of bremsstrahlung production is shown in figure 2.11. (Bushberg et al., 2002). 
 
Figure 2.11. Electron–nucleus interaction with bremsstrahlung production (classical description) 
(Adapted from MIT OCW NSE, 2007b) 
 
The probability of occurrence of bremsstrahlung production is given by Koch & Motz (1959) by 
complex formulas established for the electron kinetic energy and the medium. Their paper 
(Koch & Motz, 1959) is based on the quantum mechanical description of bremsstrahlung 
production, which differs from the classical theory. In quantum-mechanical theory, developed 
by Bethe and Heitler (Becker-Szendyl et al., 1993; Podgorsak, 2010), the electron - represented 
by a plane wave, interacts with the nucleus filed and is scattered from it accompanied with a 
very small but finite probability of photon emission. In contrast with the classical description 
which predicted the emission of bremsstrahlung in every collision in which the electron is 
deflected (Evans, 1955). 
However, in both theories the cross section for emission of bremsstrahlung, σrad, has the same 
form. Generically, this probability per atom is proportional to Z2, and it also depends on the 
inverse square of the mass of the particle, for a given particle velocity. For this reason, 
bremsstrahlung production by heavy charged particles is negligible or insignificant when 












Likewise, the bremsstrahlung production increases with the kinetic energy and the atomic 
number Z. Thus, high-Z materials provide a considerably greater bremsstrahlung production 
than low-Z materials, such as tissue (MIT OCW NSE, 2007b). If the electron has a high kinetic 
energy, the bremsstrahlung is mostly emitted in the forward direction relatively to the incident 
electron trajectory, whereas low-energy electrons lead, preferentially, to bremsstrahlung 
emission in a right-angle (between 60° and 90°) to the electron direction (Bushberg et al., 2002; 
Turner, 2007). 
At very high energies (>10MeV), the dominance of radiative over collisional energy losses 
gives rise to electron-photon cascade showers. Therefore, electrons with high energy may 
produce high energy bremsstrahlung photons, which in turn, produce photoelectric effect, 
Compton scattering and pair production, creating thus additional bremsstrahlung photons and 
others electrons, and so on. 
Analogous to the calculus of the rate of energy transfer to the medium by the mass collision 
stopping power, also the rate of energy transfer to the medium by bremsstrahlung is calculated 










𝑇𝑖𝐵𝑟𝑎𝑑    Eq. (2.29) 
Where α stands for the fine structure constant, approximately equal to 1/137 ("coupling 
constant", which measure the strength of the electromagnetic force that governs how electrically 
charged particles and photons interact), re corresponds to the classical electron radius, Z is the 
atomic number of the absorber, Ti matches with the initial kinetic energy of the electron plus its 
rest mass, and Brad is a slowly varying function of Z and T (kinetic energy of electron), with 
values given by table 2.1. (Attix, 2004; Podgorsak, 2010). Seltzer and Berger (1986) have 
provided extensive tables of mass radiative stopping power for a wide range of absorbing 
materials (see Seltzer and Berger, 1986). 
 
Table 2.1. Parameter Brad for some initial kinetic energies of the electrons (Attix, 2004; Podgorsak, 2010) 
Initial Kinetic Energy 




1MeV 10MeV 100MeV 




RADIATION OR BREMSSTRAHLUNG YIELD 
It is possible to calculates the radiation or bremsstrahlung yield, represented by Y(T0) and given 
by the equation 2.30. Y(T0) is the fraction of initial electron kinetic energy (T0) converted into 










𝑑𝑇    Eq. (2.30) 
For heavy charged particles, one considered that Y(T0)≈0. Since the bremsstrahlung production 
increases with increasing of kinetic energy and atomic number Z, the radiation yield also 
increases with increasing of the kinetic energy and Z (Podgorsak, 2010). 
According to Martin and Sutton (2002), Stabin (2007) and Casto (2008) a generalised 
approximation formula to calculate the fraction of electron energy converted to bremsstrahlung, 
f, may be given by the follow equation. 
𝑓 = 3.5𝑥10−4. 𝑍. 𝑇𝑚𝑎𝑥    Eq. (2.31) 
Where Z is the atomic number of the absorber medium and Tmax stands for the maximum beta 
energy, in MeV. However, according to Turner (2007) a problem may be encountered with this 
formula for high values of energies and Z, where the fraction can exceed 1.0, which is not 
possible. Therefore, equation 2.32 given by Turner avoids this possibility. 
𝑓 = (6𝑥10−4𝑍. 𝑇𝑚𝑎𝑥) (1 + 6𝑥10
−4𝑍. 𝑇𝑚𝑎𝑥⁄ )  Eq. (2.32) 
Additionally, Martin and Sutton (2002) estimated the average energy, Eav (Eq. 2.33) of 
bremsstrahlung produced by beta particles with a maximum kinetic energy Tmax, in keV, when 




    Eq. (2.33) 
An estimate of bremsstrahlung yield and the average energy of bremsstrahlung produced may 
give an indication of the potential bremsstrahlung hazard of a specific beta-particle source. 
The bremsstrahlung photons are the only energy detected by the gamma camera in radionuclide 
therapy able to produce an image. However, as it will be seen afterwards, there are some 
difficulties in producing a good image. The bremsstrahlung radiation is also used in the 
radiology diagnostic imaging, but only 1% of bremsstrahlung x-rays are produced and used 




PATH LENGTH AND RANGE 
After an interaction, charged particles transfer only minute fractions of the incident particle’s 
kinetic energy to the absorbing medium. Therefore, it is convenient to think in the light charged 
particles losing its kinetic energy gradually and continuously, along the medium, in a process 
often referred to as the continuous slowing down approximation (CSDA) (Strydom et al., 2005). 
According to Bushberg et al. (2002) the path length of a particle is defined as the real distance 
travelled by the particle, composed by successive ionizations and excitations until it comes to 
rest. In contrast, the range, R, of a particle is defined as the actual depth of penetration of the 
particle in matter, which depends of the particle’s kinetic energy, mass, charge, and on the 
composition of the absorbing medium (density). The range of charged particles increases with 
the energy of the particle and decreases in denser absorbers (Saha, 2013). 
A quantity introduced by Berger and Seltzer is the range in the continuous slowing down 
approximation - CSDA range (RCSDA), which represents the mean path length along the 
particle’s trajectory (Attix, 2004; Strydom et al., 2005). 
Heavy charged particles do not experience radiation losses.They transfer only small amounts of 
energy in each collisional interaction and mainly suffer small angular deflections. Therefore, 
heavy charged particles have an essentially linear path, whereas the electrons have a very 
tortuous path, since they are scattered with very large scattering angles in the elastic collisions 
and radiative losses. Consequently, for light charged particles, RCSDA exceeds the average range, 
?̅?, in an absorbing medium, whereas the straight ionization track of a heavy charged particle 
results in the RCSDA and average range being nearly equal, as shown in figure 2.12. (Evans, 1955; 
Attix, 2004; Podgorsak, 2010). The range is an important parameter for dosimetric purposes 
because it indicates the electron depth dose distribution. 
 
Figure 2.12. Representation of heavy and light charged particle tracks. Heavy charged particles produce 
rectilinear tracks, resulting in the mean path length, RCSDA, and mean range, ?̅?, being essentially equal, 










2.2. Gamma Camera Imaging 
Nuclear medical imaging is based on detecting the radiation emitted by the radiopharmaceutical 
decay after its administration inside the body. The drugs used in diagnostic imaging are labelled 
with gamma or positrons emitting radionuclides. Consequently, nuclear medicine imaging is 
divided into two lines: a) single-photon or gamma-emission imaging, where the emitted 
radiation is x- or γ-rays, detected by the conventional scintillation or gamma camera (2D) or by 
the SPECT (3D), b) or positron-emission imaging, where two gamma rays photons are detected 
by the PET, following the annihilation of the emitted positrons (Singh & Waluch, 2000). 
The present investigation of bremsstrahlung imaging deals, unavoidably, with imaging 
acquisition by the gamma camera or SPECT, which works with the same principles of a gamma 
camera. Therefore, the basic principles and characteristics of the scintillation imaging are 
described in this section. The explanation in this section is carried out based on the more 
common nuclear medicine procedure, diagnostic imaging with monoenergetic gamma emitting 
radionuclides, such as 99mTc. For this reason, a small clarification about the characteristics and 
types of radionuclides used in diagnostic nuclear medicine imaging is also undertaken. The 
characteristics of the radionuclides used in therapeutic procedures and the features of the 
therapeutic nuclear medicine imaging are addressed in the section 2.3. 
 
2.2.1. Radionuclides used in Diagnostic: Characteristics and Applications 
To visualize a specific organ or disease states in the body, a radiopharmaceutical is administered 
(by injection, swallowing, or inhalation) to the patient. A radiopharmaceutical is formed by 
attaching one or more radionuclides with a specific chemical compound with structural or 
chemical properties according to the physiological system to analyse. To determine, in vivo, the 
distribution and physiological behaviour of the radiopharmaceutical, a gamma camera detects 
the photons (x- or γ-rays) emitted from the radionuclide decay (Farstad, 2012). Through the 
measure of the radiopharmaceutical uptake by the gamma camera, it is possible create an image 
from the body or certain organ. The image has functional information at a molecular and 
cellular level that contributes to the determination of health status (Baert & Sartorm, 2006; 
National Research Council, 2007). 
The radionuclides used in nuclear medicine are produced in linear accelerators, cyclotrons or 
nuclear reactors. Each radionuclide has unique properties that make it suitable for certain 
diagnostic or therapeutic purpose (Cherry et al., 2003; National Research Council, 2007). 
When talking in diagnostic nuclear medicine some characteristics of the radionuclides are 
necessary take into account. The first of these is that the radionuclide should ideally be a pure γ-
 
Page 33 
ray emitter, decaying by EC capture or IT, with a define energy within the range of 50-250keV. 
The energy must be high enough to be detected outside the patient and to match the optimum 
scanning range of a gamma camera. The physical half-life, Tp, should be greater than the time 
required to prepare material for injection (minutes to hours). The effective half-life, Te, should 
be short enough to minimise the radiation dose to the patients and long enough than the 
examination time. Ideally, it should be approximately 1.5 times the duration of the diagnostic 
procedure. 
The choice of the pharmaceutical, which is attached to the radionuclide, is also very important. 
The choice must be done according to the place to study to maximise the efficacy of the 
diagnosis and minimise the radiation dose to patient. The radionuclide should have few 
particulate emissions (alpha or beta) and a high abundance of clinically useful photons, with the 
purpose of creating a low dose rate to both patient and personnel. It should be also non-toxic to 
the patient, readily available, easily produced and inexpensive, easy to prepare and with 
appropriate quality control (Sadek, 2003; Mettler & Guiberteau, 2006; National Research 
Council, 2007; Karesh & Lipps, 2010; Ryder, 2012). Some of the mostly radionuclides used in 
diagnostic nuclear medicine are shown in table 2.2. These are applied to diagnose some 
diseases, such as cancer, neurological disorders (e.g., Alzheimer’s and Parkinson’s diseases) and 
cardiovascular disease in their initial stages, permitting earlier initiation of treatment, as well as 
reduced morbidity and mortality (National Research Council, 2007). 
Table 2.2. Physical characteristics of the radionuclides used in diagnostic nuclear medicine (Bushberg et 
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Nearly 95% of the radiopharmaceuticals are used for diagnostic purposes, while the rest is used 
for therapy. According to Heard (2007), gamma cameras are designed primarily for diagnostic 
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nuclear medicine imaging. Since the 99mTc is the main radionuclide used in nuclear medicine, 
the equipment was tuned for energies around this radionuclide. Therefore, the components 
systems and modes of operation of the gamma camera are personalised to detect monoenergetic 
gamma radiation within an ideal energy around 50-250keV, mainly to 140keV (Baert & 
Sartorm, 2006; Heard, 2007; Farstad, 2012). 
 
2.2.2. System Components to Detect the Radiation 
The gamma camera or scintillation camera, invented by Hal Anger in 1958, is an image device 
used in nuclear medicine. The equipment allows obtaining a planar or two-dimensional project 
image of the three-dimensionally distributed radiopharmaceutical. The gamma camera converts 
photons, emitted isotropically by the radionuclide decay in the patient, into light pulses which 
are in turn converted into electric signals. The information derived from those signals indicates 
the original photon’s energy and its position of interaction in the scintillator crystal. The basic 
components of a gamma camera system used in this process are: the collimator, the scintillation 
crystal, a light guide, an array of photomultipliers tubes (PMT), electronic circuits, such as 
positioning circuit, and a pulse-height analyser (PHA), as show in figure 2.13. (Singh & 
Waluch, 2000; Heard, 2007). 
 
Figure 2.13. Basic components of a gamma camera (Adapted from Singh & Waluch, 2000) 
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The collimator is the first component of the gamma camera after the photons leave the patient. It 
is usually made of lead or a similar high atomic number substance, such as tungsten. In the 
collimator a large array of holes (circular, triangular, square or more frequently hexagonal 
shaped) are close to each other with a narrow lead walls thickness, called septa, separate them. 
The collimator characteristics influence the field of view (FOV) and hence the performance 
characteristics of the gamma camera, such as the spatial resolution and sensitivity. 
The collimator is truly essential. A scintillation camera without a collimator does not generate 
meaningful images. The photons are emitted isotropically after the radionuclide decay and some 
of them escape the patient without interaction, some are scattered within the patient before 
escaping, and some are absorbed within the patient. The only photons desired to create an image 
with valid information are the ones that do not interact within the body and are emitted parallel 
to the axis of the collimator FOV. Therefore, the function of the collimator is to restrict the 
direction of the incident photons reaching the scintillation crystal. The scattered photons that 
escape the patient with a certain angle do not carry the true information. However, they may, 
eventually, be emitted in a perpendicular direction of the collimator FOV and reach the crystal. 
When photons are emitted at oblique angles, the collimator septa stop or absorb the most 
photons, allowing that only the perpendicular photons reach the scintillation crystal (Bushberg 
et al., 2002; Ziessman et al., 2006). 
Most of the emitted photons are absorbed by the collimators and only a minute fraction has 
appropriated trajectories. According to Ziessman et al. (2006), less than 1% of emitted photons 
are used to generate the desired image, being the others 99% “wasted”. Even though, 35% or 
more events recorded by the gamma camera come from Compton-scattered photons which 
escape perpendicularly to the collimator face or can pass through the septa, degrading the spatial 
resolution of the image. Thus, the collimator is the “rate limiting” step in the imaging chain of 
gamma camera technology, influencing the performance characteristics of the imaging system. 
There are two basic types of collimators: the pinhole and multihole (Attix, 2004; Mettler & 
Guiberteau, 2006). 
A pinhole collimator has a conic form (20-25cm of height and 3-5mm of aperture) with only 
one hole at the end. This type of collimator was created to small organs, such as thyroid and 
bones of the hand and feet, because this collimator offers the advantage of image magnification, 
providing a high image resolution. However, beyond the focal point, the image orientation is 
reversed. The image is magnified when the distance from source to pinhole aperture is smaller 
than the collimator cone length to the aperture. The magnification decreases when the distance 
source-aperture increases. The major disadvantage of the pinhole collimator is the poor 
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sensitivity, which means that only a small percentage of the photons can pass through this 
collimator. Also, certain distortion is possible in the image because of the magnification 
produced (Bushberg et al., 2002; Cherry et al., 2003; Ziessman et al., 2006).  
On the other hand, a multihole collimator is set up by an array of multiple holes, which may be 
aligned in a diverging, converging or parallel manner. 
A converging-hole collimator has holes converging to a unique point in front of the collimator, 
usually at 40-50cm away. This convergence forms a magnified image in the crystal, and 
therefore, it is mostly used in paediatric nuclear medicine. The magnification increases as the 
object is moved away from the collimator. However, since magnification depends on distance 
there is also some distortion in the image. The sensitivity increases as the source (patient) is 
moved away from the collimator face up to the focal point. In contrast, the resolution decreases 
with increasing the distance. Converging collimators are usually used in cameras having large 
detectors to allow a full utilization of the area, for imaging small areas (Cherry et al., 2003; 
Mettler & Guiberteau, 2006). 
Contrary to converging collimator, diverging-hole collimator has holes and septa diverging 
from the crystal face, usually from a point 40-50cm behind the collimator. It produces a 
minified image in which the amount of minification increases as the object is moved away from 
the camera. This collimator allows a decreasing in the image size on the crystal, whilst the 
imaged area increases. Such as the others collimators referred above there is a small image 
distortion. The sensitivity and resolution decrease when the source is moved away from the 
collimator. A diverging collimator is usually used on cameras with smaller detectors, in order to 
large organs of a patient, such as liver or lungs, be imaged on a single view (Bushberg et al., 
2002; Cherry et al., 2003). 
The parallel-hole collimator is the most commonly used collimator in nuclear medicine. This 
collimator contains thousands of parallel holes, usually in a hexagonal form. There is no 
magnification when the parallel-hole collimator is used. Thus, the image created has the same 
size as the source distribution onto the scintillation crystal (Cherry et al., 2003). The 
characteristics of the parallel-hole collimators, such as septal thickness, septal length and size of 
the collimator hole, are chosen according to the energy of the radionuclide being imaged, to 
prevent photons with high energy cross the holes and reach the crystal septal. Figure 2.14 shows 





Figure 2.14. Types of the gamma camera collimators: a) pinhole collimator, b) diverging-hole collimator, 
c) converging-hole collimator and d) parallel-hole collimator (Adapted from Mettler & Guiberteau, 2006) 
 
As the parallel-hole collimators provide a wide range of specifications, diverging and 
converging collimators are seldom used today. However, a hybrid of the parallel-hole and 
converging collimator, called a fan-beam collimator, is used in SPECT to take advantage of the 




After the photons have passed through the collimator they reach the detector. The detector is a 
scintillation crystal made of sodium iodine activated with thallium, NaI(Tl). The role of the 
crystal is to convert the incident photons into visible light. Scintillators materials have the 
ability to emit visible or ultraviolet light when an excited electron in the scintillator returns to its 
ground state, after a photon-crystal interaction (Prekeges, 2009). The amount of light produced 
is proportional in intensity to the energy of the incident photon (Mettler & Guiberteau, 2006). 
Therefore, the desired event is the complete photoelectric absorption of a primary photon, where 
the energy is completely absorbed. However, the probability of that happen decreases as energy 
increases, since the Compton scattering becomes more likely (Singh & Waluch, 2000; Ziessman 
et al., 2006). 
The sodium iodine crystal has a conversion efficiency of 13%, being considered a highly 
efficient detector. This means that 13% of the deposited energy is converted into light. Since a 












absorbed by the crystal. NaI(Tl) is considered the ideal scintillator for the detection of the 
140keV γ-rays emitted by 99mTc decay. According to Peterson and Furenlid (2011), the 
attenuation coefficient at 140keV (2.64cm-1) is sufficient to reach a good detection efficiency.  
Unfortunately, the scintillation crystal is fragile and hygroscopic, i.e., it absorbs moisture from 
the atmosphere. Therefore, the crystal is surrounded by a highly reflective material to maximise 
light output and hermetically encapsulated with aluminium housing with an optical glass 
window on the back surface of the casing. The glass allows the light reaches the PMTs. It works 
as a light distribution device to spread the scintillation light optimally over more PMTs to 
improve the accuracy of position-decoding calculation (Kim & Yang, 2001; Cherry et al., 2003, 
Mettler & Guiberteau, 2006). 
Crystals may be manufactured with a circular or rectangular geometry and with a variable 
thickness. Usually, a modern gamma camera has a rectangular crystal with 6 to 12.5mm of 
thickness and 25x50cm of diameter, with sizes up to 40x60cm. Currently, the gamma cameras 
to general purpose have a crystal thickness of 9.5mm. The choice of the crystal thickness is a 
trade-off between its detection efficiency and its intrinsic spatial resolution (Cherry et al., 2003), 
as such will be seen in the next section 2.2.3. (Mettler & Guiberteau, 2006, Peterson & Furenlid, 
2011). 
It is important to refer that gamma camera achieves count rates on the order of 105 per second 
since the scintillation light rise time is very quickly and the decay time is short. A schematic 
cross section of a typical NaI(Tl) crystal is shown in the figure 2.15.  
 
Figure 2.15. Schematic cross-section of a NaI(Tl) crystal used in a typical gamma camera (Adapted from 
Cherry et al., 2003) 
 
PHOTOMULTIPLIERS TUBES (PMTs) 
After the conversion of the photons into visible light, the light produced falls on the PMTs. 
Only about 30% of the light from each event reach the PMTs. This electronic device has two 
main functions: it converts the visible light into electrical signals, and it amplifies those signals 
by more than a million times, in order that the electrical signal from each event is large enough 
to be received and processed by conventional electronic circuits (Kim & Yang, 2001). 






Light output to PMTs 
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An array of PMTs is coupled optically behind the NaI(Tl) crystal surface, usually arranged in a 
circular pattern or in a hexagonal pattern to maximise the area of the crystal that is covered. A 
modern gamma camera employs 30 to 100 PMTs, each one approximately 5cm in size. The 
PMTs may be placed directly to the crystal or connected to the crystal by light guides (usually 
quartz). The light guide minimise reflection losses by channelling scintillation light away from 
the gaps between the PM tubes and improves the uniformity of light collection as a function of 
position. The light guide may be eliminated in the cases where a hexagonal array is used, 
assuming there is sufficient spreading of the light in the glass entrance window for an accurate 
positioning (Cherry et al., 2003; Peterson & Furenlid, 2011). 
As shown in figure 2.16., a PMT consists of a glass tube in vacuum (shielded against magnetic 
fields) containing a photocathode, 10 to 12 dynodes, and an anode. 
 
Figure 2.16. Schematic diagram of a typical photomultiplier tube (Adapted from Bushberg et al., 2002) 
 
The photocathode emits electrons when it is struck by visible light. According to Bushberg et al. 
(2002), approximately one electron is emitted from the photocathode for every five light 
photons incident upon it. The electrons are released into the vacuum space of the PMT, directed 
to the first dynode. The dynode multiplies the number of the electron, emitting three to six 
electrons, according to the potential difference of the dynodes. Those accelerated electrons are, 
in turn, accelerated to the next dynode with kinetic energy equal to the potential difference 
between the dynodes. This process continues down the chain of dynodes, with the number of 
electrons being multiplied in each dynode. Usually, a typical PMT has dynodes with 100V of 
voltage, where in each one are released 5 electrons. If a PMT has 10 dynodes the total 
amplification is 510. Finally, the anode collects all the electrons produced and emits an output 
voltage signal. The electric signal amplitude is directly proportional to the amount of light that 
reach the photocathode or to the energy deposited on the crystal. 
The amount of light reaching each PM tube is inversely proportional to the lateral distance 
between the photon interaction site and the centre of that PM tube. Consequently, the signal 














point, i.e., the PMT nearest to the scintillation crystal receives the most scintillation light, 
whereas the PMT further away receives less light (Bushberg et al., 2002; Prekeges, 2009; 
Peterson & Furenlid, 2011). The amplification can be adjusted by changing the voltage applied 
to the PMT. A change of 1% in the high voltage results in a 10% change in the pulse size. 
Therefore, the high voltage supply must be steady and well regulated (Bushberg et al., 2002). 
Although measurable, there is a preamplifier attached directly to the PMT to amplify the signal 
output created, to facilitate the passage of the signal to the remaining electronic circuits. 
 
ELECTRONICS CIRCUITS: POSITION AND SUMMING ENERGY 
The localisation of photon interaction on the crystal and hence in the final image depends on the 
distribution of signal amplitudes in the PMTs. According to Peterson and Furenlid (2011), 
Anger’s original process for decoding the photon interaction position on the crystal involved 
calculate the centroid of the position-weighted PMT signal outputs, a process often referred to 
as Anger Logic or Anger Arithmetic. In older style analog gamma camera the pulses from each 
preamplifier were sent to two different electronic circuits, the positioning and summing circuit. 
The summing circuit added all the signals from each preamplifier to form a pulse known as the 
Z pulse, which is proportional in amplitude to the total energy deposited in the crystal, in each 
event (Saha, 2013). This electrical pulse was analysed by a pulse-height analyser (PHA) to 
verify if Z was within a specific energy range chosen by the operator. If the pulse corresponds to 
a lower or higher energy outside the chosen range it was discriminated against and rejected, and 
the positioning was not accounted for that event (Ziessman et al., 2006). On the other hand, the 
positioning circuit received the output signals from each preamplifier and by determining the 
centroid of these signals the X and Y coordinates of the location of photon interaction in the 
crystal were found (Bushberg et al., 2002).  
In those cameras, all the PMTs were connected through resistors to four outputs leads 
representing four directional signals, X+, X-, Y+ and Y-. The output signal from each PMT were 
weighted by the appropriate resistance value, the PMT closest to the event collected the greatest 
number of light photons with lesser contributions from the far away tubes. The four directions 
were then combined, to form each of the X+, X-, Y+ and Y- individually, as differences 
normalized by sums to give direct position values (Peterson & Furenlid, 2011), i.e., the X-
position was given by the difference in the X+ and X- signals and normalized by the total X 
signal, with the same calculus for the Y-position. The analog X- and Y-position pulses and the 
Z pulse in accordance with the energy range chosen by the user, were then sent to a cathode ray 
tube (CRT). The CRT produced a momentary dot of light in the X and Y position. A 
photographic camera aimed at the CRT recorded the flashes of light forming an image on film, 
dot by dot (Kim & Yang, 2001; Cherry et al, 2003; Saha, 2013). 
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Today, the scintillation cameras might be either hybrid or totally digital. In a hybrid camera, the 
X, Y, and Z pulses from the position and summing circuits are acquired in analog form, as did 
the earlier fully analog scintillation cameras, and then digitalized by analog-to-digital converters 
(ADCs) to digital signals. In turn, digital cameras calculate the position signals and the total 
energy deposited, Z, through a completely digital circuit. The resistors have become 
microprocessors and each PMT has its own ADC being each signal individually digitalized. The 
X, Y, and Z signals are corrected by digital correction circuits and the energy discrimination is 
applied, also in the digital domain. Nowadays, the Anger arithmetic is carried out in software, 
allowing the application of various weighting schemes to framing-up the digital image. 
According to Peterson and Furenlid (2011) the equation 2.33 shows a fairly general form for 
this type of processing with weighting factors of the amount of light regarding the interaction 
position. The approximation position ?̂? and ?̂?, are computed by combining only the PMTs at 
known locations, 𝑥i and 𝑦i which have signals, Si, that exceed a threshold Smin. The functions w 
return just the raw signals Si. 
?̂? =
∑ 𝑥𝑖𝑤𝑖(𝑥𝑖 , 𝑆𝑖)𝑆𝑖≥𝑆𝑚𝑖𝑛
∑ 𝑤𝑖(𝑥𝑖 , 𝑆𝑖)𝑆𝑖≥𝑆𝑚𝑖𝑛
          𝑎𝑛𝑑           ?̂? =
∑ 𝑦𝑖𝑤𝑖(𝑦𝑖 , 𝑆𝑖)𝑆𝑖≥𝑆𝑚𝑖𝑛
∑ 𝑤𝑖(𝑦𝑖 , 𝑆𝑖)𝑆𝑖≥𝑆𝑚𝑖𝑛
                  𝐸𝑞. (2.34) 
This form allows diminishing the noise from the PMTs by excluding some negligible pulse 
amplitudes and also by detecting of multiple events simultaneously, since only some PMTs 
surrounding by the interaction are used, letting the others far away available to detect other 
event (Cherry et al., 2003). At the end, if the sum of the signals Si (Z signal) is within the 
energy acceptance range, the pixel in the computer matrix corresponding to the estimated 
position of the event is incremented, creating thus the final image in the computer (Bushberg et 
al., 2002). Currently, the electronics, such as preamplifiers, PHA, and ADCs are connected 
directly to the PMTs to minimise the signal distortions. 
 
PULSE-HEIGHT ANALYSER (PHA) 
As stated previously, the summing circuit gives the amplitude pulse, Z, which is proportional to 
the amount of energy deposited in the crystal in each event. Since a photon may interact in 
different ways with the crystal, all or just part of its energy could be deposited on it, and 
consequently, the Z pulse could have different values corresponding to a variety of possible 
interaction scenarios. In this way, a PHA is necessary to do a selective counting of only those 
pulses within certain amplitude range of interest. It is useful to discriminate against background 
radiation or scattered radiation with energy outside the desired energy range. The PHA only 
counts the Z pulses that falling within a selected amplitude intervals or energy channels defined 
by the operator, which is usually chosen according to the radionuclide being imaged (Mettler & 
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Guiberteau, 2006, Prekeges, 2009). If this is done for only one amplitude interval at a time the 
device used is a single-channel analyser (SCA), whereas a multi-channel analyser (MCA) is 
used to analyse simultaneously many different intervals, capable to show all radiation events on 
an energy or pulse-height spectrum (Simmons, 1996; Cherry et al., 2003). 
A typical energy spectrum includes several peaks. Given the example of the pulse height 
spectrum of 99mTc, shown in figure 2.17., it is possible to see: a) the photopeak, which 
represents the total energy of the γ-ray (140.5keV) absorbed in the crystal, by photoelectric 
effect; b) the iodine escape peak, resulting from the characteristic K-shell x-rays of iodine (28 to 
33keV) which escape from the crystal after the photon has undergone photoelectric effect, with 
a consequent measured energy of the γ-ray of only 112keV; c) the backscatter peak, which may 
result when primary γ-rays undergo a 180° scattering and then enter into the detector, being 
totally absorbed. The 180° scattering may occur inside the patient, when the photon strikes the 
tissue behind the source and go back into the detector, or if the photon passes through the 
crystal without interact and strike the PMTs back, returning into the crystal; d) the lead x-ray 
peak, which is caused by the detection of the lead characteristics x-rays (75 to 90keV) when the 
photon interacts by photoelectric effect with the shielding or collimator, and e) the Compton 
edge, given by the effect of Compton scattering in the detector with a peak from 0 to 50keV. 
Also, some scattered photons, created inside the patient by Compton scattering, may travel 
toward the detector with energy from 90 to 140keV, which causes imaging difficulties, since the 
Compton scattering overlaps with the photopeak distribution (Bushberg et al., 2002; Mettler & 





Figure 2.17. Energy spectrum of the 99mTc, when it is viewed by the gamma camera as a point source (A) 
and as inside a patient (B). The use of a symmetric window (A) defined by the operator allows some of 
the Compton scatter to be counted and displayed (Adapted from Mettler & Guiberteau, 2006) 
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An energy range covering the photopeak, shown as the shaded area (fig. 2.17.), contains the 
acceptable events that fall within the energy window selected by the operator. The window 
settings are expressed in percentage with values between 10% to 20% window centred 
symmetrically on the photopeak (Prekeges, 2009). A 20% energy window set symmetrically 
over the 99mTc photopeak is equivalent to 140±10%keV or a window spanning 126–154keV 
(IAEA, 2003). It should be noted that X and Y positioning pulses are just accepted if the Z pulse 
is within the energy range selected by the PHA, being discarded if they are outside this range. 
The PHA output pulse is sent to the count register and then to the computer matrix for inclusion 
in the final image. In a typical study the data are collected for pre-set counts or a pre-set time, 
and the image data is storage in computer memory. New computer’s software allows the 
manipulation of image contrast on liquid crystal display (LCD) providing a better view of the 
images to a more accurate diagnostic (Saha, 2013). 
 
2.2.3. System Performance and Factors Affecting the Image Quality 
A gamma camera is not capable of producing “perfect” images of the radionuclide distribution. 
The images obtained by the gamma camera are affected by several parameters intrinsic to the 
gamma camera system, which define its performance and hence the quality and detail existing 
in the final image. Certain inherent limitations arise from the performance characteristics of the 
detector, electronic circuits and collimator. Some of these performance parameters include 
spatial and energy system resolution, system efficiency, uniformity, linearity and dead time. 
 
SYSTEM SPATIAL RESOLUTION 
The spatial resolution of a gamma camera system is a measure of the ability of the device to 
faithfully reproduce the image of the object with proper sharpness and detail, in order of clearly 
representing the variations in the distribution of radioactive objects in close proximity. 
According to Saha (2013) is usually defined as the “minimum distance between two points in an 
image that can be detected by the system”. 
The spatial resolution of a gamma camera is determined by the components of the system. Part 
of the blurring visualized in the images arises from collimator characteristics and part arises 
from the crystal detector and positioning electronics. Therefore, the system spatial resolution, 
Rs, comprises two components: the intrinsic resolution, Ri, which depends on the crystal 
characteristics without the collimator, and the extrinsic resolution, Rc, due to the collimator 





2     Eq. (2.35) 
The smaller the value of Rs, the better the spatial resolution achieved by the system, and hence 
the better the resolution of the image (Saha, 2013). 
The system spatial resolution of the gamma cameras is expressed quantitatively by determining 
the full width at half maximum (FWHM) of a line spread function (LSF). The LSF is a cross-
sectional profile of the image of a line source and is obtained by imaging a line source 
radioactive on the collimator (extrinsic) or on the crystal face (intrinsic). If the system had a 
perfect spatial resolution the LSF would be a single peak. However, a broadened peak, as a bell 
shaped curve, is seen because of the imperfect resolution (spatial and energy) of the detector, 
which follows a normal or Gaussian distribution (Bushberg et al., 2002), as shown in figure 
2.18. 
 
Figure 2.18. Representation of the LSF and the FWHM, which is the distance encompassed by the curve 
halfway down from its peak (Adapted from Mettler & Guiberteau, 2006) 
 
The FWHM of the LSF gives the spatial resolution of the system and it reflects the number of 
the counts detected by the crystal at different lateral distances from the source. The FWHM is a 
measure of the width of the peak at the half height position of the LSF expressed in units of the 
horizontal axis. A narrow peak shape of the LSF indicates a better spatial resolution and 
therefore the ability to resolve objects close to each other (Saha, 2013). 
The intrinsic resolution is the component contributed by the crystal and associated electronics. 
It refers to the ability of the detector localise and record the exact position of an interaction on 
the image. The intrinsic resolution arises from two factors: from the multiple scattering events, 
in which two photons interact with the crystal simultaneously in different places but recorded as 
a single event and the result is a single count mispositioned in the image, and primarily, from 




















(electrons) during the radiation detection process, which produce the broadening peak, as a bell 
shaped curve (Prekeges, 2009). 
The collection of visible light photons and subsequent production of electrical signals by the 
PMTs has significant random errors. Therefore, if N light photons are recorded on average by a 
certain PMT, the number recorded from one event to the next varies with a standard deviation 
given by √N. According to Cherry et al. (2003), it is possible verify this fluctuation by visualize 
on the image a blur created around the central peak when a narrow point source is imaged. The 
position of each event is distributed over a certain area with a certain size, which differs 
according to the magnitude of the statistical fluctuations. 
Intrinsic resolution depends of the energy of the radionuclide imaged, as well as of the detector 
thickness. Intrinsic resolution improves with higher-energy photons and becomes worse for 
low-energy photons. This is because lower energy photons produce fewer light photons per 
scintillation event, and a smaller number of light photons results in higher random errors and 
vice-versa (Mettler & Guiberteau, 2006). Therefore, the FWHM will be larger for lower-energy 
photons than for higher-energy photons. 
On the other hand, the intrinsic resolution decreases with thicker NaI crystals and becomes 
better with thinner detectors. A thinner crystal permits less spreading of the scintillation light 
photons before they reach the PMTs and also reduces the likelihood of detecting multiply 
Compton-scattered events. However, despite of the thinner crystals increase the spatial 
resolution, the efficiency of the photons detection decreases, since less photons are absorbed. 
Consequently, there is a trade-off between resolution and efficiency. Currently, the 9.5mm 
crystal thickness used on the most detectors is considered with intermediate and appropriate 
values of resolution and efficiency (Simmons, 1996; Saha, 2013). 
Likewise, the intrinsic resolution is improved by increasing the number of PMTs and decreasing 
their diameter, in order to provide better sampling of the light emitted following each 
interaction. A narrow PHA window setting also helps to improve the intrinsic resolution, 
because background and scattered radiation are avoided (Singh & Waluch, 2000; Bushberg et 
al., 2002; Mettler & Guiberteau, 2006; Ziessman et al., 2006; Saha, 2013). In modern gamma 
cameras, the intrinsic resolution (collimator off) approaches 2.7 to 4.2 mm FWHM (Bushberg et 
al., 2002). 
In most practical situations, however, the intrinsic spatial resolution has a negligible 
contribution to the overall system resolution comparison with the resolution of the collimator, 
i.e., the extrinsic resolution. 
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The extrinsic resolution, also called collimator or geometric resolution, contributes the most to 
the system spatial resolution and arises from the geometry of the holes and hence from the 




     Eq. (2.36) 
Where d is the hole diameter, b is the distance between the collimator face and the radioactive 
source, c is the distance between the back face of collimator and the midplane of the detector, te 
is the effective length of collimator holes (given by te=t-2μ
-1) and t is the septal length or 
thickness of the collimator (Saha, 2013), such as shown in figure 2.19. 
 
Figure 2.19. Schematic representation of a 
parallel-hole collimator, with length or collimator 
thickness t, hole diameter d, septal thickness a and 
source-to-collimator distance b. The collimator 
midplane is represented by c. Rc is the collimator 
resolution (Adapted from Saha, 2013) 
 
 
From the equation 2.36., it is possible to realise that the collimator resolution is improved by 
increasing the length (t), decreasing the diameter (d) of the holes and also decreasing the source-
to-collimator distance (b). The collimator spatial resolution is degraded (i.e., FWHM of the LSF 
increases) as the source-to-collimator distance increases for all types of collimators. This is one 
of the most important factors in image acquisition and for that reason the patients should be 
placed as close as possible of the collimator to provide the best resolution (Bushberg et al., 
2002). 
Septal thickness is also an important parameter on the collimator design, since the septal 
penetration by photons degrades the resolution, mainly for high-energy photons which easily 
penetrate the septa and interact with the detector blurring the image. No thickness of septal 
material is sufficient to stop all the γ-rays. So according to Cherry et al. (2003) and Saha (2013), 
the rule of thumb is to accept some reasonably small level of septal penetration, approximately 
5%. Therefore, low-energy photons are stopped by using a collimator with a thinner septa, 
whereas high-energy need much thick septa. Also, materials with a large value of μ, high atomic 
number Z and high density ρ are preferred for the collimator septa (Simmons, 1996).  
The septal length may be modified. However, there is an inherent compromise between the 
spatial resolution and efficiency (sensitivity) of the collimators when the septal length is 










collimator has a smaller acceptance angle resulting in more absorbed photons, whereas shorter 
septa result in lower spatial resolution and higher sensitivity (Mettler & Guiberteau, 2006). 
Thus, there is a trade-off between spatial resolution and count rate sensitivity. This compromise 
is the single most significant limitation on scintillation camera performance (Bushberg et al., 
2002). Figure 2.20., shows the different parallel-hole collimators with variations on the septal 
thickness and length. 
  
  
Figure 2.20. Effect of the septal thickness and length in parallel-hole collimators. Different septal 
thickness and length influence the sensitivity and resolution of the collimator: a) thickness septa used to 
stop low energy photons, b) thickness septa used to stop high energy photons, c) longer septa attenuate 
more photons, increasing the resolution and decreasing the sensitivity, and d) smaller septa allow more 
photons reach the crystal increasing the sensitivity but decreasing the resolution (Adapted from Mettler & 
Guiberteau, 2006) 
 
Due to this compromise between sensitivity and spatial resolution, most scintillation cameras 
are provided with a selection of parallel-hole collimators with different septal length and 
thickness, according to the necessary specifications. These may include: low-energy, general-
purpose (LEGP), low-energy, high-resolution (LEHR) (with a few tenths of a millimetre septal 
thickness and used to a maximum of energy of 150keV), medium energy, general-purpose 
(MEGP) (with few millimetres septal thickness and used for 67Ga and 111In, up to 300keV), 
high-energy, general-purpose (HEGP) (for 131I) and ultrahigh-energy (for 18F) collimators, for 
imaging the 511keV photons of positron emitters (Mettler and Guiberteau, 2006; Ziessman et 
al., 2006). Some properties and values of the parameters used in those collimators are given in 
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Table 2.3. Features and properties of different types of parallel-hole collimators, calculated at 10cm of 




















LEGP 1.43 23.6 0.2 9.1 360 ≈140 
LEHR 1.11 23.6 0.3 7.5 230 ≈140 
MEGP 3.02 40.6 1.1-1.4 12.1 288 ≈280 
HEGP 4.32 62.8 1.3-3.0 13.8 176 ≈360 
Ultrahigh 
energy 
3.4 75.0 3.0-4.0 10.4 60 ≈511 
 
SYSTEM SENSITIVITY 
Another parameter that influences the gamma camera performance is the sensitivity or 
efficiency, which has been enunciated so far. The efficiency refers to the detected count rate per 
unit of activity present in a source and it is usually related with the images contrast (difference 
in the grey scale of the image). It is normally expressed in counts per second per MBq [cps/ 
MBq]. Such as the resolution, also the sensitivity arises from two components: the extrinsic 
sensitivity, associated with the collimator efficiency, and intrinsic sensitivity, associated with 
the crystal efficiency (Heller & Zanzonico, 2011). 
The sensitivity of the gamma camera is mostly affected by the collimator efficiency. The 
extrinsic sensitivity, also known as collimator efficiency or geometrical efficiency (Ec), is 
defined as the number of photons passing through the collimator holes per unit activity present 
in a source. For parallel-hole collimators, the geometrical efficiency is given by the follow 






    Eq. (2.37) 
Where d is the hole diameter, te the effective length of the collimator hole, a the septal thickness 
and k is a function of the shape and arrangement of holes in the collimator (≈0.24 for round 
holes, ≈0.26 for hexagonal holes, ≈0.28 for square holes) (Cherry et al., 2003). Geometrical 
efficiency is affected by changes in the septal thickness, septal length and hole diameter. The 
efficiency increases with the diameter of the collimator holes (d) and decreases with increasing 
collimator length (t) and septal thickness (a), which is quite opposite to the spatial resolution. 
Therefore, as the collimator resolution of a system increases, its sensitivity decreases and vive-
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versa. Note that, the collimator efficiency is not affected by the source-to-detector distance in 
contrast to the extrinsic resolution (Bushberg et al., 2002). 
On the other hand, the intrinsic sensitivity (collimator off), which is the fraction of photons 
reaching the detector, is determined by the thickness of the crystal and the energy of the incident 
photons. Intrinsic efficiency becomes better for thicker crystal and higher-energy photons. 
However, when intrinsic efficiency increases and consequently the image contrast, the intrinsic 
spatial resolution decreases. Once again, there is a trade-off between intrinsic efficiency (which 
improves with thicker crystals and lower-energy photons) and intrinsic spatial resolution (which 
improves with thinner crystals and higher-energy photons). 
The contrast in nuclear images (planar images, SPECT, and PET), which are maps of the spatial 
distribution of the radiopharmaceutical in the patient, depends on the tissue's ability to 
concentrate the radioactive material. The contrast is improved with increasing administered 
activity. Nevertheless, according to Heard (2007), in diagnostic imaging the image quality is 
limited by dose limitations and patient tolerance, and therefore it is important to optimize 
sensitivity in order to reduce the dose and the image noise. Currently, the gamma camera is 
designed to provide acceptable intrinsic efficiency while maintaining high intrinsic spatial 




The energy resolution is an extremely important performance parameter of the gamma camera. 
It is a measure of a gamma camera ability to distinguish between interactions depositing 
different energies in the crystal. In broad terms, the purpose of the energy resolution is to 
discriminate the primary radiation from the scattered radiation with lower energy. PHA is the 
only option available to discriminate primary photons from scattered ones. If the energy 
resolution of the gamma camera is gradually improved, consequently the energy window width 
has to be decreased accordingly (Saha, 2013). 
The energy resolution is generally calculated by the FWHM and expressed as a percentage of 
the photopeak energy of the bell-shaped curve. The energy resolution is given by the following 
equation (Bushberg et al., 2002). 
𝐸𝑛𝑒𝑟𝑔𝑦 𝑅𝑒𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (%) =
𝐹𝑊𝐻𝑀
𝑃𝑢𝑙𝑠𝑒 ℎ𝑒𝑖𝑔ℎ 𝑎𝑡 𝑐𝑒𝑛𝑡𝑒𝑟 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑝𝑒𝑎𝑘
𝑥100%  Eq. (2.38) 
A small value of energy resolution indicates better gamma camera ability in to reject scattered 
photons, and consequently a better system spatial resolution is reached. The inadequate energy 
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measurement by the gamma camera, results from the statistical uncertainties in the detection 
process. This fact causes random amplitude pulses around the mean pulse height, giving a peak 
broadening with a Gaussian shape. For a Gaussian distribution the position of the mean (peak 
centre) and the FWHM are related to the standard deviation (σ) by (Bushberg et al., 2002):  
𝐹𝑊𝐻𝑀 = 2.36𝜎    Eq. (2.39) 
A broadened Gaussian shape with a wider FWHM implies poorer energy resolution resulting in 
a worse image quality. Currently, the energy resolution is typically of the order of 10% for 
99mTc (Heller & Zanzonico, 2011), varying according to the incident photon energy. 
 
UNIFORMITY AND SPATIAL LINEARITY 
Uniformity is a performance characteristic of a scintillation camera which measure the camera's 
response to a uniform irradiation (flood field uniformity) of the detector surface, that is, when it 
is flooded with a spatially uniform flux of incident photons. Flood field uniformity may be 
quantified intrinsically, when the uniformity is exhibited by the detector itself (intrinsic 
uniformity) or extrinsically using the collimator (extrinsic uniformity). The ideal response is a 
perfectly uniform image throughout the FOV, that is, a point source counted at different places 
in the FOV should give the same count rate by the detector at all locations (IAEA, 2009a). 
However, the detector response is not consistent over the entire FOV. This nonuniformity in 
detector response may arise from several factors, such as failure or damage of the PMTs, poor 
coupling between the PMTs and light guide, spatial non-linearities, defects in the crystal, 
incorrect setting of the position or width of the PHA window. Acceptable field nonuniformity is 
on the order of 2% to 5%. Much of this can be corrected by the computer system, through 
uniformity correction software (Bushberg et al., 2002; Mettler & Guiberteau, 2006; IAEA, 
2009a; Saha, 2013). For example figure 2.21., shows three images (30 million counts in each 
image for 99mTc) with different intrinsic uniformity as the window width (PHA) decreases. 
Uniformity can be slightly degraded as the energy window width decreases (IAEA, 2003). 
 
20% symmetric energy window. 
 
15% symmetric energy window 
 
10% symmetric energy window 
Figure 2.21. Comparison of the intrinsic uniformity in three images as the window width is decreased 
(Adapted from IAEA, 2003) 
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On the other hand, spatial distortion or linearity, is a performance characteristic of a 
scintillation camera which measure the camera's ability to represent the shapes of the objects 
accurately. Spatial nonlinearity is caused by the non-random mispositioning of events, i.e., 
systematic errors in the positioning of X- and Y-coordinates over the FOV and it can be 
estimated by inspecting the image of a linear object. If severe spatial displacements occur, the 
uniformity will be poor in the same areas. 
It is notable that the spatial distortion and flood field uniformity are closely related and the 
factors that affect the linearity are the same as those listed for flood field uniformity. Currently, 
modern cameras have digital circuits that use tables of correction factors to correct X- and Y-
position signals for spatial nonlinearity (Bushberg et al., 2002; Saha, 2013). 
Figure 2.22 shows an intrinsic image of the National Electrical Manufactures Association 
(NEMA) slit phantom pattern of a point source of 99mTc, which shows a distinct nonlinearity of 
the lines and hence a loss of spatial resolution (IAEA, 2003). 
 
Figure 2.22. Nonlinearity of the NEMA slit phantom pattern (Adapted from IAEA, 2003) 
 
According to Heard (2007), a combination of PMTs tuning and correction maps are used to 
ensure linear and uniform images, improving, thus, the spatial resolution and consequently the 
quality of the image. 
 
COUNT RATE AND DEAD TIME 
Any scintillation system takes a certain time to process an event and remain inoperable to 
receive a second event during this period of time, which is called dead time. If a second 
interaction occurs in this time the event is not counted, occurring a losing on the system 
sensitivity. On the other hand, the gamma camera may detect two or more events 
simultaneously, if they occur too close together in time. As a consequence, the photons are 
counted as one with the signal equal to the sum of the amplitudes of each one of them. This is 
referred to as pulse pileup. If the final signal is within the PHA window the two photons appears 
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as a photon of interest with consequent losing in the spatial resolution. Contrary, if the signal 
falls outside the PHA window the sensitivity of the system is diminished. Dead time loss at high 
count rates is a serious problem for any counting system, mainly in the scintillation cameras due 
to pulse pileup. Currently, there are several methods implemented in gamma camera systems to 
determine or correct the dead time (Mettler & Guiberteau, 2006; Saha, 2013). 
The next table encompasses all the performance characteristics explained so far and indicates 
some typical values of intrinsic performance parameters of a gamma camera with 9.5mm 
thickness detector (Bushberg et al., 2002). 
Table 2.4. Typical intrinsic gamma camera performance characteristics (Bushberg et al., 2002) 
Intrinsic Spatial Resolution (FWHM of LSF for 140keV) 2.7mm to 4.2mm 
Energy Resolution (FWHM of photopeak for 140keV) 9.2% to 11% 
Uniformity 2% to 5% 
Absolute Spatial Linearity Less than 1.5mm 
Observed maximal count rate (measured without 
scattered) 
170000 to 500000 counts/sec 
 
2.2.4. Modes of Image Acquisition 
There are numerous parameters that must be decided before starting the image acquisition on a 
gamma camera, which will affect the exam and consequently the data collected, such as the scan 
duration, the sampling frequency (pixel size and number of views), the energy window, the 
collimator characteristics and the type of image and data acquisition (Heard, 2007). Currently, 
the data acquisition, and the procedures after it, such as, data processing, image display and 
manipulation, data storage and system control, are carried out by digital computers and may be 
acquired and stored in one of two ways: (a) frame mode and (b) list mode. 
 
FRAME MODE ACQUISITION 
Frame mode is the most common practice in nuclear medicine. In this type of acquisition the 
incoming data are placed in a spatial matrix used to generate an image. The matrix size, formed 
of pixels, is chosen according to the area of the detector and all the pixels are set to zero. This 
means that each spatial position X and Y corresponds to a pixel position in the matrix. 
Therefore, a digital X and Y coordinate is stored in the corresponding pixel position of the 
matrix and one count is added to the counts in that pixel, and so on until the image is formed. In 
 
Page 53 
frame mode acquisition the data are acquired for either a pre-set time interval or until the total 
number of counts reaches a stipulated number (Cherry et al., 2003; Saha, 2013). 
The size and the depth (8 or 16bits/pixel) of the matrix and the number of frames per study must 
be specify. Typical image matrix sizes are 64x64 and 128x128, although others may be 
possible. It is the matrix size which specifies the spatial resolution of a digital image, and hence 
the pixel size. The pixel size is calculated by dividing the FOV by the number of pixels across 
the matrix. Therefore, if the FOV has 40cm and the data is acquired over a 128x128 matrix size, 
the pixel size of the image is 3.1cm. However, the greater the matrix size, the greater the 
acquisition time and memory used in computer. Thus, there is a trade-off between the spatial 
and temporal resolution (Mettler & Guiberteau, 2006; IAEA, 2009a). 
The frame mode acquisition is widely used in static, dynamic, and tomographic (SPECT) 
studies. In a static study, a conventional 2D (planar) static image of an unchanging distribution 
of radioactivity is acquired in a single view of the region of interest (ROI). The static planar 
mode or planar scintigraphy is useful for whole-body studies, which may be obtained by 
scanning the gamma camera across the entire length of the patient (Bushberg et al., 2002). 
Alternatively, dynamic studies are used to study dynamic physiological processes, such as the 
transport of a radiopharmaceutical through the heart or the extraction and excretion of it by the 
kidneys. In dynamic studies, a series of static images (frames) are acquired and each frame is 
collected over a certain period of time (frame rate) selected by the operator. The frames are 
obtained one after the other until the desired number of frames is reached (Kantzas et al., 2000; 
Bushberg et al., 2002; Saha, 2013). Both static and dynamic studies acquire projections which 
represent a two-dimensional image of a three-dimensional distribution of the 
radiopharmaceutical and they can be either recorded directly onto film or stored in a computer 
(Kantzas et al., 2000; Mettler & Guiberteau, 2006). 
Although planar imaging is sufficient for many clinical applications, this technique suffers from 
artefacts and errors due to superposition of underlying and overlying objects which interfere 
with the region of interest (ROI) (Singh & Waluch, 2000; Ziessman et al., 2006). The technique 
of computer tomography (CT), which have been developed for both single-photon and positron 
tomography, offers some advantages over planar images, because it allows an accurate portrayal 
of the distribution of the radioactivity in the patient, improving consequently, the diagnostic 
accuracy (Fahey & Harkness, 1996; Groch & Erwin, 2000; Ziessman et al., 2006). 
The principle of tomographic imaging in nuclear medicine is based on the detection of photons 
emitted isotropically from inside the patient and detected at different angles around the patient, 
providing a series of static images at distinct depths (slices) of the organ in study (Kantzas et al., 
2000). Therefore, contrary to the planar images, the SPECT allows an in vivo quantitative 
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acquisition of the distribution of the radiopharmaceutical in truly three dimensions, through 
reconstruction of the projections views according to the principles of the tomographic imaging 
(Saha, 2013). 
The most common SPECT system is characterized by a typical rotating gamma camera with one 
to three NaI(Tl) detector heads (multihead) mounted on a gantry, an online computer for 
acquisition and processing of data, and a display system (Singh & Waluch, 2000; Saha, 2013). 
A typical dual-head SPECT system is shown in figure 2.23. 
 
Figure 2.23. A dual-head SPECT camera, GE NM630 model (From GE Healthcare, 2011) 
 
The detector head rotates around and parallel to the long axis of rotation (AOR). The gantry 
may rotate with an orbit of 180 or 360 degrees, acquiring the data in several projections 
simultaneously, over multiple angular views with small angle increments, 3 to 10 degrees. In 
typical applications about 32 stops per 180° of rotation and 64 stops per 360° of rotation are 
obtained, in order to acquire sufficient counts per pixel. At each angular position the data are 
collected in the form of pulses from the PMTs and then stored in a 64×64 or 128×128 matrix in 
the computer (Saha, 2013). Reconstruction mathematical algorithms, such as filtered 
backprojection technique or an interactive reconstruction algorithm, are then used to assimilate 
all the two-dimensional projection images and reconstruct them into three-dimensional images 
(Fahey & Harkness, 1996; Groch & Erwin, 2000; Kantzas et al., 2000). 
In SPECT, as well as in planar scintigraphies, the patient must be placed the closest as possible 
to the detector head, in order to improve the spatial resolution. Since the circular orbits deviate 
some centimetres from the surface body when they pass in noncircular body parts (chest or 
abdomen), decreasing the system resolution, body contouring orbits must be used instead of the 
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circular ones, in order to keep the radius of rotation as small as possible (Tsui, 1996; Mettler & 
Guiberteau, 2006; Ziessman et al., 2006).  
According to Mettler and Guiberteau (2006), the rotational SPECT has highlighted the need to 
improve every aspect of gamma camera system performance. Performance characteristics of the 
SPECT are the intrinsic spatial resolution, FWHM of 3 mm, linearity distortion of 1 mm or less, 
uncorrected field uniformity within 3% to 5%, and corrected field uniformity within 1%. All 
current rotational SPECT systems have correction circuits such as uniformity correction, energy 
correction and attenuation correction. The SPECT systems use the Chang method in the 
attenuation correction which assumes a uniform attenuation throughout the patient (Ziessman et 
al., 2006). Currently, the existence of hybrids instrumentations, such as SPECT-CT, solves 
many of problems associated with the attenuation correction, affording a better anatomic 
localization of radiopharmaceutical distribution (Ziessman et al., 2006). 
 
LIST MODE ACQUISITION 
Contrary to the frame mode acquisition, in list mode acquisition the digital data, representing 
the coordinates of each photon interaction in the crystal, are simply stored as lists. 
Consequently, all data are put in the memory as a time sequence list of events. If a physiologic 
monitor is being used, as in gated cardiac study, trigger marks are also included in the list 
(Bushberg et al., 2002).  
This type of data acquisition is really flexible regarding to the images formation. List mode 
allows combining, dividing, sorting or eliminating some X and Y positions to form images in a 
variety of ways to suit a specific need, at a later time. However, it has the disadvantage of a low 
acquisition rate and a large memory requirement, since it generates large amounts of data 
(IAEA, 2009a; Saha, 2013). 
A schematic representation of data acquisition in the frame mode and the list mode is 
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2.3. Targeted Radionuclide Therapy and Imaging Radionuclide Therapy 
The present dissertation relies in understanding the behaviour of the bremsstrahlung photons 
created within the body when the patient is subject to radionuclide therapy. The information 
acquired may be used to improve the bremsstrahlung imaging, in order to allow a patient-
specific dosimetry in the future. To achieve this purpose is useful recognise the physics 
underlying the radionuclide therapy. Therefore, the follow section explains the principles of 
radionuclide therapy, the radiopharmaceuticals used in this therapeutic and the dosimetry 
required in this type of procedures.  
The focus of this section is mainly based on a pure beta emitter, the 90Y. This radionuclide has a 
high amount of applications in the radionuclide therapy. Since the 90Y do not emit any γ-ray, its 
detection relies on the bremsstrahlung imaging. The challenges to detect the bremsstrahlung 
photons are explained on section 2.3.4., the 90Y applications are described in section 2.3.2. and 
the internal dosimetry associated with pure beta emitters in section 2.3.3. 
 
2.3.1. Principles of Radionuclide Therapy 
According to Stanciu (2012), the concept of targeted radionuclide therapy (TRT), also 
designated as unsealed source therapy, has developed from the diagnostic radionuclide imaging 
and appeared for the first time in 1898, when Paul Erlich used an antibody as vector of a 
radionuclide. The antibody recognised antigens associated to the tumour. 
Nowadays, the TRT is a promising modality in cancer treatment. It has developed due to 
advances in the understanding of tumour biology, molecular biology and radionuclides, 
allowing for the creation of new therapeutic radiopharmaceuticals (IAEA, 2010). 
TRT has the aim of targeting and destroying both malignant and non-malignant cancer cells, as 
well as, treating specific diseases such as rheumatoid arthritis (IAEA, 2009b). TRT uses an 
unsealed source of ionising radiation, combined with a biological vector of known 
biodistribution, such as monoclonal antibodies, antibody fragments, small peptides, liposomes 
or microspheres. The radiopharmaceutical delivery in the TRT takes advantage of the 
biokinetics of the patient, once the biological compound can selectively target particular cancer 
cells and bind to them (Stanciu, 2012), in contrast with the delivery principle used in traditional 
radiotherapy. Consequently, the efficacy of the TRT relies on the delivery of the 
radiopharmaceutical to the intended tumour site. When the radiopharmaceutical is effectively 
delivered, it is retained on those tissues and decays for a certain period of time, emitting a 
prolonged radiation dose to those tumoral cells and destroying them. Since the 
 
Page 58 
radiopharmaceutical is retained on the tumour site, this therapeutic approach protects the 
surrounding normal tissue (Manjunatha & Rudraswamy, 2010; Wheat et al., 2011). 
Usually, when a monoclonal antibody is used as a vector, the therapy is usually called of 
radioimmunotherapy (RIT). In RIT the tumour-specific antibodies are derived from the patient's 
own cancer and, hence, the antibody labelled to the radionuclide selectively targets the tumour 
when injected into the patient. In the same way, radiopharmaceutical binds to the cancer cells, 
allowing the delivery of a high dose of radiation directly in the tumour (NAS, 2007; SNMMI, 
2012). Figure 2.25., shows the RIT process. 
 
Figure 2.25. Schematic representation of the RIT, through the use of an antibody as biological vector. 
TRT takes advantage of the differences between cancer cells and normal cells, for example by different 
protein expressions on the cell surface. Therefore, antibodies labelled with radionuclides are used to 
target those structures (Adapted from Nestor, 2012) 
 
Although the principle of the radiation therapy (radiotherapy) and radionuclide therapy is the 
same, there are some significant differences that make TRT a promising method. While external 
beam radiation and brachytherapy emissions are composed of photons, TRT employs particulate 
emissions, damaging only the target volume with significantly lower collateral damage of the 
surrounding tissues; TRT uses antibodies and specific peptides as biological compound, 
allowing a selective uptake to the specific cancer cells; and the radiopharmaceutical is 
administered in a systemic fashion, which mean that TRT can deliver therapeutic doses to both 
a primary tumour and distant (including widespread) metastases concurrently. Therefore, in 
comparison with others therapeutic approaches, TRT has the advantage of both systemic 
administration, as in chemotherapy, and the selective irradiation of tissues, like brachytherapy 
and external beam radiation (Ersahin et al., 2011). According to Flux (2006), is also considered 
as a relatively benign treatment that does not incur the side-effects seen in more conventional 
treatments, such as the hair loss and prolonged nausea. 
Radiolabel antibody 
target antigen 






The radiopharmaceutical may be administered by some routes such as oral, intra-tumoural, 
intra-arterial, intra-portal, intravenous and intra-cavital. According to each therapeutic 
procedure, the route is chosen to maximising and optimising the dose delivery, to retain the 
radiopharmaceutical (biodistribution) in the target site (tumour) and to minimising the radiation 
burden to non-target tissues (Eary, 2007; Wheat et al., 2011). 
 
2.3.2. Radionuclides used in Therapy: Characteristics and Applications 
Such as in diagnostic imaging, in which the radionuclides have some specific characteristics, 
also in nuclear medicine therapy the physical characteristics of the radionuclides must be 
considered. The choice of the therapeutic radionuclide is governed by some ideal properties 
such as clinical indication, chemical and physical properties (type of emission, mode of decay, 
energy, abundance and half-life), range in tissue penetration, good stability when attached to a 
vector, quick excretion through a known simple route, readily available at needed scale, easily 
produced and cheap (Eary & Brenner, 2007; Rajendran, 2007; Ersahin et al., 2011; Wheat et al., 
2011; Stanciu, 2012). 
In terms of half-life, the physical and effective half-life of the radionuclide constitute a 
significant consideration for the therapy planning. The physical half-life should be similar to the 
drug or biologic agent half-life, so that the resulting effective half-life be an appropriate time for 
maximum therapeutic effect and minimal to eliminate radiation hazards and toxicity to the 
health cells (Eary & Brenner, 2007; Wheat et al., 2011). In therapy, the half-life of the 
radionuclides is higher than those used in diagnostic. It is also important that the 
radiopharmaceutical reaches a high target-to-background ratio. This means that it is preferred a 
prolonged retention of the radiopharmaceutical in the target tumour and a rapid elimination of it 
from normal tissues, by the kidneys and bladder (Wheat et al., 2011). 
The type and energy of radiation used in TRT are one of the most important factors when a 
therapeutic radionuclide is selected. Whereas the radionuclides used in diagnostic imaging emit 
γ-rays, which may penetrate deeply into the body, the radionuclides used in TRT emit 
particulate radiation, such as beta particles, alpha particles, and Auger electrons (National 
Research Council, 2007). Each type of charged particle transfers to the medium energy, which 
contributes to the dose in the patient. This energy may be calculated by the linear energy 




       Eq. (2.40) 
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Where dEL is the average energy locally imparted to the medium by a charged particle passing 
through a length of medium dl (SNMMI, 2012). The value of LET is important to understanding 
the effects of each charged particle on living cells (Stabin, 2007). 
The specifications of the radionuclide chosen to be used in the therapy, and consequently the 
type of charged particle used, takes into account the characteristics of the lesion to treat. 
Alpha particles have a range of 40 to 100μm, for mean energies of around 5 to 8 MeV. These 
particles might be preferred if high LET, usually greater than 10keV/μm, over a very short 
distance is preferred (Stanciu, 2012). These values of LET are ideal for inducing fatal double-
strand breaks in DNA, since the ionizing events occur in a range of about 2nm, close to the 
diameter of the DNA double helix. Beta particles have the longest range in tissue followed by 
alpha particles. The range of beta particles is 0.2 to 12mm, for mean energies of around 0.1 to 
1MeV. Low energy beta emissions might be suitable for small tumours while higher energy beta 
emissions are needed for penetration of the tissues up to 1cm. Beta particles have a LET less 
than about 10keV/μm, which causes less damaging than high-LET radiation. Auger electrons 
have the lowest energy of all charged particles, typically just a few keV, and the shortest range 
in tissue, in order of a few nanometres (Heard, 2007). 
According to Manjunatha and Rudraswamy (2010), beta particles emitters are preferable in 
nuclear medicine therapy since they have lower tissue penetration (typically less than 1cm), 
which maximise the self-irradiation in the target region and minimise irradiation in non-target 
regions. Increasingly, pure beta emitters are being considered and used as therapeutic 
radionuclides. There are clinical therapeutic values in use the pure beta emitters. From the 
radiation safety perspective, these radionuclides without γ-rays emissions are desirable since 
they eliminate any external radiation hazards. In this way, the amount of radiation involved is 
only confined to the patient. There is no exposure of the staff, public or others through external 
irradiation and patients may go home immediately (Zanzonico et al., 1999; Joseph, 2006; IAEA, 
2009b). 
Whilst the particulate property of the radiation decay process determines the therapeutic 
potential, the photon emission provides the ability to image the biodistribution in vivo, 
indicating the tumour localization and non-target uptake and retention. Therefore, the presence 
of a photon emission in the radionuclide decay affords the luxury of imaging the biodistribution. 
However, in the case of the pure beta emitters the only photons produced are the 
bremsstrahlung. Consequently, the pure beta emitters are subjected to the bremsstrahlung 
imaging to do the map of the biodistribution in vivo of the radiopharmaceutical. 
Currently, researchers aim to finding new radionuclides, with simultaneous β- and γ-rays 
emission, which offer the possibility to both administer treatment and imaging the radiation of 
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the treatment in vivo (Wheat et al., 2011; Stanciu, 2012). ). However, the gamma rays will give 
a dose to the normal tissues. 
There are some radionuclides like 131I, Samarium-153 (153Sm) and 177Lu which have both beta 
emitters, for therapeutic effects, and γ-ray emitter for external imaging of the biodistribution 
(Stanciu, 2012), making them as ideal radionuclides for TRT. A wide range of radionuclides 
available for TRT and their characteristics is shown in table 2.5. 
Table 2.5. Physical characteristics of the radionuclides available for common use in the therapeutic 


















14.3days β- 1.71 - 8.2 
Yttrium-90 
(90Y) 
64.1hrs β- 2.28 - 11.3 
Iodine-131 
(131I) 
8.0days β- 0.61 0.364 2.3 
Lutetium-177 
(177Lu) 
6.7days β- 0.50 0.113 and 0.208 1.8 
Strontium-89 
(89Sr) 
50.5days β- 1.49 - 7.0 
Rhenium-188 
(188Re) 
17hrs β- 2.12 0.155 10.4 
Samarium-153 
(153Sm) 
1.95days β- 0.81 0.103 3.0 
Copper-64 
(64Cu) 
12.9hrs β- and β+ 0.57 1.35 - 
Bismuth-212 
(212Bi) 
60.5min α 7.8 - 0.075 
Radium-223 
(223Ra) 
11.4days α 27.4 0.154 0.05 
 
According to the International Atomic Energy Agency (2009a, 2009b) some therapeutic 
applications include the treatment of numerous cancers, bone pain (palliation) and rheumatoid 
arthritis, bone marrow ablation, and inhibition of coronary restenosis. 
TRT is well established for the treatment of hyperthyroidism, mostly Graves and Plummer’s 
disease, and thyroid cancer by administration of the radioactive iodine 131I, because 131I 
administered as radionuclide NaI takes the advantage of the thyroid gland’s activity for iodine. 
Oral administration of 131I has been used to treat benign conditions of the thyroid gland since the 
1940s, making this procedure the oldest and the most commonly practiced TRT. In the case of 
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thyroid cancer, 131I therapy aims at destroying residual tumour tissue to reduce the recurrence 
rate, whereas in hyperthyroidism, 131I is used to decrease thyroid bulk (volume) and thus 
decrease thyroid function without necessarily removing function altogether (Stokkel et al., 
2010; Wheat et al., 2011). 
TRT is also used in palliation of painful bone metastases through the intravenous administration 
of 89Sr chloride, 153Sm lexidronam (153Sm EDTMP), and 186Re etidronate (186Re HEDP). Among 
these agents, 186Re HEDP is approved in Europe while the others are approved in the US. The 
goal of palliation is to improve the life quality of the patients who have widespread skeletal 
metastases (Ersahin et al., 2011; Wheat et al., 2011). 
32P phosphate was the first therapeutic radioisotope used in leukaemia about 70 years ago. 
Nowadays, it is used in others conditions such as myeloproliferative disorders (haematological 
proliferations with a poor survival) by intravenous or oral administration. 32P is usually used in 
older patients who does not responding to other treatments, in order to induce a long survival 
with an excellent quality of life (Tennvall & Brans, 2007; Wheat et al., 2011). 
Beyond the radionuclides describe before, one of the most important radionuclide used in TRT 
is the 90Y. 90Y is a high-energy pure β- particle emitter (table 2.5.) and it is used in numerous 
treatments in nuclear medicine therapy. It takes the advantages of the beta particle decay, 
delivering a well located dose to the target cells with minimum radiation safety concerns. For 
example, 90Y-microspheres have been used in radioembolization. An innovative therapeutic 
approach used to treat primary liver cancers, which may cause rapidly fatal liver failure in a 
large majority of the patients. Radiomicrospheres treatment involves the intrahepatic arterial 
administration of either 90Y bound to resin, 90Y-resin (SIR-Spheres®, Sirtex Medical, Lane 
Cove, Australia) or embedded in a glass matrix, 90Y-glassmicrospheres (TheraSphere®, MDS 
Nordion, Kanata, ON, Canada) (Gulec & Siegel, 2007; Ersahin et al., 2011; Francesco et al., 
2011). According to Gulec and Siegel (2007) 90Y-microspheres are not registered as unsealed 
sources, since they are not metabolized. However, the microspheres are delivered in aqueous 
solution, and therefore the radioactive contamination must be taken into account and 
microspheres should be handled as an open source, like other radiopharmaceutical. 
Beside this type of treatment, the most important application of the 90Y is in RIT. Specific 
peptides, such as 90Y-labelled octreotide or 90Y-labelled monoclonal antibodies are used in RIT. 
The European Association of Nuclear Medicine (EANM) approved the 90Y-radiolabelled 
ibritumomab tiuxetan (Zevalin®; Biogen-Idec Pharmaceuticals, San Diego, CA) in 2004, to be 
used in B-cell lymphoma treatment and related cancers. The FDA approved Zevalin® in 2002, 
together with the 131I tositumomab (BEXXAR®, GlaxoSmith- Kline, Philadelphia, PA) 
(Tennvall et al., 2007; Ito et al., 2009).  
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Zevalin® and BEXXAR®, commercially approved at present, are two RIT agents that used 
murine anti-CD20 antibodies. These antibodies target the CD20 antigens expressed in more than 
95% of the patients with B-cell malignancies, inducing in vitro apoptosis in CD20+ B-cell lines. 
Particles emitted from 90Y and 131I damage target B and neighbouring cells. The treatment is 
mainly used for patients with non-Hodgkin’s lymphoma (NHL), which accounts for 85% of all 
lymphomas in the lymphatic system (National Research Council, 2007; Tennvall et al., 2007; 
Minarik et al., 2010; Rhymer et al., 2010; Ersahin et al., 2011). 
Zevalin® and BEXXAR® are now in general clinical use with impressive response rates and 
limited and reversible toxicity. The number of European nuclear medicine departments using 
Zevalin® is continuously increasing, since the therapy is often considered successful (Tennvall 
et al., 2007).  
Others radiopharmaceuticals have the 90Y as radionuclide, such as 90Y-DOTATOC and 90Y 
lanreotide, which are used in TRT to treat neuroendocrine tumours (NETs), metastatic carcinoid 
and pancreatic neuroendocrine tumours in patients whose symptoms are not controlled by 
conventional therapy (Lewington, 2003). 
 
2.3.3. Internal Dosimetry for Radionuclide Therapy 
Radiation is an inherent characteristic of all radiopharmaceuticals and the patients always 
receive an unavoidable radiation dose when subject to diagnostic or therapeutic purpose. In case 
of therapeutic procedures, the radiation is what produces the therapeutic effect (Farstad, 2012). 
However, the effectiveness of the TRT is limited by the amount of undesired radiation given to 
a dose-limiting normal tissue. 
Through the internal dosimetry, the concentration and the spatial and temporal distribution of 
the radiation energy deposited in tissues may be determined (Zanzonico, 2000; DeNardo et al, 
2002). There are three fundamental quantities that should be considered in dosimetry and in 
radiation protection: the absorbed dose, D, which define the mean energy absorbed per unit 
mass of tissue or organ and measured in Grays [Gy=J.kg-1], the equivalent dose, HT, established 
when the adsorbed dose is weighted for harmfulness of different radiations (type and energy) 
which is measured in Sieverts [Sv], and finally the effective dose [Sv], which is defined as a 
summation of the tissue equivalent dosses, each one multiplied by the appropriate tissue 
weighting factor. This last quantity takes into account the radiation sensitivity of particular 
tissues (Martin & Sutton, 2002; IAEA, 2005). 
The current system of radiation protection that is internationally accepted (International 
Commission on Radiological Protection, ICRP, and IAEA) provides no dose limits for patients 
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and comforters or carers. However, dose limits are prescribed for staff and members of the 
public. The dose limits recommended by the ICRP and the IAEA for members of the general 
public, staff, patients and carers are set out in table 2.6. (IAEA, 2009b). 
Table 2.6. Annual dose limits recommended by ICRP 1990, 2007 and IAEA (IAEA, 2009b). 
Application 
Employees (18 years 
and above) dose limit 
General public 
dose limit 
Patient, comforter and 
carer dose limit 
Effective Dose 20mSv 1mSv No dose limit 
Equivalent dose to lens of eye 150mSv 15mSv No dose limit 
Equivalent dose to skin 500mSv 50mSv No dose limit 
 
Absorbed dose calculations are based on modelled biodistribution data and on quantitative 
imaging procedures. The Medical Internal Radiation Dose Committee (MIRD) of the American 
Society of Nuclear Medicine has developed a method of estimating organ absorbed dose after 
the radiopharmaceutical administration. This method is referred to as the MIRD schema and the 
aim is estimating average doses to critical organs resulting from diagnostic procedures (Flux et 
al., 2006). In the MIRD schema, the body is considered to consist of source organs, which 
accumulate radioactivity, and target organs, which are irradiated by activity of the source 
organs. According to the MIRD schema, the mean absorbed dose to a target organ (rk) from its 
exposure to a source organ (rh), ?̅?(𝑟𝑘 ← 𝑟ℎ) is given by the follow equation. 
?̅?(𝑟𝑘 ← 𝑟ℎ) = ?̃?ℎ𝑆(𝑟𝑘 ← 𝑟ℎ)    Eq. (2.41) 
Where ?̃?ℎ is the source organ cumulated activity, measured in terms of the activity time product 
[MBq.s] (which represents the number of millions of decays) and the term 𝑆(𝑟𝑘 ← 𝑟ℎ), usually 
referred to as the S-value or S-factor, represents the mean dose in the target organ per unit 
cumulated activity in the source organ, which may include the situation of a target organ and a 
source organ being the same (Martin & Sutton, 2002). The cumulated activity is dependent on 
biological parameters whereas the S-factor deals with the physical components of the absorbed 
dose. The MIRD S-factor are published for most source-target pairs and calculated for a range 
of clinically relevant radionuclides. The S-values takes into account the energy released from 
each radioactive decay, the relative geometry of the source organ and the organ in which the 
absorbed dose is calculated (Flux et al., 2006). 
Beside the MIRD schema, there are others dosimetry approaches to estimate radiation doses in 
the patients, such as the use of MIRD methodology with voxel S-values; convolution of the 
cumulated activity with dose point kernels (DPKs) derived analytically or by Monte Carlo 
methods; and full Monte Carlo simulation of radiation transport through the patient. These 
methods generally depend on quantitative gamma camera imaging to determine the time-
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varying activity distribution and on target volume determination (see e.g. Wilderman & 
Dewaraja, 2007; Kinase, 2011; Ljungberg & Sjögreen-Gleisner, 2011). 
The focus of dosimetry in diagnostic nuclear medicine is the assessment of risk to normal 
tissues during imaging procedures. In MIRD schema traditional application to diagnostic 
radiopharmaceuticals, the method assumes that activity and cumulated activity are uniformly 
distributed within organ size source regions and that radiation energy is uniformly deposited 
within organ size target regions (Heard, 2007). 
However, the dosimetry in radionuclide therapy estimates delivered absorbed doses to tumours 
and ensures that absorbed dose levels to normal organs are below tolerance levels, avoiding the 
toxicity to normal tissues (Ljungberg & Sjögreen-Gleisner, 2011). In therapeutic procedures, far 
higher quantities of radioactivity are administered than in diagnostic procedures. Consequently, 
it is vital to calculate real absorbed doses. 
Adaptations and alternative methods are required to deal with therapeutic applications, since 
specific patients deviate kinetically and anatomically from the model used (Zanzonico, 2000; 
Martin & Sutton, 2002; Flux et al, 2006). 
With the increasing therapeutic applications and the need for greater accuracy and efficacy, 
various techniques beyond the traditional MIRD schema have been developed. Radiation 
dosimetry in TRT is now evolving to patient-specific dose estimation, in order to improve the 
accuracy of dose estimates (Zanzonico, 2000). 
Nevertheless, most of the TRT treatments still based on empirical fixed administered activities, 
or, more rarely, according to the patient’s weight, or yet, age- and sex-specific reference data for 
human anatomy and body composition, according to MIRD schema (Flux et al., 2006). This 
approach provide errors of internal dosimetry calculations, since two patients may react in a 
different way for the same amount of radioactivity administered, either in the quantity of 
radiation that is taken up in a tumour or in a normal organ, or in the time that the radiation 
remains there (Flux, 2006). As a result, internal and individual patient dosimetry is currently the 
only possible way to establish an individual minimum effective absorbed dose and a maximum 
tolerated absorbed dose to the normal organ. The aim is to calculate the tumour response and the 
normal organ toxicity on the basis of pre-therapy dosimetry and increase the knowledge of 
clinical radionuclide radiobiology by observation the post-therapy effects (DeNardo et al, 2002; 
Flux et al, 2006). 
If the tumour dose can be calculated then the treatment dose for a particular patient may be 
verified, and dose-response relationships for the treatment in general may be developed. 
Additionally, clinicians can use dose predictions to determine the effectiveness of the trial and 
whether they can hope for curative or only palliative results (IAEA; 2005).  
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Ideally, each radionuclide therapy patient should receive dedicated treatment planning and 
verification. The planning stage includes pre-therapy dosimetry by imaging in vivo the time-
varying distribution of the radiopharmaceutical. The therapeutic absorbed dose required is 
determined by measure the organ and tumour volumes and biokinetics. Subsequently, the 
verification stage requires post-therapy dosimetry to calculate the actual doses delivered through 
the images obtained at various time-points after administration (Heard, 2007). 
Pre-therapy imaging of 90Y biodistribution (Zevalin®) is required by FDA. The nonexistence of 
γ-rays emission from 90Y-ibritumomab tiuxetan has led to the use of 111In-ibritumomab tiuxetan 
as a substitute tracer for prediction of the absorbed dose, which it is possible due to its similar 
chemical properties. However, according to Ito et al. (2009) and Minarik et al. (2008, 2010), 
111In imaging may not completely reflect the distribution of 90Y, since the behaviour of free 
circulating 90Y and 111In has been shown to be different. Jonsson et al (1992) and Lovqvist et al 
(2001), quoted in Ito et al. (2009) claim that free 111In accumulates in the liver, spleen and bone 
marrow, whereas uptake of free 90Y occurs at bone surfaces.  
Once there is no solid evidence that currently available dose calculations can predict the 
therapeutic efficacy or toxicity of 90Y treatment, European countries (with exception of 
Switzerland) do not require pre-therapeutic imaging with 111In-ibritumomab tiuxetan, in 
accordance with the guidelines of the EANM (Ito, et al., 2009). However, because 90Y is a high-
energy pure beta emitter with bremsstrahlung photons production, a quantitative bremsstrahlung 
imaging of 90Y biodistribution is necessary for confirming its uptake and estimating the 
absorbed doses. There are, however, several problems associated with the use of 90Y 
bremsstrahlung imaging for quantitative purposes (Minarik et al., 2008, 2010). 
In clinical practice, internal treatment planning has not yet been implemented and simplistic 
dosimetry assessment procedures are frequently reported which cannot accurately predict or 
evaluate the absorbed doses delivered. The necessary measurements to trace a patient-specific 
dosimetry planning are not always made for a diversity reasons, including the challenges of 
therapeutic imaging or simply a lack of resource or expertise (Walrand et al., 2011). Therefore, 
technicalities and knowledge have to be augmented and stimulated in order to achieve a more 
satisfactory correlation between absorbed dose estimates and treatment response or correlation 
with organ toxicity. Many practical issues remain before patient-specific dosimetry in 






2.3.4. Why is Bremsstrahlung Imaging Difficult? 
The image quality of bremsstrahlung photons is compromised due to several reasons. Such as 
explained in section 2.2.3., gamma cameras are designed primarily for diagnostic nuclear 
medicine imaging. The equipment is tuned to detect monoenergetic gamma radiation, 
particularly radionuclides emitters of γ-rays with energies between 50 to 250keV. 
In the case of bremsstrahlung imaging, for high-energies radionuclides, such as 32P and 90Y, a 
set of gamma camera performance characteristics cause problems in the image quality. The 
performance characteristics of gamma cameras provide a difficult precision on the 
radiopharmaceutical distribution imaging. 
One of the main problems in the bremsstrahlung image acquisition is the choice of the energy 
window. For conventional gamma emitters, the energy window is centred on the photopeak 
energy, accepting the majority of primary photons and rejecting the scattered photons. However, 
in bremsstrahlung imaging there is no photopeak, since bremsstrahlung radiation produces a 
continuous spectrum from the highest beta particle energy down to zero (see section 2.1.4.). 
Therefore, there has been great inconsistency on the choice of the energy window due to the 
continuous and broad energy distribution of the bremsstrahlung photons, becoming inefficient 
the simplest method of the scatter correction. The challenge in bremsstrahlung imaging is to 
choose an appropriate width and position in the spectrum, and hence in the energy window, in 
order to maximise the proportion of primary photons and minimise the scatter ones (Gulec & 
Siegel, 2007; Rong et al., 2012). 
Another challenge to take into account is the collimator. In diagnostic imaging, the collimator is 
chosen according to the trade-off between the spatial resolution and the sensitivity. According 
to Heard (2007), in bremsstrahlung imaging this choice is more complicated. First, the spatial 
resolution is already poorer due to the septal penetration and because the fact that electrons may 
travel several mm from the source before photons are produced. Even for medium- and high-
energy collimators, the septal penetration may happen since the high-energy of the 
bremsstrahlung photons. This fact, consequently, produces lead characteristic x-rays which may 
blur the images. On the other hand, bremsstrahlung sensitivity is small. As mentioned before 
(section 2.1.4.), only 2 to 3% (or even less) of the electron interactions produce bremsstrahlung 
photons (Attix, 2004), which difficult the collimator choice (Minarik et al., 2008, 2009, 2010). 
Performance characteristics, such as uniformity, linearity and attenuation correction, are energy-
dependent. In diagnostic nuclear medicine, those features are tailored to standard monoenergetic 
imaging with values around to the photopeak energy. However, for a wide energy spectrum 
created by bremsstrahlung photons, the correction’s maps and the attenuation coefficients are 
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not established causing errors in the acquisition signals and in the accuracy of the image 
produced (Ito et al., 2009; Minarik et al., 2010; Rong et al., 2012).  
Thus, the gamma camera systems are tailored for diagnostic nuclear medicine and consequently 
windowing and scatter correction techniques for the pure beta emitters are complicated by the 
lack of the photopeak in the bremsstrahlung spectrum (partly due to septal penetration and down 
scatter into the imaging window). 
Today, with the revolution in medical equipment, hybrids SPECT-CT systems have 
implemented advanced software for acquisition and reconstruction. Therefore, according to 
Fabbri et al. (2009), the quantitative analysis of SPECT-CT 90Y bremsstrahlung images and the 
appearance of the three-dimensional dose distributions are feasible, allowing to address the 
dosimetric verification to patients during the course of the therapy. These systems provide better 
information of the density distribution (by CT) and biokinetics of pure beta-emitter 
radiopharmaceuticals (by SPECT), improving images quality during the therapeutic procedures. 
Figure 2.26. shows the benefits when imaging 90Y glass microspheres administered in hepatic 
radioembolization, with following quantitative bremsstrahlung imaging acquired with SPECT-
CT. 
 
Figure 2.26. Application of hepatic radioembolization with 90Y glass microspheres. (a, b) illustrate the 
benefit of hepatic radioembolization with 90Y glass microspheres in a cystic hepatocellular carcinoma. (a) 












3. DISSERTATION METHODOLOGY 
 
3.1. Methods and Materials 
With the increasing therapeutic use of relatively high-energy pure beta emitters (<1MeV), such 
as 32P or 90Y, particularly in materials with high atomic number (such as bone), the production 
in vivo of bremsstrahlung photons is sufficient for external detection and imaging. 
According to Zanzonico et al. (1999) and Gulec and Siegel (2007), the bremsstrahlung 
component of the beta emitters has been traditionally ignored in internal and external dosimetry 
calculations. This fact may be due to a lack of available methods for including this component 
in the calculations or to the belief that the contribution of this component is negligible compared 
to that of other emissions. However, with the ample use of those radionuclides in therapy, 
evaluation of the bremsstrahlung contribution to dosimetry calculations should be considered. 
Thus, the present study aims at investigating the properties of the emitted bremsstrahlung 
photons. One attempts to understand the characteristics of the bremsstrahlung photons, such as 
efficiency, direction or radiative yield, when those photons are formed inside different 
biological mediums and taking into account different features of the beta particles source, such 
as emission direction or energy of the particles. 
To achieve this purpose it was used the Monte Carlo simulation. Amongst the available systems 
that use Monte Carlo simulation, the one chosen in this investigation was the EGSnrc (V4 
2.3.2), due to its advantages relatively to the electrons transport, in comparison with the others 
methods. EGSnrc is a Monte Carlo simulation package for coupled electron-photon transport, 
widely used in medical physics applications. It is a free software where the source code along 
with a user manual is available in official Ionizing Radiation Standards (IRS) web page from the 
National Research Council (NRC) of Canada (IRS/NRC, 2011). The computational language to 
create the EGSnrc code is written in an extended Fortran language known as Mortran3, which in 
turn is translated by a processor into a Fortran program. 
Other of the main aims of this study was to obtain the strong knowledge of EGSnrc system in 
order to be able to modify and produce a wide range of different simulations in different 
physical conditions. 
EGSnrc software, supporting documents and the computational codes developed constitute the 
main material used in this investigation. 
To reach the aim proposed two main Mortran codes were computed in EGSnrc, in order to study 
the bremsstrahlung photons. First, a scintillation detector model was developed to detect and 
count the interactions with the crystal from a point source of photons, and second, a source 
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model was created to mimic a point source of beta particles inside the patient with the purpose 
of produce bremsstrahlung photons in vivo. These two codes were modified along the study 
according to the measurements to test in this investigation. The results and method used in each 
simulation are explained in chapter 4. 
Consequently, the Monte Carlo simulations were split into two broad areas. The first part and 
the initial simulations were executed with the scintillation detector model using a point source 
of photons. This model was initially used to validate the code developed, since the photons 
behaviour may be easily understood and there is more literature and data available (see section 
4.1.). With this model, a full understanding of the EGSnrc system was undertaken, as well as the 
accuracy of the obtained results by comparison with the theoretical data. 
After assessed the first computational code, some simulations were developed with the source 
model. Realistic events with a beta particles source were simulated in different homogeneous 
media and with different beta energies. The bremsstrahlung photons produced from those 
simulations were recorded and studied (see section 4.2.). 
It would have been interesting to continue to the next step of the bremsstrahlung investigation, 
i.e., imaging the bremsstrahlung photons in a gamma camera. For that purpose an EGSnrc 
gamma camera model would have to be properly developed and the information obtained in this 
study would have to be read it on that model. The aim would have been change the performance 
characteristics of the gamma camera, such as collimator characteristics, energy windowing or 
crystal size and its material, in order to improve the quantitative analysis of bremsstrahlung 
images. However, due to lack of time this part of the study was not possible concretize, since a 
faithful and realistic gamma camera model written in Mortran3 is very time consuming. 
Nevertheless, the preliminary information acquired is useful, not only to understand the 
behaviour of bremsstrahlung photons, but also for to be used in future investigations. 
In addition with the bremsstrahlung measurements undertaken for this study, some list mode 
acquisitions were made in the INM, using a 99mTc cylindrical source. This part of the 
investigation was performed on a NM/CT 670, a hybrid SPECT-CT dual head camera by GE 
Healthcare (GE Healthcare, 2010), and the data were stored in the GE Xeleris nuclear medicine 
workstation, which is the software used to display, process, film, archive, and communicate 
nuclear medicine images. The purpose of these measurements was the verification and 
validation of a specific list mode decoding program developed by the University College 
London Institute for Cancer Research (ICR), in confidentiality agreement with the GE 
healthcare. The final data obtained by the decoding program were binned in sequential and 
small energies bins, forming an energy spectrum according to the PHA window chosen. The 
spectrum was compared with the theoretical values to validate and prove the accuracy of the 
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decoding program (method explanation in section 4.3.). As list mode would be used in patient 
studies, the decoding program had to be verified. 
The decoding program read the raw data from the SPECT-CT and the output is the X and Y 
pixel positions and the respective energies of each single photon interaction, which are 
represented in a table format. To visualise the final image, a Matlab code was computed and 
developed and tested in order to “frame up” the list mode data, forming a frame image. 
All the simulations were undertaken with a computer HP Pavilion dv6-1120ep, 32-bit Operating 
System Architecture and 2GHz Pentium (R) Dual-Core CPU T4200 processor with 4GB RAM. 
The next sections explain how the EGSnrc models were created, and consequently, the 
principles of Monte Carlo Simulation. 
 
3.1.1. Principles of Monte Carlo Simulation 
The Monte Carlo simulation is used in various fields of science, such as radiation protection, 
diagnostic radiology, radiotherapy and nuclear medicine, with applications in both diagnostic 
and therapeutic purposes. This method allows simulate and understand complex phenomena and 
physical systems, through simulated processes by statistical methods employing random 
numbers. It is a useful and effective method, because in complex systems, at a microscopic 
level, the interaction processes are random and the analytical method become extremely 
difficult. This contrasting to the physical simple systems (e.g. homogeneous medium and 
monoenergetic particle) where it is possible to predict the outcomes from the interactions of 
radiation with matter through analytical calculations, for example by using the appropriate 
attenuation coefficient (Zaidi, 2004; Heard, 2007). 
In the concrete case of radiation transport, this is simulated by the creation of photons or 
electrons from a defined source region. The particles are tracked as they travel through the 
system, with sampling of the probability distribution functions (PDFs) for their interactions, to 
evaluate their trajectories and energy deposition at different points in the system (Zaidi, 2004). 
The key of the Monte Carlo method is, thus, the use of PDFs and random number generators 
(RNGs). 
The user defines some details relative to the conditions of the particle transport 
(energy, geometry, medium). The PDFs express the range of possible outcomes for 
each particle at each step, which are stored within the Monte Carlo program as material- 
and energy-dependent cross-sections. In each step of each particle's simulated progress is 
determined at random, as well as its changing attributes (Brown, 2009). 
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Once the PDFs are known, the Monte Carlo simulation can proceed by random sampling from 
the PDFs to generate random numbers uniformly distributed on the interval 0 to 1, which map 
to unique values of the cumulative PDFs, based on experimental data, theoretical models, or 
both. By simulating a large number of photons or electrons transported through the medium 
(source events, called “histories”, “showers” or “cases”), the information can be obtained about 
average values of the result of the system. As the simulation converges on this result, the 
macroscopic and final result of the system is revealed. 
In many practical applications, one may predict the statistical error (the “variance”) in this 
average result, and hence, an estimated number of Monte Carlo trials that are needed to achieve 
a given error (Heard, 2007; Rogers & Bielajew, 2012).  
The accuracy of the method is dependent on the number of histories. A larger number of 
histories improves the accuracy of the simulation, which means that the statistical uncertainty 
decreases. However, increasing the number of cases involves a large computational time and 
large data storage capacity. 
The Monte Carlo technique is useful to answer questions which cannot be addressed by 
analytical investigation (Brown, 2009). Examples of studies that used the Monte Carlo 
method in the area of nuclear medicine, both to investigate electron transport, as well 
as, the bremsstrahlung production, may be read in Lauterbach et al. (1999), Natter et al. 
(2003), Calderaro (2004), Cengiz and Almaz (2004), Salvat et al. (2006) and Peeples and 
Gardner (2012).  
Several Monte Carlo codes systems to model coupled electron–photon transport are freely 
available in the public domain. The code systems vary in aspects such as, the type of the 
particle, the physics theories and cross-sections and the sampling techniques for using 
them, their ease of use and the speed with which simulations run. According to Rogers 
(2006), the most commonly Monte Carlo systems used in nuclear medicine are the 
EGSnrc, PENELOPE, MCNP and GEANT4. 
The code system used in this investigation was the EGSnrc. Rogers (2006) claims that EGSnrc 





3.1.2. How EGSnrc works? 
The EGSnrc system is a package for the Monte Carlo simulation of coupled electron-photon 
transport, which uses an arbitrary medium and geometry defined by the user. Its current energy 
range of applicability, for electrons, is a few tens of keV up to a few hundred GeV, whereas for 
photons is 1keV to several hundred GeV (IRS/NRC, 2011). 
In EGSnrc the electrons and photons “born” in accordance to the user input. The particles travel 
certain distances to the site of a collision, which are determined by the PDF depending on the 
total interaction cross section, and are absorbed or scatter to the next point of collision. The 
procedure is continued until all the particles are absorbed or leave a specific geometry defined 
by the user. EGSnrc takes into account all the physical processes that happen in radiation 
interactions with matter (section 2.1.3. and 2.1.4.). 
Because of the complex nature of electron transport in the process of slowing down, in which 
hundreds of thousands of interactions may occur with the surrounding medium, the EGSnrc 
employs the condensed history (CH) technique, develop by Berger (1963). For electrons, a 
simulation event-by-event is not possible due to limitations in computing power. Therefore, the 
CH method “condenses” large numbers of interactions into a single step. According to 
Kawrakow et al., (2011) this technique is possible due the fact of single electron collisions with 
the atoms cause small changes in the particle’s energy and direction of flight. The final and 
single step takes into account the cumulative effect of the individual interactions by sampling 
the change of the particle’s energy, direction of motion, and position from appropriate multiple 
scattering distributions. 
The EGSnrc is an extended and improved version of the EGS4 package originally developed at 
Stanford Linear Accelerator Centre (SLAC). It incorporates significant improvements. The new 
physics models included a new CH scheme for the simulation of electron transport - Class II, 
an option to apply more accurate bremsstrahlung cross-sections (IRS/NRC, 2011). 
The computational language used in EGSnrc is Mortran3, an extended Fortran language 
with a powerful macro facility. The Mortran language is implemented as a set of macros 
which are used by the macro processor to translate the language into Fortran. To create any 
EGS program code the user must write a “user code”. The user code comprises the MAIN 
routine and three user-written subroutines HOWFAR, HOWNEAR and AUSGAB. The EGS 
code itself consists of two user-callable subroutines, HATCH and SHOWER, which in turn call 






Figure 3.1. Structure of the EGSnrc code system (Kawrakow et al., 2011) 
 
In the blue rectangle are represented the subroutines of the EGS code itself. These are 
used to establish the cross-sections for the media and particles in the simulation. The 
subroutines inside the bottom rectangle are those by which the user interacts with the 
EGS code system. The user communicates with EGS by means of various COMMON blocks, 
which are sets of parameters that define the variables to use in the program (Kawrakow 
et al., 2011, see appendix 1). 
In the MAIN routine, the user executes any initialisation needed for the HOWFAR and 
HOWNEAR subroutines, as well as defines initial parameters by using the COMMON 
variables or creating new ones in Macros definitions. For example, in the COMMON 
block called “MEDIA” the variables MEDIA and NMED are used to define the array of 
media names and the number of media used in the system, respectively. In MAIN 
routine the user may specify such things as the initial particle characteristics (type of 
particle, position, energy, trajectory), the number of histories, the desired electrons and 
photons cut-off energies (MeV) defined as ECUT and PCUT, respectively, or the 
materials in which interactions will take place. 
The user creates the composition of the medium in a package called PEGS4, which is a data 
pre-processor for the EGS system. The medium may be an element, compound, or mixture. 
Also, two or more media may be selected in the same PEGS4 file. The energy thresholds at 
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which EGS will be desired to transport electrons and photons are defined in PEGS4. Together 
with the medium composition and energy thresholds, the interaction cross-sections for each 
material are calculated and consequently the PDFs to be used in subsequent Monte Carlo 
simulation will be formed. In PEGS4, the short form AP and UP define, respectively, the PEGS 
lower and upper photon cut-off energy and AE and UE define, respectively, the PEGS lower 
and upper electron cut-off energy. When the particles reach any of those values, or the 
ECUT or PCUT defined in MAIN, their histories are complete and any remaining 
energy is deposited and absorbed locally. 
After finishing of the user code, the HATCH subroutine is called by MAIN and initialises the 
simulation by reading the material interaction cross-sections from the specific PEGS4 data 
file previously created. When this initialisation is complete, the MAIN routine may then call the 
SHOWER. Each call to SHOWER results in the generation of one history or event, initialising 
the interaction cascade. For the initial particle and for any subsequent particles sets in 
motion, the EGS subroutines (ELECTR, PHOTON, BREMS, COMPT, ANNIH, etc.) 
determine the characteristics of the interaction, whether interaction takes place, what 
kind, and how energy will be shared between resultant particles and the medium. 
The user-written HOWFAR are HOWNEAR are subroutines that define the geometry of the 
physical condition to test. Those subroutines determine the location of the particles in 
the system at each step and determine whether the particles may or may not continue to 
the next interaction without encountering a boundary. The other user-written subroutine, 
AUSGAB, is responsible by the results output. In AUSGAB the user selects and defines which 
data will be stored in a text file. This selection is undertaken through the parameters available 
in the AUSGAB (IARG) which the user has the ability to switch on or off, in order to 
know, respectively, when a certain event are about to occur or after it has occurred 
(Kawrakow et al., 2011, see appendix 2). When all histories are complete, the 
information collected in MAIN and AUSGAB is summarised and stored according to 
the user's instructions. 
Concisely, the user communicates with EGS by means of subroutines (HATCH - to establish 
media data; SHOWER - to initiate the cascade; HOWFAR & HOWNEAR - to specify the 
geometry and AUSGAB - to store and output the results), COMMON blocks by changing 
values of variables and finally by Macros definitions to call all the pre-defined variables or 




3.1.3. The Models’ Code in Words 
The codes developed in this study were based on the tutor1.mortran, a tutorial program provided 
in the EGS manual (Kawrakow et al., 2011). In broad terms, the EGS program may be 
divided into 9 steps, i.e., EGS has a sequence of operations needed be followed for the 
correct operation of the program. The step 0 is the file initialisation and the statement call 
egs_init must be written to this purpose (should be the first executable statement and thus is 
usually after step 1 and possibly in step 2); in step 1 the user overrides the EGS Macros; the step 
2 is the pre-HATCH call initialisation. This step consists of setting the EGS COMMON 
variables that are used by HATCH. The subroutine HATCH is called in step 3. The step 4 is 
responsible for the initialisation of the user-written subroutines HOWFAR and HOWNEAR, 
whilst the step 5 is used to initialise the user-written subroutine AUSGAB. In step 6 the user 
defines all the parameters of the incident particle, such as type of particle, kinetic energy, 
particle position, and number of histories or events. In step 7 the SHOWER is called. This EGS 
subroutine is called as often as desired, according with the number of histories considered 
necessary. In step 8 the output of results are defined as well as the display format. Finally, the 
step 9 properly closes files and places them back on the user-code's directory through the use of 
a last executable statement call egs_finish. 
All those steps are declared in the MAIN routine and written with base on the COMMON 
variables existent on EGS. However, in order to create a properly EGS code the user must 
specify the physical system, i.e., the geometry of the process. Consequently, it is necessary 
define all the regions along which the particle may travel in the subroutines HOWFAR and 
HOWNEAR. The geometry system could have one or more media. 
HOWFAR determines the exact distance at which the particle can intersect a boundary. This 
subroutine can answer if the particle may or may not travel a certain distance, defined randomly 
by the EGS in the variable USTEP, without crossing a boundary. If USTEP is smaller than the 
distance to the next boundary then the particle may travel USTEP. Otherwise, the program 
defines USTEP equal to the distance to the boundary and identifies a new region to the particle 
equal to the far side of the boundary. 
The most trivial geometry that may be written in HOWFAR is the case of a homogeneous 
infinite medium, in which one can define two infinite parallel planes delimiting three regions of 
any material, as shown in figure 3.2. A plane is defined by the coordinates of one point on the 
plane and its direction vector. The triangles point in the direction of the unit normal vector that 
is generally initialized in MAIN routine, in step 4. Independently of the geometry, the unit 




Figure 3.2. Simple geometry to the HOWFAR subroutine: two parallel planes separating three regions 
along z. This is a three region geometry example for HOWFAR. The x axis is into to the paper (Adapted 
from Kawrakow et al., 2011) 
 
For inhomogeneous media and complex geometries with arbitrary surfaces, the subroutine 
HOWFAR becomes more difficult to define. However, a number of geometry subprograms and 
their macro-equivalents are distributed within the EGS system in order to make it easier to write 
the HOWFAR. For example, the subroutine that defines the geometry in figure 3.2. is the 
PLANE1 (determines if particle trajectory strikes a planes surface). Other examples of 
geometry subroutines are: CYLNDR (determines if the particle trajectory strikes a cylindrical 
surface), CONE (determines if the particle trajectory strikes a conical surface), SPHERE 
(determines if the particle trajectory strikes a spherical surface), PLAN2P (Determines the 
intersection point for two parallel planes), PLAN2X (determines the intersection point for two 
crossing planes), CYL2 (determines the intersection point for two concentric cylinders), CON2 
(determines the intersection point for two concentric cones), SPH2 (determines the intersection 
point for two concentric spheres). Information to explain those geometries and others is 
available in documents as Nelson and Jenkins (1988) and Bielajew (1995).  
The subroutine HOWNEAR defines the minimum distance (direction independently) to any 
surface from the location of the particle position. HOWNEAR is used to speed up the 
simulation by comparing the value returned with a user supplied constant TPERP. If the 
distance to the boundary is greater than TPERP the ‘condensed’ electron transport, where many 
individual interactions are grouped into one, is used. This is much faster than using single 
stepping where every individual interaction is simulated separately (single stepping). Only when 
the distance to the boundary is less than TPERP is single stepping used. 
When the user defines TPERP with a high value, the simulation condenses all the interactions in 
that distance. However, if TPERP is set to zero all the interactions are considered and the 
program takes long time to run. 
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The subroutines HOWFAR and HOWNEAR will be different according to the physical 
geometry necessary to each simulation. Both subroutines may be modified depending on the 
specific study. For example, in one simulation a sphere may be used as geometry and for 
another test a cube may be preferable. 
The subroutine HOWFAR defined in each EGS models (scintillation detector model and source 
model), as well as some variables necessary to undertake the simulations, are described below. 
 
SCINTILLATION DETECTOR MODEL 
The scintillation detector model was the first model to be constructed and developed in EGSnrc. 
The model is similar with a detector head of the gamma camera. Such as the gamma camera 
function, also this model was developed to detect and count all the photon interactions that 
occur with the crystal. It was developed to understand and simulate all the interactions 
mechanisms that take place inside the crystal. 
The code of the scintillation detector model is presented in appendix 3. The sequence of 
operations needed for the correct operation of EGS, i.e., the 9 steps described above and the 
subroutines are properly identifiable in the code. 
In terms of geometry (HOWFAR), the detector may be thought of as a rectangular prism, 
created as a series of slabs (infinite slabs that when intersected produce a rectangular prism). 
This detector is constituted by two materials, NaI and Glass, which is placed in front of the 
crystal. Those two media were created in the same PEGS4 file. The thallium activator was not 
modelled since it constitutes only about 10-3 fraction of the crystal. Though existent in the real 
gamma camera, also the collimator and the aluminium shield involved in the detector were not 
computed since it would require much time and because this model was developed to validate 
the accuracy of the results produced by EGSnrc. The general model is shown in figure 3.3.. 
 
 
Figure 3.3. Scintillation detector model 
created in EGSnrc. A slab of NaI and 
Glass close together 
 
 




Six different infinite planes were defined to create a rectangular prism, plus one to separate the 
NaI of the Glass, the two media used in this model. The planes were defined in step 4: 
initialization of HOWFAR. When the infinite planes are intersected, they generate the 
rectangular prism, as well as, eight different and separate regions: two finite regions inside the 
prism, NaI and Glass, and six infinite regions outside the prism. The particle is transported 
along to the regions and the regions are identifiable when the particle interacts. Figure 3.4. 
shows the planes to create the detector geometry and figure 3.5. the regions produced. The 
regions 7 and 8 match to the regions inside the rectangular prism, made of NaI and Glass, 
respectively, and the others 1 to 6 regions, were defined as vacuum placed around the detector, 
which served as an air gap. 
 
Figure 3.4. Planes 
necessary to define the 
detector geometry. The 
planes 1 to 6 separate the 
vacuum regions and the 
plane 7 separate the 
crystal from the glass 
 
Figure 3.5. Regions 
produced by the creation 
of the planes. The 
regions 1 to 6 are 
vacuum, the region 7 is 
the crystal made of NaI 
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Due to the existence of the macro-equivalents in EGS, the creation of the detector geometry in 
the subroutine HOWFAR is easily feasible. In this model the Macro used was the PLAN2P. 
This Macro defines a pair of parallel planes. Since to create a rectangular prism is necessary 
three pairs of parallel planes, one pair normal to the x-y plane, other to the x-z plane and the last 
to the z-y plane, it was necessary to write the Macro PLAN2P three times. 
When the HOWFAR is called, it works exactly how was explain before, but now taking into 
account more planes. This subroutine considers the direction of the particle, which plane is 
closest and what region is after that plane, in case the particle cross the boundary. 
Some components of this model were modified along with the simulations, such as, the 
dimensions of the camera, the thickness of the NaI and Glass, the region where the photon point 
source was placed and the direction of the particle, which could travel along the z-axis or in an 
isotropic direction (see code lines for isotropic emission, explain in step 7). The photon 
interactions were counted inside the crystal (region 7), being discarded outside of it. But once 
again, the region of interest could be modified according to the simulation. 
For all regions and for all simulations tested using this model the cut-off energies were defined 
as follows: ECUT=3.511MeV (0.511MeV rest mass + 3MeV) and the PCUT=0.01MeV. 
EGSnrc requires the addition of the rest mass energy of the electrons to the kinetic energy. 
Since this model was used to simulate photons and calculate the energy absorbed in the crystal, 
the chosen value to the ECUT was high (3MeV) in order to stop all the electrons with kinetic 
energy immediately below this value, avoiding unnecessary transport calculations and CPU 
time-consuming. In contrast, the photons were followed until they deposit almost all of their 
energy. Therefore, 0.01MeV for the PCUT was chosen. 
When the NaI and Glass data file was created in PEGS4, also the energy thresholds at which 
EGS will be desired to transport electrons and photons were defined. Those were chosen 
according to the ICRU report 37, i.e., AE=0.521MeV (0.511+0.01MeV), AP=0.01 MeV, 
UE=55 MeV and UP=55 MeV. The subroutine HATCH read both values ECUT/AE and 
PCUT/AP and chooses the maximum between both of them. EGSnrc stops tracking the particles 
inside the crystal when they fell off below those energy thresholds. 
 
SOURCE MODEL 
The source model was used to simulate bremsstrahlung photons inside the patient. The 
geometry (HOWFAR) of this model tries to mimic a pure beta particles point source placed 
inside a biological material. The code created is presented in appendix 4. 
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To achieve this purpose a sphere was created by the geometric subroutine SPHERE. In this 
subroutine only one boundary and two regions were defined. The boundary corresponds to the 
total surface of the sphere which separates the region inside from the region outside the sphere. 
The region outside the sphere was set up as vacuum and the material inside the sphere was 
changing according to the simulation. Four different biological materials were used: inflated 
lung, soft tissue, cortical bone and adipose tissue. All those materials were created in PEGS4, 
providing a data file for each material with the interactions cross-sections and the energy 
thresholds. 
The general model is shown in figure 3.6. One may thinks in this model as a spherical phantom, 
used to do the simulations. 
 
Figure 3.6. Source model created in EGSnrc. 
Radionuclide emitting beta particles in the middle 
of a sphere, made of biological material 
 
 
A point source of electrons was positioned in the middle of the sphere and the particles emitted 
isotropically. The radius of the sphere was varying according to the simulations, as well as the 
kinetic energy of the electrons. Such as in the scintillation detector model, also in this one the 
energy thresholds defined in PEGS4 were chosen according to the ICRU report 37, i.e., 
AE=0.521MeV (0.511+0.01MeV), AP=0.01 MeV, UE=55 MeV and UP=55 MeV. 
However, the cut-off energies, ECUT and PCUT, were defined differently. Since the interest in 
this model is the production of the bremsstrahlung photons inside the sphere, the photons that 
cross the surface sphere are discarded. For that reason, cut-off energies were manipulated in 
order to stop the bremsstrahlung photons immediately over the surface area of the sphere. 
Consequently, in the region inside the sphere ECUT=0.521MeV (0.511+0.01MeV) and 
PCUT=0.01MeV, and outside the sphere the ECUT=0.521MeV (0.511+0.01MeV) and 
PCUT=5MeV. Inside the sphere the electrons are followed until their kinetic energy reached 
10keV, as well as, the photons. This value ensures the simulation of all bremsstrahlung photons 
of high enough energy (usually 50keV for a gamma camera imaging). For the region outside the 
sphere the photons were terminated as soon as they were created by setting the PCUT=5MeV, 
higher than the maximum electron energy used in the simulation. This ensures that the photons 
are stopped when they cross the surface of the sphere. Below the PCUT the photons are 
discarded, depositing locally all of their energy, which may be counted if the user requires it.  





3.2.1. Photons Simulations 
In order to validate the computed codes and verify the accuracy of the EGSnrc outcomes, the 
followed measurements were realised with a point source of photons: 
 Verification of the inverse square law; 
 Analysis the effect of the crystal thickness, by testing the detector count efficiency and 
linear attenuation coefficient; 
 Analysis the effect of the glass in front of the crystal by testing the backscattered 
photons. 
 
3.2.2. Bremsstrahlung Simulations 
To achieve the aim proposed to this investigation the following simulations were tested, in order 
to understand the properties of the bremsstrahlung photons: 
 Analysis of the bremsstrahlung production efficiency by varying the sphere thickness 
and the beta particles energy; 
 Analysis of the bremsstrahlung yield by varying the biological material; 
 Comparison of the bremsstrahlung spectrum shapes produced in different materials; 
 Analysis of the angular distribution of the bremsstrahlung produced; 
 Analysis of the spatial distribution of the bremsstrahlung photons from the point source; 
 Analysis of the bremsstrahlung spectra produced by 90Y and 32P. 
 
3.2.3. List mode Acquisitions 
In order to validate the list mode decoding program, planar acquisitions (2D) were undertaken 
with a cylindrical source of 99mTc. Different energy windows were chosen according to the 
measurements. The measurements carried out are listed below. 
 List mode acquisitions using 99mTc point source, positioned in different places of the 
gamma camera, acquired in two energy windows (140.5±10% and 450±10%); 















4. RESULTS AND DISCUSSION 
 
Chapter 4 describes all the results and respective discussions relative to the measurements 
undertaken in this study. The method used in each simulation is properly explained for each 
one. 
 
4.1. Photons Simulations 
A substantial part of the work involved in producing a Monte Carlo simulation consists 
in its validation. In Monte Carlo simulation is important for the user to check whether the 
results given by the program are within the expectations. Therefore, it is advisable to do a 
validation of the code and see if the outcomes are according to the physics theory. 
Since the photons behaviour and their interactions are easier to understand, photons were used 
in this part of the study to validate the first code computed, i.e., the scintillator detector model. 
This part of the work also aimed to gain a working knowledge of the EGSnrc system, in order to 
be easier to change the code to any physical condition. 
All the simulations undertaken in this part of the study were performed with a point source of 
photons, using the scintillator detector model with the geometry and components described in 
section 3.1.3. 
The photons simulations and the corresponding method and discussion are explained below. 
The data recorded in each simulation were processed with Excel (Microsoft Corp., Redmond, 
USA). 
 
4.1.1. Verification of the Inverse Square Law 
The first simulation consisted in verifying whether the inverse square law is obeyed for photons. 
The inverse square law is used to understand the influence of the distance on the intensity of the 
radiation beam. When an isotropic radioactive source is placed at a certain distance from the 
detector, r, only a fraction of radiation (number of photons detected divided by the total number 
of photons emitted) is detected. At a distance r, the radiation emitted passes through the surface 
of an imaginary sphere having a surface area 4πr2. Therefore, the fraction of radiation detected 
by the crystal per unit of area is given by A/4πr2, where A is the detector surface area, 4πr2 the 
total spherical area reached by the photons and r the source-detector distance (Cherry et al., 
2003, Saha, 2013). If one considers an isotropic point radiation source at the center of the 
sphere, the surface area over which the radiation is distributed increases as the square of the 
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distance from the source (A∝r2). Consequently, the inverse square law states that the radiation 
detected by the detector per unit area decreases with the inverse square of distance between the 
source and the detector (photons detected∝1/r2), since the radiation is spread out over larger 
areas when r increases (Bushberg et al., 2002). If the distance is doubled, the radiation is spread 
out over four times as much area, so the dose is only one fourth as much. The inverse square 
law is an important fact to takes into account at a dosimetric level. 
To undertake the simulation a point source of monoenergetic photons, with 140keV of kinetic 
energy, was placed behind the crystal. 106 photons (histories) were emitted uniformly with 
equal intensity in all directions (isotropically). The Mortran code lines written to define the 
photons isotropy are clear in the EGSnrs code (appendix 3). 
To achieve this purpose the number of photons that reach the crystal was stored by varying the 
source-detector distance and the size of the crystal. The sizes of the crystal chosen to be 
simulated were: 1, 5, 10, 20 and 40cm2. For each detector surface area, the photon point source 
was moved away from the detector. The source-detector distances tested, for each surface area, 
were as following: 1, 3, 5, 10, 20, 30, 50, 75 and 100cm. In all simulations, both crystal and 
glass had 1cm of thickness. 
Figure 4.1. gives the output data obtained from the simulation, i.e., number of photons detected 
by the crystal vs. the source-detector distance. Considering figure 4.1., it is possible to confirm 
an exponentially relationship between the amount of photons that reaches the crystal and the 
source-detector distance. Each line in the figure represents one of the five different crystal sizes. 
 
Figure 4.1. Analysis of the 
Inverse Square Law. Number of 
photons detected vs distance from 
the crystal to the source [cm]. 
Different crystal sizes [cm2] 
tested. Simulation using 106 
photons, emitted isotropically 
 
When the source-detector distance increases the number of absorbed photons decreases 
exponentially. The error bars are not visible in the figure, since they are smaller compared with 
the thickness of the line, less than 1%. 
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Analysing the trend line equations (potential function in form a/xb, where x is the source-
detector distance), one notices that only the detectors with small sizes are in agreement with the 
inverse square law. This is because the inverse square law is only valid when the source to 
detector distance is large in comparison to detector size. A general rule of thumb states that the 
distance to a radiation source should be greater than five times the crystal size. For that reason, 
the smaller crystal size, 1cm2, was chosen to do a detailed analysis using distances higher than 
five times the crystal size. Those values were compared with the theoretical ones, given by the 
formula above (A/4πr2) (Cherry et al., 2003). Table 4.1. gives the simulated and the theoretical 
values, in fraction, of the photons detected by the crystal. 
Table 4.1. Simulated and analytical values of the fraction of photons reaching the detector by varying the 
source-detector distance. Simulation for 1cm2 crystal size and 1million photons emitted isotropically with 
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5 2582 0.0025820 ± 0.0001016 0.0031831 18.88 
10 677 0.0006770 ± 0.0000520 0.0007958 14.93 
20 187 0.0001870 ± 0.0000273 0.0001989 6.00 
30 74 0.0000740 ± 0.0000172 0.0000884 16.31 
50 26 0.0000260 ± 0.0000102 0.0000318 18.32 
75 11 0.0000110 ± 0.0000066 0.0000141 22.25 
100 10 0.0000100 ± 0.0000063 0.0000080 25.66 
 
The simulated values give the fraction of photons detected by the crystal taking into account 106 
photons emitted. For this reason, the uncertainty of the simulated values is also represented as a 
fraction of the total particles emitted, within two standard deviations (±2σ). Percent errors 
between the simulated and analytical values as a fraction of the analytical values (multiplied by 
100) were calculated to determine how close or accurate to the analytical values, the simulated 
values really are. To an easier interpretation and verification of the inverse square law, the latest 





Figure 4.2. Comparison 
between simulated and 
theoretical of the fraction of 
photons reaching the crystal 
in order to verify the Inverse 
Square Law (Theoretical 




The simulated values demonstrate a close match with the theoretical values, with the trend line 
equation following the inverse square law. Also, the coefficient of determination (R2) is equal to 
1, indicating the goodness of the fit in the regression analysis. 
The values are consistent with the expected with approximately 95.45% confidence, within ±2σ. 
Therefore, there is a 95.45% chance that the confidence interval covers the true value. Since the 
theoretical values are inside the confidence interval for each simulated value is it possible to 
confirm that the isotropic photon beam propagating through the air or vacuum (in this model the 
vacuum is used) is governed by the inverse square law, proving thus the accuracy of the user-
written EGSnrc code. 
Table 4.2. gives the CPU times for each simulation undertaken in this section. The time does not 
include the store of parameters in the computer memory, such as energy absorbed or interaction 
position (X, Y, Z) in the detector. 
Table 4.2. CPU times [seconds] spent in the simulations to test the inverse square law. Longest CPU 
times were obtained for small distances and shortest CPU times were acquired in major distances. Values 
obtained for 106 photons emitted isotropically with 140keV 
 SOURCE-DETECTOR DISTANCE [cm] 
CRYSTAL SIZE [cm2] 1 3 5 10 20 30 50 75 100 
1 1.7 1.6 1.5 1.5 1.5 1.5 1.5 1.6 1.5 
5 2.6 2.0 1.8 1.6 1.5 1.6 1.5 1.6 1.6 
10 3.0 2.4 2.1 1.8 1.7 1.6 1.6 1.6 1.6 
20 3.2 2.9 2.6 2.1 1.8 1.7 1.6 1.6 1.6 




































4.1.2. Analysis the Effect of the Crystal Thickness 
Other simulation undertaken consisted in the analysis of the detector counting efficiency, by 
varying the crystal thickness and the energy of the photon beam. For this purpose, 106 photons 
were emitted along the z-axis, incident perpendicularly to the crystal (the director cosines were 
defined in scintillator detector model as U=0; V=0 and W=1), simulating a narrow beam. All the 
simulations were performed at 10cm away from the crystal (source-detector distance) and for a 
crystal size of 40cm2 (surface area). A range of photon energies were run individually for 
several crystal thicknesses. The energies chosen were: 50, 100, 250, 500, 1000, 1500, 2000, 
2250 and 2500keV. The crystal thicknesses chosen were: 2, 5, 7.5, 10, 15, 25, 30 and 50mm. 
In order to evaluate the intrinsic efficiency of the detector, the number of absorbed photons by 
the detector was stored, for every crystal thickness mentioned above and varying the kinetic 
energy of the photon beam. The simulated data were compared with the theoretical ones. 
From the theory, the detector counting efficiency relates the amount of radiation emitted by a 
radioactive source to the amount of that radiation measured in the detector. It is calculated as a 
ratio between the detected photons by the total radiation emitted from the source. To facilitate a 
comparison between simulated and theoretical values the percentage of absorbed photons were 
calculated. 
The narrow beam used in this simulation is a difficult condition to test in real life. For this 
reason, it was also possible modelled the true narrow beam attenuation. Since the absorbed 
photons are calculated by the simulation and the total emitted photons is known (106 photons 
emitted), it is possible to identify the transmitted photons, and hence the attenuation coefficients 
considered for the energies used in the simulation. Consequently, besides the analysis of the 
detector counting efficiency, also the attenuation coefficients were calculated and compared 
with the theoretical attenuation coefficients. 
Figure 4.3. shows the detector intrinsic efficiency vs. photon energies (keV), for different 




Figure 4.3. Intrinsic 
Efficiency of the NaI crystal. 
Simulation obtained for 
several crystal thicknesses 
[mm] by varying the energy 
of the incident photons 
[keV]. 106 photons emitted, 
normally incident on the 
crystal 
 
The error bars are not visible in the figure (smallest than 1% for all the measurements). To an 
easier analysis and comparison with the theoretical values, the x-axis of the figure is represented 
in logarithm scale. Each line represents the percent absorption of a narrow beam of photons 
normally incident on the detector in accordance to its thickness. As expected, it is possible 
verify that the gamma camera is nearly 100% efficient for energies up to about 100keV, for all 
crystal thicknesses. After this energy, however, the detector shows a rather marked decrease in 
efficiency with increasing energy, which depends of the crystal thickness. 
Analysing the figure 4.3., it is possible to infer that as the energy increases the intrinsic 
efficiency decreases, due to the decreasing in the attenuation coefficient when the energy 
increases which implies less attenuation of photons. Likewise, one verifies that the intrinsic 
efficiency increases with increasing crystal thickness, since the volume of the crystal rises 
allowing more interactions and absorbed photons inside the crystal. Consequently, the detector 
efficiency tends to zero for high-energy photons and thinner detectors. Those conditions are 
applied to all solid scintillation detectors.  
Figure 4.4. gives the theoretical data of the detector efficiency for a NaI(Tl) crystal, collected 







































Figure 4.4. Absorption 
Efficiency of NaI(Tl) 
crystal. Theoretical data 
collected from SGC 
(2008). The calculation of 
these data was based on 
the exponential function 
given in equation 2.23, for 
certain values of thickness 
 
Comparing the simulated data with the theoretical values by a qualitative analysis procedure, it 
is possible to realise that the curves are very similar. For example, comparing the curves of 
2mm and 25mm thickness in both figures 4.3. and 4.4., one verifies that the curves follow the 
same shape with identical values, which demonstrate, once again, the truthfulness of the code. 
For photons with 100keV of energy, 2mm thickness attenuates almost 75% of the photons, 
whilst for higher thicknesses all the photons are attenuated. Low-energy photons, 100keV or 
less, are predominantly absorbed by photoelectric events in the detector. Above that energy, 
Compton scattering becomes more appreciable and above 2MeV the pair production become 
more relevant.  
From the figures illustrated above, one confirms that the probability of the photon interactions 
depends of the energy of the photons, the crystal thickness and the material traversed. This 
probability, known as linear attenuation coefficient, μ, was calculated based on the simulated 
values obtained above. From equation 2.23., the natural log of fractional reduction of the 





) = 𝜇𝑥    Eq. (4.1) 
Consequently, by plotting the Ln(I/Io) against the crystal thickness, x, the linear attenuation 




Figure 4.5. Natural Log of the 
fractional reduction of the 
intensity beam. Simulation 
obtained to find the linear 
attenuation coefficient 
 
By linear regression analysis and additional regression statistics in Excel, it is possible to find 
the slope of the regression line, μ, and the standard error of the slope. The values of μ and the 
standard error (±1σ) of the slope are shown in table 4.3., in addition with the analytical values of 
the μ given by XCOM from NIST (Berger et al., 1998). 
Table 4.3. Simulated and analytical values of the linear attenuation coefficient (Theoretical Data from 
XCOM: Berger et al., 1998 in NIST) 
ENERGY [keV] TREND LINE 
SIMULATED [cm-1] 





50 y = 37.528x + 0.0052 37.528 ± 0.0901 38.4302 2.35 
100 y = 5.5235x + 0.1571 5.5235 ± 0.05343 6.1202 9.75 
500 y = 0.3331x + 0.0402 0.3331 ± 0.00102 0.3484 4.38 
1000 y = 0.2122x + 0.0229 0.2122 ± 0.00062 0.2156 1.59 
1500 y = 0.1701x + 0.0177 0.1701 ± 0.00053 0.1723 1.30 
2000 y = 0.1517x + 0.0132 0.1517 ± 0.00038 0.1522 0.32 
2250 y = 0.1454x + 0.0127 0.1454 ± 0.00037 0.1479 1.67 
2500 y = 0.1411x + 0.0117 0.1411 ± 0.00034 0.1436 1.72 
 
In all trend lines the coefficient of determination (R2) was equal to 0.999, presenting a very good 
linear relationship between the thickness and natural log of the fractional reduction of the 
intensity beam. Percent errors (difference between theoretical and simulated values as a fraction 
of the theoretical value, multiplied by 100) show a good accuracy between simulated and 
theoretical values. The percent errors are larger at low photon energies than at high energies. 
This smooth discrepancy might result from the slight difference between the material used in 
the simulation (just NaI) and the real material used in equipment (NaI(Tl)), being the difference 
much more marked at low photon energies. Theoretical and simulated attenuation coefficients 





























































Figure 4.6. Simulated and analytical 
values of the linear attenuation 
coefficients. (Theoretical Data from 
XCOM: Berger et al., 1998 in NIST) 
 
The y-axis of the figure 4.6. is represented in a logarithm scale to an easier analysis and 
comparison with the theoretical data. The error bars, uncertainty of the simulated values, are 
represented by ±1σ. However, they are not visible because they are smaller (<1%) in 
comparison with the size of the dots. Since one might expect that roughly 2/3 (68.2%) of one’s 
simulations will fall within this range, one may infer that the simulated values are consistent 
with the expected values. Consequently, the linear attenuation coefficients for primary photons, 
obtained from the simulation, agree well with the published data providing an additional 
validation of the EGS code model. 
It is important to refer that in radionuclide therapy, the number of incident and transmitted 
photons is activity-dependent. However, the product μx is an important parameter relating to the 
anatomy of the patient along a given ray photon. Therefore, patients with larger anatomy 
attenuate more photons in comparison with a thin anatomy. 
Table 4.4. gives the CPU times for each simulation undertaken in this section. The time includes 
the store, in the computer memory, of the energy absorbed and interaction positions (X, Y, Z), 
for each photon event. 
Table 4.4. CPU times [seconds] spent in the simulations to test the effect of the crystal thickness. Values 
obtained for 106 photons emitted perpendicularly to the crystal 
 CRYSTAL THICKNESS [mm] 
ENERGY [keV] 2 5 7.5 10 15 25 30 50 
50 51.4 54.6 53.5 52.3 52.5 52.5 52.4 53.9 
100 49.6 56.9 57.0 55.5 57.4 57.0 57.3 56.1 
250 32.3 39.7 46.0 49.0 58.3 65.5 69.5 75.1 
500 26.3 31.2 35.7 39.2 47.0 62.1 66.8 83.8 
1000 22.0 25.8 28.9 32.1 38.1 49.2 55.4 76.5 
1500 20.5 23.1 26.8 29.0 34.4 44.5 50.0 68.1 
2000 19.5 21.5 23.7 27.1 31.1 41.5 46.1 64.7 
2250 19.2 21.3 23.5 25.8 31.2 40.3 45.3 64.7 









































4.1.3. Analysis the Effect of the Glass behind the Crystal 
The analysis of backscattering photons was also tested. In this simulation the point source of 
photons was placed on the surface of the glass and 106 photons were emitted. Photons were 
emitted both in a straight direction, along the z-axis and entering perpendicularly into the glass 
(U=0; V=0 and W=1) and also isotropically, in order to see the spectrum differences. 
Since the amount of energy transferred to the scattered photon varies with photon energy, three 
different photons energies were tested, being these: 100, 200 and 500keV. Also, for every 
photon energy, different glass thicknesses were simulated. The glass thicknesses tested were: 1, 
5, 10, 20 and 50mm. The crystal was unchanged, with measures of 1cm thickness and 40cm2 
size. The aim was to detect the backscattering photons by varying the thickness of the glass and 
the energy of the photons emitted. 
The subroutine HOWFAR was defined to discard all the photons outside the crystal and count 
only the ones that interact with the crystal. Therefore, since the point source is placed at the 
beginning of the surface glass, in front of the crystal, it is to expect that, according to the Klein-
Nishina formulation, only the photons scattered with angles higher than 90º are detected and 
added to the count. 
In a first analysis, the effect of the glass thickness was investigated in order to analyse the 
backscattered photons, by varying the energy of the photons and the thickness of the glass. 
The first figure on the left corresponds to the photons emitted along the z-axis perpendicularly 
to the glass whereas the figure on the right is related with the photons emitted isotropically. 
  
Figure 4.7. Effect of the glass thickness to analyse 
the photons' backscatter. Photons emitted along the 
z-axis, perpendicularly to the crystal 
Figure 4.8. Effect of the glass to analyse the 

























































As expected, when the photons are emitted perpendicularly to the glass and the glass thickness 
is small, an insignificant amount of backscattered photons are detected by the crystal. As the 
thickness increases, the photons encounter a higher volume in their path. Consequently, increase 
the number of interactions and the likelihood of the photons being backscattered. Thus, when 
the glass thickness increases, more photons are backscattered and hence more photons are 
detected and counted by the crystal. 
In figure 4.7. the idea is the same with the slight difference that the photons are emitted 
isotropically. In this case the monoenergetic photons are emitted equally in all directions. 
Therefore, the number of photons detected by the crystal is much higher in comparison with the 
photons emitted normally to the glass even when the glass thickness is insignificant. In broad 
terms, all the photons emitted in the semicircle inside the crystal are counted, as well as the 
photons emitted through the glass and scattered by it, in an angle higher than 90º. 
It is possible to note in both figures that low energies cause more backscattering photons and 
high energies less backscattering photons. This is due to the fact of low energies are easily 
attenuate and have a highest likelihood of interact, contrary to the high-energy photons that 
might pass through the material without interact, having for that a high value of attenuation 
coefficient.  
The following figure shows the number of absorbed photons by the crystal vs. their energy 
deposited, plotted for 1, 10 and 50mm of glass thickness. All the graphics on the left are related 
with the photons emitted along the z-axis, normally to the glass and the graphics on the right 
side correspond to the photons emitted isotropically. The first line of the graphics represent 
simulation for photons with 100keV, followed 200keV and the last line represent photons with 
500keV. 
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 C  C1 
Figure 4.9. Analysis of backscattering photons. Spectrum A and A1 acquired for 100keV photons 
energies; spectrum B and B1 acquired for 200keV photons energies and spectrum C and C1 acquired for 
500keV photons energies. Spectra A, B and C developed for photons emitted perpendicularly to the 
glass, forming the backscatter peak, and A1, B1 and C1 created for photons emitted isotropically 
 
From the theory, as explained in section 2.1.3., backscatter peak is caused by the detection of 
photons that have been scattered toward the crystal after undergoing a 180º scattering outside 
the detector. Usually, the majority of scatter events occur from the photons which have 
undergone Compton interaction. In this case the electron receives the maximum energy and the 
scattered photon the minimum. The energy of the backscatter peak is the energy of the scattered 
photon after a 180º scattering. This energy varies according to the energy of the photons 
emitted, i.e., high-energy photons, high-energy backscatter peak. For that reason three different 
energies were simulated. The backscattering energy can be calculated applying the Klein-
Nishina formula, given in equation 2.17., defining the angle θ equal to 180°. From this equation, 
theoretical values of the energy of the backscatter peak are given in following table, together 



























































































































Table 4.5. Analytical and simulated values of the energy of the scatter photons, for a point source of 





[keV] AND ERROR (±1σ) 
PERCENT ERROR 
[%] 
100 71.87 73 ± 8.54 1.57 
200 112.18 114 ± 10.68 1.62 
500 169.09 172 ± 13.12 1.72 
 
Analysing, in broad terms, the theoretical and the simulated values, one verifies that there is a 
close correspondence between those values, with percent errors in all of them less than 2%. 
Such as verified in figures 4.6 and 4.7 and for the same reasons explained, in all graphics 
presented above it is possible verify that the greater glass thickness causes more absorption of 
photons, contrary to the small glass thickness. According to the figure, it is also notable that as 
the energy increases (comparison between lines) the backscatter peak is shifting the right. The 
centre of peak undergoes a translocation to the right, which mean that the energy of the 
backscatter peak increases as the photon energy increases, which is in accordance with the 
theory. Also, when the energy increases the number of photons absorbed decreases, for the same 
reason explain above. For example, for 50mm of glass thickness, a point source of photons 
emitted in straight direction with 100keV generates twice and seven times more scatter photons 
in comparison with a point source of photons with 200keV and 500keV, respectively. 
The figure shows, for all the materials, a broad backscatter peak because backscattered photons 
may enter the crystal from angles other than 180º. 
In the spectra A, B and C, which were modelled with photons emitted perpendicularly to the 
glass, two peaks are visible: the backscatter peak and a peak that appears on the left side of the 
backscatter peak. This corresponds to the iodine escape peak, resultant from the photoelectric 
event between the scatter photons and the iodine atoms. The iodine escape peak occurs at an 
energy approximately equal to the photon energy subtracted ≈30keV, corresponding to the 
biding K-shell energy of the iodine. From the analysis of the figure, one confirms that the 
energy of the iodine peak, in each figure, is in accordance with the theory. 
In isotropic emissions, represented by the spectra A1, B1 and C1 there are four different peaks. 
Since in an isotropic emission the photons emitted inside the semicircle of the crystal are 
counted, a photopeak is created. The photopeak (represented by a dot on the small figure in the 
corner) results from the total absorption of the major photons from the radionuclide. The other 
three peaks corresponds to the backscatter peak, and a two iodine escape peaks, one caused by 
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the interaction between the scatter photons and iodine and other between the primary photons 
emitted from the source and iodine. 
All the events represented in the figure are in agreement to the expected and therefore with the 
theory, which proves once more the truth and veracity of the code. 
Table 4.6. and 4.7. gives the CPU times for each simulation undertaken in this section. The time 
includes the score of the parameters, energy absorbed, interaction position (X, Y, Z), and 
direction cosines (U,V,W) for each photon interaction, in the computer memory. 
Table 4.6. CPU times [seconds] spent in the simulations to test the effect of the glass thickness. Values 
obtained for 106 photons emitted along the z-axis, perpendicularly to the glass 
 GLASS THICKNESS [mm] 
ENERGY [keV] 1 5 10 20 50 
100 23.4 34.4 50.1 78.2 134.4 
200 21.9 31.6 44.9 71.5 150.2 
500 20.7 28.1 37.6 60.1 134.9 
 
Table 4.7. CPU times [seconds] spent in the simulations to test the effect of the glass thickness. Values 
obtained for 106 photons emitted isotropically 
 GLASS THICKNESS [mm] 
ENERGY [keV] 1 5 10 20 50 
100 65.8 79.9 92.1 110.0 128.2 
200 62.2 79.5 90.9 112.3 145.3 





4.2. Bremsstrahlung Simulations 
The conditions simulated before were according to the theoretical and published data, proving 
the accuracy of the code. After this confirmation of the veracity of the code, different 
simulations in different types of physical conditions were undertaken to test the 
bremsstrahlung comportment. 
The source model was the EGSnrc code used for all the simulations tested in this section, 
with the geometry and components described in section 3.1.3. The parameters of the sphere 
defined in this model were changed according to the physical conditions to test. A point 
source of pure beta emitters, placed in the middle of the sphere, also change its kinetic 
energy according to the simulation. It is important to refer, once again, that in EGSnrc it 
is necessary add the rest mass energy of the electrons into the energy parameter. 
Therefore, if 100keV of kinetic energy must be chosen, 611keV have to be defined in the 
energy parameter. 
In order to understand in what way the bremsstrahlung photons are produced in different 
media, using different energies of the beta particles, four different biological materials were 
chosen to do the simulations. These are cortical bone, inflated lung, soft tissue and 
adipose tissue. All the media were previously defined in PEGS4. 
It is also important to refer that, in order to know with accuracy the effective atomic number of 
each material used in the simulations some calculations were made.  
According to Murty (1965) a heterogeneous material, compose by different elements in varying 
proportions can be defined as a “fictitious element” having an effective atomic number (Zeff). 
Mayneord, quoted by Khan (2003), developed the following expression to calculate the Zeff, 
which was used in the study. 
𝑍𝑒𝑓𝑓 = √∑𝑎𝑖 . 𝑍𝑖
2.942.94
    (Eq. 4.1) 
Where ai is the relative electron fraction of the element i and Zi the atomic number of each 
element i that compose the material. The fractional contribution of each element to the total 




       (Eq. 4.2) 
Where NA is the Avogadro’s number, Pi is the percentage weight of element i, Ai the atomic 
weight and no is the total number of electrons/g of the material, which is given by: 
𝑛𝑜 = 𝑁𝐴. ∑
𝑃𝑖.𝑍𝑖
.𝐴𝑖
      (Eq. 3) 
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Substituting no in Eq. 4.2, the effective atomic number of any material might be achieved 
(Khan, 2003). Zeff was founded in this investigation with base in the values given by PEGS4 
data files for each compound. After the creation of the PEGS4 file for individual material, it 
provides all the elements that compose the medium, the respect fraction weight, and the atomic 
weight. The effective atomic number calculated for each biological material is given in table 
4.8. 
Table 4.8. Effective atomic number of some biological compounds 
COMPOUND EFFECTIVE ATOMIC NUMBER (Zeff) 
Cortical Bone 12.970 
Lung Tissue 7.489 
Soft Tissue 7.223 
Adipose Tissue 6.231 
 
Bremsstrahlung simulations and the corresponding method and discussion are explained below. 
The data recorded by the simulation were processed Excel (Microsoft Corp., Redmond, USA). 
 
4.2.1. Analysis of the Bremsstrahlung Production Efficiency 
The first simulation to assess bremsstrahlung photons consisted in to test its efficiency of 
production in different sphere thicknesses. The aim was to see what is the maximum sphere 
thickness required from which the number of bremsstrahlung photons become constant. 
This simulation was undertaken for different beta particles kinetic energies, namely for 0.5, 1, 
1.5, 2.23 and 3MeV. The point source of beta particles was placed in the middles of the sphere, 
and various sphere radii were simulated. These radii ranged from 0.01 to 10mm, according to 
the medium. 106 beta particles were emitted isotropically. 
From the theory the efficiency of bremsstrahlung production is related with the penetration of 
the beta particles in the media, which in turn depends of the beta particles energy and the atomic 
number of the material penetrated. It is to expect that, as the energy and the atomic number of 
the media increase, the bremsstrahlung production efficiency also increases. 
The figure below shows the results obtained from the simulation. The outcome is the 
bremsstrahlung production efficiency by varying the sphere thickness and the beta particles 





Figure 4.10. Bremsstrahlung production efficiency by varying the radius of the sphere and the beta 
particles energy, in the four different materials. 106 beta particles emitted from a point source in the 
middle of the sphere 
 
From the analysis of the figure, one notices that some characteristics are common for all the 
biological materials. It is possible to verify that the number of the bremsstrahlung produced 
increases with increasing of the kinetic energy of the beta particles and also with increasing of 
the radius of the sphere, which is in accordance with the physics theory. 
In all the materials, when the sphere thickness is insignificant almost no bremsstrahlung photons 
are produced. As the radius of the sphere increases, the efficiency of the photons production 
also increases, creating a steep line. However, from a certain radius this number becomes 
constant, and the line becomes flat. One confirms that the radius of the sphere, from which this 
flat line starts to appear, is slightly higher for high-energy beta particles. Those mechanisms are 












































































































































rest. The electrons range is in turn related with electrons kinetic energy. Thus, in comparison 
with low-energy beta particles, high-energy beta particles create a greater range, consequently 
there is a greater bremsstrahlung efficiency and therefore it is necessary a greater radius of the 
sphere until the efficiency becomes constant. 
Beyond the increase of the bremsstrahlung photons with the electrons kinetic energy, they also 
increase with the effective atomic number, Zeff, of the absorber. Comparing the materials 
between each other, such as it was expected, the cortical bone is the material that produces more 
bremsstrahlung photons, due to its high value of Zeff (12.97). On the other hand, adipose tissue 
has the smallest value of Zeff (6.231) and consequently the lowest number of bremsstrahlung 
produced. Soft tissue and the lung have almost the same efficiency of bremsstrahlung 
production since both have Zeff very similar (7.223 and 7.489, respectively). For example, 
considering the electron kinetic energy equal to 1.5MeV, the cortical bone produced 38% more 
bremsstrahlung photons than the lung, and 39% and 48% more bremsstrahlung photons than the 
soft tissue and adipose tissue, respectively. However, the lung requires the higher sphere 
thickness to achieve a constant production efficiency, in comparison with all the others 
materials. This is because inflated or expanded lung is considered in these measurements and 
therefore, the electrons may travel a large distance until losing all their energy. 
Values in the table 4.9. show, for all the biological materials, the maximum number of the 
bremsstrahlung produced for a certain sphere thickness, taking into account the different initial 
beta particles kinetic energy. 
Table 4.9. Maximum radius of the sphere, from which the number of bremsstrahlung produced inside it 
become constant. Bremsstrahlung photons produced when 106 beta particles are emitted isotropically, for 
different beta particle kinetic energy and in four different biological materials 
  
KINETIC ENERGY OF THE BETA PARTICLES [keV] 
  
250 500 1000 1500 2230 3000 
CORTICAL 
BONE 
Sphere Radius [cm]  0.05 0.1 0.25 0.5 0.75 1 
Num. of Brem. 
Produced and Error 
(±1σ) 
10849±104 27539±166 69202±263 118665±345 200740±448 296790±545 
INFLATED 
LUNG 
Sphere Radius [cm] 0.25 0.75 2 3 4 5 
Num. of Brem. 
Produced and Error 
(±1σ) 
6476±81 16573±129 42939±207 73771±272 124330±353 181445±426 
SOFT 
TISSUE 
Sphere Radius [cm] 0.075 0.25 0.5 0.75 1 3 
Num. of Brem. 
Produced and Error 
(±1σ) 
6321±80 15969±126 41104±203 71883±268 121926±349 183218±428 
ADIPOSE 
TISSUE 
Sphere Radius [cm] 0.075 0.25 0.5 0.75 1 3 
Num. of Brem. 
Produced and Error 
(±1σ) 
5190±72 13465±116 34922±187 61372±248 101878±319 158483±398 
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The uncertainties of the counts are given within ±1σ. Therefore, there is a 68.2% chance that the 
confidence interval covers the true value. 
Figure 4.9. and the table 4.8., show that the maximum value of the sphere radius, for which the 
efficiency of the bremsstrahlung production stagnates, is dependent of the material composition 
and the initial kinetic energy of the beta particles. 
From table 4.8., one verifies that, for each material, when the initial kinetic energy increases, the 
radius of the sphere also increases, as well as the efficiency of bremsstrahlung production. This 
fact is due to the greater penetration of the electrons inside the sphere. On the other hand, denser 
materials produce a shorter electrons range. Therefore, for the same initial kinetic energy, 
denser materials have the shorter radius of the sphere and the highest number of bremsstrahlung 
produced. At a dosimetric level, it is vital to know the maximum electrons range, since it is 
along this path that occurs the dose absorption in the tissues. As explained in section 2.1.4., 
figure 4.9. confirms that the efficiency of photons production increases with the atomic number 
of the material and with the initial kinetic energy of the electrons. 
Table 4.10. gives the CPU times. The values presented in the table correspond only to the 
simulations whose values are presented in the table above, table 4.8., i.e., the values in which 
the bremsstrahlung production is maximum. The time includes the score of the parameters – 
produced and escaped bremsstrahlung spectra (number of bremsstrahlung photons 
produced/escaped vs. respective energies), in the computer memory. 
Table 4.10. CPU times [seconds] obtained for the maximum radius of the sphere from which the number 
of bremsstrahlung produced become constant 
  
KINETIC ENERGY OF THE BETA PARTICLES [keV] 
  
250 500 1000 1500 2230 3000 
CORTICAL 
BONE 
Sphere Radius [cm] 0.05 0.1 0.25 0.5 0.75 1 
CPU time [sec] 134.0 203.1 328.0 448.2 629.5 782.6 
INFLATED 
LUNG 
Sphere Radius [cm] 0.25 0.75 2 3 4 5 
CPU time [sec] 90.5 139.1 223.3 302.8 421.5 510.5 
SOFT 
TISSUE 
Sphere Radius [cm] 0.075 0.25 0.5 0.75 1 3 
CPU time [sec] 90.8 137.8 217.4 178.6 309.9 410.4 
ADIPOSE 
TISSUE 
Sphere Radius [cm] 0.075 0.25 0.5 0.75 1 3 







4.2.2. Analysis of the Bremsstrahlung Yield (%) 
The radiation or bremsstrahlung yield (Y) was also investigated. In order to know the fraction of 
kinetic energy of primary electrons converted into bremsstrahlung photons, 106 beta particles 
were emitted isotropically inside a sphere with 1cm of radius. For all the biological materials 
considered in these study and such as the previously simulations, different initial kinetic energy 
were tested, namely, 250, 500, 1000, 1500, 2230 and 300keV. 
To identify the bremsstrahlung yield the number of bremsstrahlung produced and the respective 
energy were scored. Then, the total of energy produced by bremsstrahlung was calculated, for 
each energy tested and for individually materials. Such as explained in section 2.1.4., the 
bremsstrahlung yield is defined as the fraction of kinetic energy of primary electrons converted 
into bremsstrahlung photons, through the slowing down process of the particle in the absorber 
Therefore, to calculate it, the total bremsstrahlung energy was then divided by the total of 
kinetic energy emitted from the source (the kinetic energy tested multiply by the 106 particles 
emitted). Instead the fraction, the analysis of the percent of bremsstrahlung produced was 
preferable. Figure 4.11. illustrates the result of this simulation for the different materials, i.e., 
the percentage of the total energy emitted from the source converted into bremsstrahlung. 
 
Figure 4.11. Bremsstrahlung yield, in 
percentage. Values obtained for four 
biological materials, when 106 beta 
particles are emitted isotropically 
inside a sphere of 1cm of radius 
 
 
The graph presents a logarithm scale, in the x-axis, to an easier analysis. The uncertainty of the 
bremsstrahlung yield and hence, the error bars, are represented as percentage (%), with ±1σ. 
However, the values are smallest than 1% and the error bars are not visible. 
From the analysis of the figure and for all the biological materials, it possible to verify that, as it 
was expected in accordance with the theory, the radiation yield increases with the electron 
kinetic energy. At very high energies, the dominance of radiative over collisional energy losses 
gives rise to electron-photon cascade showers. This means that high-energy beta particles emit 
high-energy photons, which in turn in turn, produce Compton electrons and electron-positron 
































bremsstrahlung yield also increases with the atomic number, Z of the material, since cortical 
presents the highest value of Z, followed by soft tissue and adipose tissue. The bremsstrahlung 
yield in the inflated lung is small in comparison with the other materials because in these 
simulations the sphere radius used is 1cm. By the analysis of the table 4.8., one verifies that, 
from 1MeV, the number of bremsstrahlung produced in inflated lung might only increase if the 
sphere radius also increases. For that reason the value of bremsstrahlung yield almost stagnates 
from 1MeV onwards. 
Since for light charged particles the radiation yield is determined from stopping power data, a 
comparison between the theoretical and the simulated values are possible. Throughout the 
ESTAR program (Berger et al., 2011), available in NIST, the radiation yield was calculated for 
the diverse materials and energies investigated. Figure 4.11. shows the comparison between 
simulated and analytical data. 
  
  
Figure 4.12. Analytical and simulated values of bremsstrahlung yield, in percentage. Values presented for 
different biological material. 106 beta particles emitted from a sphere with 1cm radius (Theoretical Data 


















































































































Once again the errors are given as percentage uncertainty (%) with ±1σ. The values simulated 
agreed well with the analytical values. However, there are slight differences at high-energies 
because a fixed sphere radius of 1cm is used. At high-energies, the range of the electrons is 
higher and consequently the radius of sphere should be higher in order to permits the increase of 
bremsstrahlung photons production. Using 1cm radius this production is restricted to that 
thickness. Furthermore, the inflated lung presents differences between the values. Beyond the 
fact explained previously, also this may be due to the values given by the ESTAR do not take 
into account the inflated lung but the radiation yield in lung tissue. 
Table 4.11. gives the simulated and analytical values, as well as the percentage uncertainty and 
the percent error. 
Table 4.11. Simulated and analytica values of the bremsstrahlung radiation yield (Theoretical Data from 
ESTAR database: Berger et al., 2011in NIST) 
   
TOTAL KINETIC ENERGY EMITTED FROM THE SOURCE [x106 keV] 
   





0.1931 0.3236 0.5755 0.8382 1.2550 1.6890 
SIMULATED 
VALUES±ERROR [%] 
0.1725±0.0022 0.3073±0.0028 0.5641±0.0036 0.8346±0.0043 1.2606±0.0053 1.7126±0.0062 





0.1159 0.1973 0.3576 0.5279 0.8026 1.0920 
SIMULATED 
VALUES±ERROR [%] 
0.1031±0.0017 0.1853±0.0022 0.2829±0.0027 0.2915±0.0029 0.3140±0.0031 0.3355±0.0032 





0.1102 0.1880 0.3416 0.5051 0.7690 1.0470 
SIMULATED 
VALUES±ERROR [%] 
0.1019±0.0017 0.1769±0.0021 0.3360±0.0028 0.5014±0.0034 0.7622±0.0042 0.9554±0.0048 





0.0924 0.1588 0.2915 0.4334 0.6630 0.9055 
SIMULATED 
VALUES±ERROR [%] 
0.0830±0.0015 0.1476±0.0019 0.2856±0.0026 0.4282±0.0046 0.6456±0.0038 0.7935±0.0044 
PERCENT ERROR [%] 10.2345 7.0723 2.0187 1.1935 2.6287 12.3656 
 
In most of the measurements the percent error is less than 10% which show a good accuracy 
between theoretical and simulated values. The simulated values are consistent with the 
published data, with approximately 68.2% confidence, within ±1σ. This provides an additional 
validation of the Monte Carlo model and of the method for calculating Y.  
Analysing the table, one confirms that, except the cortical bone at high-energies, the percentage 
of the total energy emitted from a monoenergetic point source converted into bremsstrahlung is 
less than 1%, when 106 beta particles are emitted. In practical cases, for example patients with 
hepatic tumours, who may be treated with 90Y resin or glass microspheres, receive more than 
3GBq of activity. These represent ≈1015 radiative atoms, which mean that less than 3% of the 
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total energy emitted inside the patient will be converted into bremsstrahlung, and consequently 
will be the only radiation available to be imaged. These values demonstrated the small 
efficiency of bremsstrahlung photons production, which difficult the pure beta emitters. 
Table 4.12. gives the CPU times for each simulation undertaken in this section. The time 
includes the score of the parameters – produced and escaped bremsstrahlung spectra (number of 
bremsstrahlung photons produced/escaped vs. respective energies) and the photons escaped 
position (X, Y, Z), in the computer memory. 
Table 4.12. CPU times [seconds] spent in the simulations to analyse the bremsstrahlung yield. Values 
obtained for 106 beta particles emitted isotropically inside a sphere with 1cm radius 
   
TOTAL KINETIC ENERGY EMITTED FROM THE SOURCE [x106 keV] 
   




















63.8 97.9 159.9 221.8 284.6 249.8 
 
4.2.3. Analysis of the Bremsstrahlung Spectrum Shapes  
Other simulation undertaken consisted in to analyse the shapes of the bremsstrahlung spectrum 
produced in each material. For this purpose 106 beta particles were emitted isotropically, inside 
a sphere with 1cm of radius. The beta particles were emitted with 500keV of kinetic energy. The 
spectrum of bremsstrahlung was studied for all the materials. Therefore, the number of 
bremsstrahlung produced inside the sphere vs. its respective energy of production was scored.  
To compare the spectra shapes between the four different biological materials, normalization of 
each spectrum were required. The y-axis data – number of bremsstrahlung, was normalized as a 
function of the total of bremsstrahlung photons produced. Normalizing the data is useful to scale 
heterogeneous sets of data, so that might be compared relevantly. This process, followed for 
eliminating redundant data, establishes a meaningful relationship among the spectrum in order 
to maintain integrity of data. 
Figure 4.12. shows the bremsstrahlung spectra obtained in the simulation, for cortical bone, 
inflated lung, soft tissue and adipose tissue, when 106 monoenergetic beta particles are emitted 
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isotropically with 500keV of energy. The entire spectrum is normalized as a function of the total 
number of bremsstrahlung produced. 
 
Figure 4.13. Normalized spectra of 
bremsstrahlung produced, in the four 
different biological materials. 106 
beta particles emitted with 500keV 
kinetic energy, in the middle of a 
sphere of 1cm diameter 
 
The x-axis is presented in a logarithmic scale to show an exponential decrease in the underlying 
quantity for the given base. 
By simply looking at the normalized spectra it is observable that shapes of the bremsstrahlung 
spectra are identically analogous between all the materials. One deduces that the composition of 
the material has reasonably little effect on the shape of the bremsstrahlung spectra. Therefore, 
after the normalization, it is visible that the number of bremsstrahlung produced with certain 
energy varies in the same way in all the materials. This means that if anyone wants to use the 
bremsstrahlung spectrum data might do it for any one of these biological material by 
normalizing the data. 
It is also evident a steep fall off in the curves when the energy is 10keV. This is because the 
PCUT and AP, the cut-off energies, defined in the EGSnrc code are equal to 10keV. Therefore, 
the photons that have energies below the specified transport threshold energies are stopped and 
their histories terminate in the region. This fact proves, once again, the veracity of the code.  
In order to understand how the bremsstrahlung spectrum looks like without normalization, for 
each biological material, individual spectra were constructed. The data used were the same to 
generate the figure 4.13.. 
The figure below illustrate the bremsstrahlung spectrum for every individually material. Two 
spectra are presented in each image, the bremsstrahlung produced spectra, which comprise the 
bremsstrahlung photons created inside the sphere, and the bremsstrahlung escaped spectra. The 
escaped spectrum has considered the photons that cross the sphere surface boundary and are 









































Figure 4.14. Bremsstrahlung spectra produced and escaped in the four different materials. 
Bremsstrahlung spectra produced by a monoenergetic point source of 106 beta particles emitted with 
500keV kinetic energy inside a sphere with 1cm of radius and bremsstrahlung spectra escaped from the 
sphere, in the four different materials 
 
It is noticeable that more than a half of the photons produced are absorbed or attenuated inside a 
sphere with of 1cm radius. In the case of the cortical bone, only 10% of the produced 
bremsstrahlung photons are detected outside the surface sphere being the other 80% attenuated 
inside the material. On the other hand, inflated lung absorb 50% of the photons produced, 
followed by the adipose tissue, which absorb 60% of the photons and finally the soft tissue, 
which absorb almost 75% of the photons produced. This fact is in accordance with the values of 
the linear attenuation coefficients, for the energies of the bremsstrahlung produced which 
ranged from 10 to 100keV. Analysing the figure 4.15., the cortical bone presents the highest μ, 
and therefore almost the photons are attenuated by the material, followed by the soft tissue, 
















































































































Figure 4.15. Linear attenuation coefficients 
[cm-1] for cortical bone, inflated lung, soft 
tissue and adipose tissue (Theoretical Data 
from XCOM: Berger et al., 1998 in NIST) 
 
By the analysis of the spectra in figure 4.14, it is perceptible that only a small fraction of the 
bremsstrahlung photons produced inside the patient are able of reaching the gamma camera. 
Also, the energies of the majority bremsstrahlung photons produced ranged from 10 to 100keV, 
which means that there is a higher likelihood of the photons being absorbed by the septa 
collimator if they do not reach the crystal perpendicularly. However, photons from the higher 
energy range have an increased probability of transversing the collimator septum (producing 
lead characteristic x-rays) and detector crystal, resulting in a significant image degradation. 
To perform patient-specific dosimetry, one needs to apply quantitative methods to correct for 
scatter, photon attenuation and the degradation in spatial resolution due to the design of the 
collimator. With a better knowledge of how different components contribute to the image, such 
as scattered photons, un-scattered photons, which have penetrated the septa, back-scattered 
photons etc., one will be able to optimize acquisition parameters such as the choice of an energy 
window and a collimator. 
Table 4.13. gives the CPU times for each simulation undertaken in this section. The time 
includes the score of the parameters – produced and escaped bremsstrahlung spectra (number of 
bremsstrahlung photons produced/escaped vs. respective energies) and the photons escaped 
position (X, Y, Z), in the computer memory. 
Table 4.13. CPU times [seconds] spent in the simulations to analyse the spectra shapes. Values obtained 
for 106 beta particles emitted with 500keV, isotropically, inside a sphere with 1cm radius 
 CORTICAL BONE INFLATED LUNG SOFT TISSUE ADIPOSE TISSUE 















































4.2.4. Analysis of the Angular Distribution of the Bremsstrahlung Produced 
The distribution of angles (degrees) between incident electrons and emitted bremsstrahlung 
photons as a function of electron kinetic energy was investigated. In order to analyse the angular 
distribution 106 beta particles were emitted isotropically, also inside a sphere with 1cm of 
radius. The beta particle energies chosen to do the simulation were: 250, 500, 2230 and 
3000keV. 
Figure 4.16., shows the results from the simulation number of bremsstrahlung produced vs. 
angle of emission, for the different biological materials. 
  
  
Figure 4.16. Angular distribution between incident electrons and emitted bremsstrahlung photons as a 
function of electron kinetic energy [MeV]. Values obtained from 106 beta particles emitted isotropically, 
inside a sphere with 1cm radius 
 
It can be seen by the figure that, in all the materials, the tendency for backward scattering 
decreases with increasing electron kinetic energy. The lower the electron kinetic energy 
becomes, the more backward the bremsstrahlung photons are emitted, in comparison with the 
electron direction. Contrary, when the electron kinetic energy increases, bremsstrahlung photons 
are mainly emitted in a forward direction, i.e., the bremsstrahlung photons and the electrons 
which originate them, follow roughly the same direction. Thus, comparing between the four 
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which mean that the effective atomic number is slightly important in the angular bremsstrahlung 
distribution. 
Table 4.14. gives the CPU times. The time includes the score of the parameters – produced and 
escaped bremsstrahlung spectra (number of bremsstrahlung photons produced/escaped vs. 
respective energies) and the angle distribution spectra, in the computer memory. 
Table 4.14. CPU times [seconds] spent in the simulations to analyse the angular bremsstrahlung 
distribution. Values obtained for 106 beta particles emitted isotropically, inside a sphere with 1cm radius 
   
ELECTRON KINETIC ENERGY [keV] 
  
 
250 500 2230 3000 
CORTICAL BONE CPU time [sec] 79.4 115.6 368.2 484.4 
INFLATED LUNG CPU time [sec] 54.2 82.0 55.6 54.8 
SOFT TISSUE CPU time [sec] 54.0 134.7 249.0 232.5 
ADIPOSE TISSUE CPU time [sec] 53.4 81.8 230.5 204.1 
 
4.2.5. Analysis of the Spatial Distribution of the Bremsstrahlung Produced 
The spatial distribution of bremsstrahlung photons produced in the vicinity of the beta particles 
point source, as a fraction of the electron kinetic energy was investigated. To study the spatial 
distribution of the bremsstrahlung produced, 106 beta particles were emitted in a forward 
direction (U=0; V=0; W=1) inside a sphere, to the four biological materials studied so far. In 
order to assess the spatial distribution with more accuracy, the radius of the sphere was chosen 
with the purpose of ensure a constant efficiency in the bremsstrahlung production, i.e., 
maximise the bremsstrahlung production. As previously explained the bremsstrahlung 
efficiency varies with the media and the beta particles kinetic energy. Therefore, by the analysis 
of the table 4.8., the highest and maximum radius sphere for each material was chosen. For the 
cortical bone 1cm radius was used, for the inflated lung 5cm radius and for the soft tissue and 
adipose tissue 3cm radius was tested in the simulations. For every single material, the beta 
particles kinetic energy chosen to undertaken the simulations was 500keV and 1500keV. 
The distribution of all photons in terms of the radial distance between the point source and the 
bremsstrahlung production according to the beta particles kinetic energy is shown in the figure 
4.16. The figure 4.17 illustrates the histogram of the total number of bremsstrahlung photons 
produced between certain distances from the point source, with a distance binned of 0.05cm 
chosen for the cortical bone, soft tissue and adipose tissue, and 0.2cm for the inflated lung, since 
this material require a great radius sphere in comparison with the other materials. Figure 4.18., 
represents the histogram of the total bremsstrahlung energy (in MeV) produced within those 
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distances. To create this histogram the energies of all bremsstrahlung photons produced within a 
certain distance (bin) were identified and summed. 
   
   
   
   
Figure 4.17. Spatial distribution 
of bremsstrahlung photons as a 
fraction of the electron energy 
Figure 4.18. Frequency of the 
number of bremsstrahlung 
produced within distance ranges 
Figure 4.19. Total energy of the 




By the analysis of the figure 4.17., in all the materials, it is possible verify that the 
bremsstrahlung photons with the highest energies are produced near to the point source. As the 
electrons move along the material and move away from the point source, they lose their energy 
and consequently, the energy of the bremsstrahlung photons produced decreases. 
Analysing the figure 4.18. and 4.19., one verifies that in the cortical bone, of all bremsstrahlung 
photons produced when the beta particles are emitted with 0.5MeV, about 99.99% of those, are 
produced within 2mm, which corresponds to 1.5GeV of energy produced. When the beta 
particles are emitted with 1.5MeV, of all bremsstrahlung photons produced, approximately 86% 
are created inside a sphere with 5mm, corresponding to 7GeV of energy. 
In the case of the inflated lung, when beta particles are emitted with 0.5MeV, all the 
bremsstrahlung photons produced are radially distributed within 1cm, which correspond to 
0.9GeV of kinetic energy. On the other hand, beta particles emitted with 1.5MeV, create 
81.22% of all bremsstrahlung photons within 2cm, resulting in 6.8GeV of photons energy.  
For the soft tissue and the adipose tissue, all the bremsstrahlung photons are created within 
2mm, when the beta particles are emitted with 0.5MeV. The total kinetic energy of the 
bremsstrahlung photons is 0.9GeV, for both the biological materials. In contrast, when the 
electrons are emitted with 1.5MeV, approximately 86% of all bremsstrahlung photons are 
radially distributed within 5mm of soft tissue, corresponding to 7GeV of kinetic energy. For the 
adipose tissue, roughly 80% of photons are produced within 5mm, corresponding to 5.7GeV of 
kinetic energy. 
It is possible to confirm that, the higher the beta particles energy, the wider the spatial 
distribution of the bremsstrahlung photons produced. Therefore, bremsstrahlung photons are 
produced further away from the point source with the increase of the electrons kinetic energy. 
Table 4.15. gives the CPU times. The time includes the score of the parameters – produced and 
escaped bremsstrahlung spectra (number of bremsstrahlung photons produced/escaped vs. 
respective energies) and the spatial distribution spectra, in the computer memory. 
Table 4.15. CPU times [seconds] spent in the simulations to analyse the spatial bremsstrahlung 
distribution. Values obtained for 106 beta particles emitted in forward direction, along the z-axis 
   




CORTICAL BONE CPU time [sec] 189.6 435.0 
INFLATED LUNG CPU time [sec] 131.3 290.4 
SOFT TISSUE CPU time [sec] 75.8 171.7 




4.2.6. Analysis of the 90Y and 32P Bremsstrahlung Spectra. 
To finalise the set of Monte Carlo simulations, the bremsstrahlung production of the two most 
commonly used pure beta emitters in radionuclide therapy was characterised. The pure beta 
emitters tested were 90Y and 32P. 
The bremsstrahlung production with the point sources of 90Y and 32P was characterised in terms 
of the number of bremsstrahlung photons produced relatively to the energy spectrum of those 
bremsstrahlung photons. Also the radiation yield was calculated for each radionuclide. 
As referred in section 2.1.1., beta particles exhibit a continuous spectral kinetic energy 
distribution, resulting in a polyenergetic spectrum, ranging from zero to Emax. So far, all the 
simulations have considered monoenergetic beta point sources. However, the polyenergetic 
energy spectra for the beta sources, 90Y and 32P, was considered to undertaken the simulation of 
the bremsstrahlung spectra. To evaluate the bremsstrahlung production of the pure beta emitters, 
90Y and 32P point sources were simulated in a sphere of cortical bone, inflated lung, soft tissue 
and adipose tissue, at a depth of 1cm in a 2cm diameter sphere. Polyenergetic beta particles 
were emitted isotropically. 10 million histories were tested (107 beta particles emitted) for each 
radionuclide and in each biological material. 
Before the polyenergetic spectra being used to characterize the bremsstrahlung photons 
production, verification was first made in order to ensure a correct used of the energy spectra in 
the EGSnrc code. The confirmation was done by comparing the values of the energy spectra of 
the beta sources generated by the EGSnrc code with the theoretical data given by RADAR 
(2012). 
Theoretical data of the 90Y and 32P just provide 20 energy points, distributed in wide bins of 
114.2keV and 85.5keV, respectively. The points, at the mid-value of each bin, give the 
probability of the beta particles emission with certain energy. Theoretical points were used in 
Excel to find the energy spectra equations of the 90Y and 32P, with the intention of be used in 
EGSnrc code. 
In the case of the 90Y, the best fit was found with a fifth degree polynomial equation, whereas to 
32P the best fit was found with a fourth degree polynomial equation. The equations of 90Y and 
32P were placed in EGSnrc code, such as represented below, respectively, and verified against 








"STEP 6   DETERMINATION-OF-INICIDENT-PARTICLE-PARAMETERS     " 
"------------------------------------------------------------" 













 SPECTNUMYT(I)=SPECTNUMYT(I)+0.03522; ] 
 











 SPECTNUMPH(I)=SPECTNUMPH(I)+0.02385; ] 
 
In both equations, the values were represented with five decimal numbers to reduce the 
uncertainty. In the case of 90Y spectrum, the variable SPECTENYT (x-axis variable) denotes the 
input beta particles energy in intervals of 10keV. This variable was substituted into the resultant 
equation to obtain the output spectrum - the number of beta particles emitted with particular 
energy, which is given by the variable SPECTNUMYT (y-axis variable). For the 32P those 
variables are represented, respectively, by SPECTENPH and SPECTNUMPH. 
In order to compare the theoretical spectra with the simulated spectra, the theoretical energy 
bins width of the 90Y (114.2keV) and 32P (85.5keV) were scaled to 10keV, such as in the 
equations used in EGSnrc code. The emission spectra of the beta sources were simulated to the 
cortical bone, inflated lung, soft tissue and adipose tissue. The average of the number of beta 
particles emitted with certain energy obtained in all the materials was calculated, as a fraction of 
the total beta particles emitted (107 events), with the intention of to achieve the probability. The 
simulated and the analytical results of the energy spectra for the beta point sources, 90Y and 32P, 




Figure 4.20. Comparison between theoretical and simulated energy emitted spectra for A) 90Y point source 
and B) 32P point source (Theoretical data from RADAR, The Decay Data, 2012) 
 
By the comparison between the theoretical data and the simulated values, both for 90Y and 32P, it 
is possible to confirm that the simulated values fit the theoretical points accurately. Therefore, 
simulation with polyenergetic spectra of 90Y and 32P point sources could be used and carried out, 
in order to characterise the bremsstrahlung photons spectra of those pure beta emitters in 
different homogeneous and biological materials. The small errors in figure 4.20., might be 
associated with the polynomial degree chosen to define the equation. The higher the polynomial 
degree, the higher the probability of associated errors in the obtained values. Polyenergetic 
spectra of the beta sources were then used in EGSnrc to generate the emission of the beta 
particles with random energy, between 0 and 2.23MeV for 90Y and 1.67MeV for 32P.  
The data presented in figure 4.21 were summed to create the cumulative probability density 
functions shown in figure 4.20. 
A B 
Figure 4.21. Comparison between theoretical and simulated cumulative probabilities for A) 90Y point 
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After the validation, the bremsstrahlung photons production was simulated and characterised in 
a simulation of 107 histories, using the polyenergetic 90Y and 32P spectra. As previously referred, 
the pure beta emitters were tested individually in a sphere of cortical bone, inflated lung, soft 
tissue and adipose tissue, at a depth of 1cm in a 2cm diameter sphere. 
Bremsstrahlung produced spectra and bremsstrahlung escaped spectra were scored. The 
simulated spectra - number of bremsstrahlung photons vs. their energy, for both radionuclides, 



























































































































Figure 4.22. Bremsstrahlung photons spectra created from polyenergetic point sources of 90Y and 32P, 
for different biological materials. 107 beta particles emitted isotropically 
 
By the analysis of all the spectra in the figure 4.22., for both radionuclides 90Y and 32P, it is 
possible to perceive that the shapes of the spectra are very similar, with slight differences in the 
escaped spectra. By the comparison between 90Y and 32P spectra, it is possible observe that 
when the 90Y is the source more bremsstrahlung photons are produced, and consequently more 
emitted photons. This fact is caused by the fact of the 90Y has a wide energy spectrum in 
comparison with the 32P – 90Y has a maximum energy of 2.23MeV whereas 32P has a maximum 
energy of 1.67MeV. It is also evident a steep falloff in the curves when the energy is 10keV. As 
explained previously this is because the PCUT and AP chosen in the EGSnrc code, which is 
defined as 10keV. All photons with energy below this threshold are stopped and their histories 
terminate in the region. 
Investigating, individually, each physical medium and taking into account that 107 pure beta 
























































































































6.8% of all the beta particles interactions produce bremsstrahlung photons. Of those photons, 
about 47.1% escape from the geometric sphere in study, which means that of all beta 
interactions only 3.2% of bremsstrahlung photons produced are able to escape and being 
detected outside 1cm radius sphere. The others 52.9% of all bremsstrahlung photons produced 
are absorbed inside the sphere. On the other hand, when the 32P is the point source, 4.5% of all 
pure beta particles emitted are able to produce bremsstrahlung photons. Of those photons, 
43.3% may escape from the sphere and 56.7% are totally absorbed. In comparison with the 
others biological materials, one verifies that in the cortical bone the escaped spectra, in both 
sources, are more shifted to the right. This fact is caused by the high linear attenuation 
coefficient of the material (see table 4.14). Therefore, the low-energy bremsstrahlung photons 
are absorbed easily by the medium whereas only the high-energy photons may escape from the 
sphere. 
Examining the inflated lung, one confirms that when the 90Y is the point source, only 2.4% of 
all interactions are able to produce bremsstrahlung photons. 91.7% of those photons escape 
from 1cm radius sphere, able to be detected outside this thickness. The others 8.3% are 
completely absorbed. Alternatively, for the 32P, about 2.14% of all interactions produce 
bremsstrahlung photons. 88.8% of those photons escape from the sphere and 11.2% are 
absorbed. Since the inflated lung has the lower linear attenuation coefficient, in comparison 
with the other materials, it is perceptible this small value of absorbed photons. 
In case of the soft tissue, when the 90Y is the particles source, about 4.1% off all beta 
interactions produce bremsstrahlung photons. Of all those photons produced, 76.1% may escape 
from the sphere, which means that of all bremsstrahlung photons produced only 3.12% are able 
to escape from 1cm radius sphere. The remaining 23.9% photons are absorbed. For the 32P, 
about 2.7% of all beta interactions may produce bremsstrahlung photons. Of those, 73.3% has a 
range superior of 1cm radius and therefore they escape from the sphere in study. The others 
26.7% are absorbed. 
In the adipose tissue, when the 90Y is the point source, about 3.47% of all interactions are able to 
produce bremsstrahlung photons. Of all those photons, 83.6% may escape from the sphere in 
study. This means that only 2.9% of all bremsstrahlung produced are able to be detected outside 
of 1cm radius sphere. The remaining 16.4% are totally absorbed inside the adipose tissue. For 
the 32P, only 2.3% of all beta interactions may originate bremsstrahlung photons. Of all those 
photons, 78.3% may be detected outside the sphere, being the others 21.7% absorbed inside the 
adipose tissue. 
The next table illustrates clearly the differences between the bremsstrahlung produced, absorbed 
and escaped from the sphere with 1cm radius. The values are shown in percentage and the 
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values of the absorbed and escaped photons are associated with the total bremsstrahlung 
photons produced. 
Table 4.16. Percentage of the bremsstrahlung photons produced, absorbed and escaped, for 90Y and 32P 
sources. Percentage of the bremsstrahlung photons produced when 107 beta particles are emitted and 
percentage of those photons absorbed inside the material and escaped from 1cm radius sphere 
















6.8% 47.1% 52.9% 4.5% 43.3% 56.7% 
INFLATED 
LUNG 
2.4% 91.7% 8.3% 2.14% 88.8% 11.2% 
SOFT 
TISSUE 
4.1% 76.1% 23.9% 2.7% 73.3% 26.7% 
ADIPOSE 
TISSUE 
3.47% 83.6% 16.4% 2.3% 78.3% 21.7% 
 
In comparison with all the materials, the cortical bone is the medium that produces and absorbs 
more bremsstrahlung photons, respectively, due to its high atomic number Z and its high linear 
attenuation coefficient. 
Contrary, the inflated lung is the material that produces and absorbs the less percentage of 
bremsstrahlung photons, respectively, due to its low density material and its low linear 
attenuation coefficient. Also, the low percentage of the bremsstrahlung photons produced is due 
the small radius sphere that is taking into account in this simulation. By the analysis of the table 
4.9., and the figure 4.18., inflated lung required a higher radius sphere to produce more number 
of photons. The spatial distribution of the bremsstrahlung photons (figure 4.8.) shows that, for 
electrons with energies higher than 500keV, the highest amount of the bremsstrahlung photons 
are produced in the inflated lung after 1cm of distance from the point source. 
Soft tissue and adipose tissue show analogous values since the atomic number and the linear 
attenuation coefficients are similar. 
Table 4.17., shows the bremsstrahlung yield, in percentage, produced in the four biological 






Table 4.17. Radiative yield [%] produced by 107 beta particles emitted from 90Y and 32P point sources. 
Percentage values of the total energy emitted from the sources converted into bremsstrahlung 
 SIMULATED RADIATION YIELD AND ERROR [%] 
 90Y 32P 
CORTICAL BONE 0.689 ± 3% 0.505 ± 3.6% 
INFLATED LUNG 0.269 ± 2.8% 0.25 ± 2.6% 
SOFT TISSUE 0.417 ± 3.3% 0.298 ± 2.8% 
ADIPOSE TISSUE 0.354 ± 3% 0.255 ± 2.6% 
 
The total energy emitted from the point sources were divided by the total energy of the 
bremsstrahlung produced, and the error was calculated throughout the propagation of errors 
within ±1σ, both transformed to percentage. Analysing the table, one confirms, such as before, 
that the cortical bone is the material with the highest radiation yield and the inflated lung with 
the lowest value of radiation yield. However, the radiation yield is less than 1% in all the 
materials, which show the low efficiency of the bremsstrahlung photons production. 
From the figure 4.22. and the table 4.17., it is perceptible some of the problems found in the 
bremsstrahlung imaging. First, in all the materials and for both the radionuclides, it is visible 
that the spectrum set up by the bremsstrahlung photons that escape from the area in study is a 
continuous spectrum, ranged from 10keV (because the PCUT chosen to do the simulations) to 
the maximum kinetic energy of the pure beta particles which originate them. This is, indeed, a 
problem in the bremsstrahlung imaging since there is no a clear photopeak. Therefore, the 
choice of the energy window becomes a difficult step to imaging the bremsstrahlung photons.  
Another difficult regards to the choice of the collimator. By the figure 4.22., it is seen that the 
majority of the photons produced have energies less than 100keV. If a low-energy collimator is 
used, the high-energy photons may pass through the septa, producing lead characteristic x-rays 
and consequently the quality of the image is degraded. With this type of collimator there is a 
high sensitivity but low spatial resolution. On the other hand, if a high-energy collimator is 
used, the high-energy photons may be stopped but also the majority of the photons produced, 
reducing the sensitivity. By the analysis of the table 4.16., it is visible that the sensitivity is 
already small (less than 1%), therefore, if this collimator is used, the sensitivity may be further 
diminished, becoming insignificant to produce an image with quality. 
Thus, all the bremsstrahlung spectra, showed the three main characteristics that confirm the 
challenge in imaging the bremsstrahlung photons: they are continuous (without a photopeak), 
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they include high-energy photons (difficult to be stopped by the collimator) and they are of low 
efficiency (quantity, less than 1%). 
Table 4.18. gives the CPU times spent in these simulations. The time includes the score of the 
parameters – produced and escaped bremsstrahlung spectra (number of bremsstrahlung photons 
produced/escaped vs. respective energies) and the emission beta particles spectra, in the 
computer memory. 
Table 4.18. CPU times [seconds] spent in the simulations to analyse the bremsstrahlung spectra created 
by polyenergetic pure beta emitters, 90Y and 32P. Values obtained for 107 beta particles emitted 




CORTICAL BONE CPU time [sec] 3049.7 2357.1 
INFLATED LUNG CPU time [sec] 635.0 1196.2 
SOFT TISSUE CPU time [sec] 1783.7 1636.0 
ADIPOSE TISSUE CPU time [sec] 1208.1 1555.8 
 
With the knowledge of the characteristics of the bremsstrahlung photons produced by the 90Y 
and 32P sources, such as the photons energy, spectrum shape, the material or the radiation yield, 
it would be essential expand the study and use these information to find the better performance 
parameters of the gamma camera in order to maximise the quality of the bremsstrahlung image. 
There are relevant issues regarding to the formation of the bremsstrahlung image which require 
particular attention. If the bremsstrahlung imaging is improved, a patient-specific dosimetry can 





4.3. List-mode Acquisitions 
Beyond the bremsstrahlung simulations, it was done a set of measurements in the NM/CT 670, a 
hybrid SPECT-CT dual head camera (GE Healthcare), available in the INM. The purpose was to 
test a developed program to decoding the list mode data obtained from each acquisition, as well 
as, to assess the accuracy and performance of the gamma camera in to detect the energy of the 
photons. 
As explained previously, the data acquired during the gamma camera scan may be stored in 
frame mode or list mode. The frame mode is the most commonly used. Currently, the NM/CT 
670 SPECT-CT performs through the standard frame mode acquisition and, consequently, the 
images are visualised with based of this mode. However, the NM/CT 670 SPECT-CT, also 
allows, the storage of the list-mode data in the GE Xeleris workstation system. In the GE Xeleris 
software, the user define the parameters and specifications of the acquisition, such as the type of 
acquisition, time of acquisition, radionuclide used, patient details, collimator type and desired 
energy window(s). 
It was important validate and test the list mode decoding program, since the list mode 
acquisition allows much more flexibility the in post-processing data than is possible with frame 
mode. The list mode acquisitions the energy and positional information are stored individuality 
for each photon interaction and therefore this type of acquisition offers a widely variation of 
choices to re-binned repeatedly the data into various energies windows, matrix sizes and time 
periods. As a result, it may permit improvements in the choice of the set of the performance 
characteristics to imaging the bremsstrahlung photons. 
In each measurement undertaken to achieve the purpose, the list mode data was stored in the GE 
Xeleris workstation. Then, the data were exported to a specific directory and decoding by the 
specific program. Table 4.19. shows a simplified sample of raw data after the use of the 
decoding program.  
Table 4.19. List mode acquisition data after the use of the decoding program 
ENERGY X POSITION Y POSITION 
143.91 292.70 306.67 
140.44 297.00 297.05 
133.13 301.71 280.00 
129.28 294.00 298.40 
 
Each line of the table represents a single event. The first column represents the total energy 
deposited in the NaI(Tl) crystal of the gamma camera and the second and third columns 
characterize, respectively, the x and y positions of each interaction. In order to validate the list 
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mode decoding program, 60seconds planar (2D) acquisitions were done by using a cylindrical 
source of 99mTc, with 10MBq of activity. The source was completely shielded with lead, with 
only one side of the cylindrical able to allow the photons emission. Different energy windows 
and collimators (LEGP or MEGP) were chosen according to the measurements. The data were 
treated and binned in order to form the resultant spectrum. 
To visualize a final image obtained from the processed data and, consequently, from the 
acquisition, a Matlab code was developed. The Matlab code creates an image in a binary format. 
The code created is presented in appendix 5. 
 
4.3.1. List mode acquisitions with two energy windows selected (140.5±10% and 
450±10%). Source placed in different positions 
The first set of measurements consisted in planar acquisitions with the LEGP collimator and 
two energy windows defined in the GE Xeleris software, 140.5keV±10% and 450keV±10%. 
Three planar acquisitions were undertaken with these features. The two heads of the gamma 
camera were positioned front to front (180° between them), in a vertical position. Only one head 
were used as detector and this was defined in the workstation (head 1 or head 2). 
In the first acquisition the 99mTc source was placed in the centre of the patient table. The inferior 
head, below the table, functioned as the detector. Therefore, the open space of the lead shielding 
was pointed down and the photons were emitted through the patient table. In the second 
acquisition, the source was placed in the corner of the inferior collimator and the photon 
interactions were detected on the crystal beyond that collimator. In the last acquisition, the 
source was placed in the centre of the collimator of the inferior head, with the open space of the 
lead shielding pointed up to the superior head which functioned as the detector. Five slabs of 
perspex, with 1cm each, were placed in the patient table, right above the cylindrical source, in 
order to test the scattering and therefore see the blur in the resultant image. The setting-up of 
these acquisitions is represented in the figure 4.23. 
A B C 
Figure 4.23. Schematic representation of the setting-up used to undertake the list mode acquisitions with 
two energy windows (140.5keV±10% and 450keV±10%). Cylindrical source was placed in the A) centre 


















After the acquisitions, the list mode data were decoded one at a time by the specific program. 
The column of the energy of the raw processed data was used to plot a histogram of the total 
number of photons detected by the gamma camera vs. their energy. Therefore, three histograms 
were plotted with an energy binned of 2keV, starting in 36keV up to 176keV, since outside this 
energy range only an insignificant percentage of photons were detected. To plot the histograms, 
a program developed by Professor Rui Assis (2012) was used to an easy data processing. The 
figure 4.24 illustrates the histograms, i.e., the 99mTc spectrum of the three acquisitions. 
   
A B C 
Figure 4.24. 99mTc spectra acquired in a 60sec planar acquisitions, using a MEGP collimator and two 
energy windows 140.5±10% and 450±10%. A) cylindrical source placed in the centre of the patient table, 
B) cylindrical source placed in the corner of the collimator and C) cylindrical source placed in the centre 
of the patient table with 5slabs of perspex 
 
Two photopeaks are clearly visible in all the spectra. The photopeaks are broader due to various 
statistical variations in the process of forming the pulses, such as referred in section 2.2.3. The 
first photopeak easily identifiable regards to the characteristic x-ray peak of the collimator or 
shield lead. This peak is caused by the absorption of the lead K-shell characteristics x-rays by 
the gamma camera, when the photons interact with the collimator or shield. The lead x-ray peak 
appears, approximately, at 80keV. The second peak is caused by the total absorption in the 
crystal of the γ-rays emitted from 99mTc. In the spectra this peak appears at 142keV. It is visible 
that the spectrum B has the highest number of photons interactions, whereas the spectrum C 
admits the lowest number, followed by the spectrum A. From the acquisition A, 247883 counts 
were detected by the gamma camera in 60seconds. In the acquisition B, 266000 counts were 
detected and from the acquisition C, 102271 counts were identified by the detector. 
The different values of the detector counts are explained by the setting-up used in each 
acquisition. Such as represented in figure 4.23., in the acquisition B the source is upon the 



































































































the photons with the slabs of perspex causes many scattered photons. Therefore, fewer amounts 
of photons are absorbed and the highest left portion of the spectrum appears due to the scattered 
and backscattered γ-rays. 
For the same reason, it is expected that the images of the acquisitions A and B will appear with 
better spatial resolution than image obtained from acquisition C, which should appear more 
blurred. Applying the developed Matlab code to create a binary image from the decoding list 
mode data, one obtains the following figure. 
   
A B C 
Figure 4.25. Binary images obtained from the Matlab code. Images acquired from the processed list 
mode data and obtained from the three different setting-up. A) cylindrical source placed in the centre of 
the patient table, B) cylindrical source placed in the corner of the collimator and C) cylindrical source 
placed in the centre of the patient table with 5slabs of perspex 
 
The images were obtained with a matrix size of 256x256, a binary image with 16bits (2bytes), 
an energy window of 20% (±10%), a photopeak on the 140.5keV, which imply an energy range 
starting in 126.5keV up to 154.5keV. The value of the FOV was defined as 56.5cm (values of 
the GE NM/CT 670) which imply a pixel size approximately of 2.2mm, by the formula: pixel 
size=FOV/matrix size. All the formulas required to create the images are in the Matlab code, in 
appendix 5. 
After the decoding of the list mode data by the specific program and the spectra construction, 
one verified that all the spectra represented in figure 4.24. were continuously distributed, 
whereas only the values inside of the energy window defined by the user (140.5±10% and 
450±10%) should appear in the spectra. Once there was no photon interaction with an energy 
absorption highest than 176keV, only one photopeak was supposed to appear in the spectra 
(140.5±10%). Therefore, the decoding list mode files were analysed. In the files, one notices 
that there were some incident photons with different energies but the same X and Y positions. 
One realised that the duplicated values were related with the photons that reached the crystal 
with energies outside the energy window defined by the operator. Consequently, the position of 
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those photons was equal to the last position of the incident photon with energy between the 
acceptable values. These duplicated position values do not affect the image but only the spectra. 
Thus, after the mistake discovered the program to decoding the list mode data obtained from the 
planar acquisitions was modified and the duplicated values were eliminated. 
The first acquisition - cylindrical source placed in the centre of the patient bed (acquisition A), 
was repeated in order to recognise the spectrum which takes into account the energy window 
selected by the user. Figure 4.26., shows the correct 99mTc spectrum where the photons are 
absorbed with energy inside the energy window selected. Such as the spectra above, also this 
spectrum was plotted with an energy binned of 2keV, starting in 36keV up to 176keV. Figure 
4.27., illustrates the duplicated position values which correspond to the absorbed photons with 
energy outside the energy window. 
  
Figure 4.26. 99mTc spectrum by incident photons 
with energies inside the energy window selected 
Figure 4.27. 99mTc spectrum by incident photons 
with energies outside the energy window selected 
 
One verifies that if both spectra were overlapping, the resultant spectrum would represent the 
spectrum A in the figure 4.24. Thus, the decoding program was tested and validated. To test 
once more the correct decoding program other measurement was undertaken. 
 
4.3.2. List mode acquisition with one energy window (256±100%) defining the full 
energy spectrum 
The last measurement undertaken to validate the correct program to decoding the list mode data 
had the same setting-up as the image A of the figure 4.23., i.e., the 99mTc source was placed in 
the centre of the patient table and the inferior head served as detector. In this planar acquisition 
the LEGP collimator was used. Only one energy window was selected in the GE Xeleris 
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512keV. After the acquisition, the list mode data were decoded by the specific program and 
once again, the column of the energy of the raw processed data was used to plot a histogram of 
the total number of photons detected by the gamma camera vs. their energy, also with an energy 
binned of 2keV. Despite the fact of the full energy window has been select the maximum energy 
binned in the spectrum was 176keV, because only an insignificant percentage of photons were 
detected with highest values. By reducing the energy range in the spectrum the photopeaks are 
more easily visible. 
Since a full energy window was selected, it is expected visualise a continuous spectrum after the 
decoding of the list mode files. Figure 4.28., shows the 99mTc spectrum, plotted up to 176keV of 
energy, instead of 512keV as it was expected since the full energy window was selected. Figure 
4.29., illustrates the binary image after applying the developed Matlab code. 
  
Figure 4.28. 99mTc spectra acquired in a 60sec 
planar acquisitions, using a LEGP collimator and 
one energy window, 256±100%. The cylindrical 
source was placed in the centre of the patient table 
Figure 4.29. Binary image obtained from the 
Matlab code by using the processed list mode data. 
The cylindrical source was placed in the centre of 
the patient table 
 
The binary image were obtained with a matrix size of 256x256, with 16bits (2bytes), an energy 
window of 200% (±100%), a photopeak on the 256keV, which imply a full energy range 
starting in 0keV up to 512keV. The value of the FOV was defined as 56.5cm (values of the GE 
NM/CT 670) which imply a pixel size approximately of 2.2mm, by the formula: pixel 
size=FOV/matrix size. 
Analysing the figure 4.28., as it was expected the 99mTc spectrum is continuously distributed, 
proving once again the veracity of the decoding program. 
In all these measurements, the histograms were plotted with 2keV of energy bin. This value may 
change according to the specifications of the investigator, as well as, the energy window 
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TRT has becoming increasingly important because of the number of treatments that it now 
offers to both malignant and non-malignant conditions. Relatively high-energy pure beta 
particle emitters, such as 90Y, are the most used radionuclides in therapeutic nuclear medicine, 
with the consequent production in vivo of bremsstrahlung photons. As a result, it is crucial to 
perform new dosimetric calculations in order to measure the absorbed dose when TRT is 
performed, namely in radioimmunotherapy, since higher quantities of activity are administered. 
At a dosimetric level, the bremsstrahlung photons have an important role. Despite the fact that 
hese photons increase the absorbed dose in the patient, they are the only radiation able to be 
detected externally when the high-energy pure beta particles are administered. Thus, 
bremsstrahlung imaging may allow a dedicate treatment planning (pre-therapy), in order to 
achieve an optimal activity administered to minimise the absorbed dose by the organs, and also 
the verification of the dose delivered (post-therapy). Nevertheless, there are great challenges in 
bremsstrahlung imaging. Therefore, in many cases, the actual doses delivered are not verified 
and are simply based on pre-therapy dosimetry. On the other hand, in some circumstances, the 
administered activity is determined by minimum toxicity levels established in clinical trials. 
Accordingly, there are great benefits in to know the features of the bremsstrahlung photons in 
order to facilitate their detection externally. 
The present dissertation reports the development of a study of the characteristics of 
bremsstrahlung photons obtained through Monte Carlo simulations. The project aim was to 
investigate the characteristics and the behaviour of bremsstrahlung photons, produced by the 
emission of fast electrons in different biological homogeneous media. To reach this purpose the 
EGSnrc software (V4 2.3.2), a package of Monte Carlo simulation, was used. With this study, it 
was also intended to obtain a strong knowledge of EGSnrc system in order to be able to modify 
and produce a wide range of different simulations. Mortran codes were developed to simulate 
photon and electron transport. 
A source of photons was initially used to attain a complete knowledge of the EGSnrc system 
and to allow an easy interpretation of the results, since photons are easily understandable. Basic 
simulations with photons were firstly undertaken to test the proper working of the developed 
codes by comparing the results with the theory. The conditions simulated were in accordance 
with the theoretical and published data and therefore the codes were validated and their 
accuracy proved. Afterward, monoenergetic electron sources were simulated in four different 
biological media, namely, cortical bone, inflated lung, soft tissue and adipose tissue, with the 
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intention to study the bremsstrahlung photons. The pure beta emitters 90Y and 32P were also 
simulated by using their polyenergetic spectra. 
Results showed that the bremsstrahlung efficiency increases with the electron’s kinetic energy 
and also with the effective atomic number of the material. Cortical bone showed to be 38% 
more efficient than the lung, 39% more efficient than the soft tissue and 48% more efficient 
than the adipose tissue, when the electrons were emitted with 1.5MeV of kinetic energy. The 
production efficiency also became constant, for a particular electron kinetic energy, which 
implies a maximum electron range where the bremsstrahlung photons might be produced. For 
electrons with 1.5MeV kinetic energy, it was found that the maximum distance from which the 
bremsstrahlung efficiency has become constant depends of the material. In the cortical bone this 
distance is equal to 0.5cm, in the inflated lung it is 3cm and in the soft tissue and adipose tissue 
the value is equal to 0.75cm. After these maximum distances, the 1.5MeV electrons cannot 
produce any bremsstrahlung photons and therefore the efficiency remains independently of the 
material thickness. 
Also, results revealed that the bremsstrahlung yield (%) was less than 1% when 106 beta 
particles were emitted with energies up to 3MeV, in inflated lung, soft tissue and adipose tissue. 
In the cortical bone, bremsstrahlung yield was less than 1% for electrons with kinetic energy up 
to 1.5MeV, and 1.7% for electrons with 3MeV kinetic energy. 
When 106 electrons were emitted with 500keV in the four biological materials studied, the 
bremsstrahlung spectra obtained were normalized and the results showed that the composition 
of the material has reasonably little effect on the shape of the bremsstrahlung spectra. This 
means that the data of the bremsstrahlung photons obtained in one of these materials, may be 
used in any other study with other of these materials, if the data are normalized. 
The simulation of the angular distribution of the bremsstrahlung emission revealed, in all the 
materials, that the tendency for backward emission decreases with increasing electron kinetic 
energy, in comparison with the electron direction. When the electron kinetic energy increases, 
bremsstrahlung photons are mainly emitted in a forward direction. It was concluded the 
effective atomic number of the material is slightly important in the angular bremsstrahlung 
distribution. On the other hand, the simulation of the spatial distribution of the bremsstrahlung 
showed that the bremsstrahlung photons are produced further away from the point source with 
the increase of the electrons kinetic energy. Therefore, the higher the beta particles energy, the 
wider the spatial distribution of the bremsstrahlung photons produced. 
90Y and 32P polyenergetic spectra were simulated, revelling that 90Y produce more 
bremsstrahlung photons than 32P, due to its wide energy spectrum. In the case of the 90Y which 
is one of the most used radionuclides in TRT, for 107 beta particles emitted isotropically, the 
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results of the simulation showed that the number of the bremsstrahlung photons produced, 
absorbed and escaped from 1cm radius sphere, varied according to the material used in the 
simulation. The cortical bone was the material in which the electron interactions produced the 
highest number of bremsstrahlung photons, followed by the soft tissue, adipose tissue and 
inflated lung. On the other hand, inflated lung has revealed as the material in which more 
bremsstrahlung photons escape from 1cm radius sphere, followed by the adipose tissue, soft 
tissue and cortical bone. Thus, it was concluded that, cortical bone is the material which absorbs 
more photons inside 1cm radius sphere, followed by the soft tissue, adipose tissue and finally 
inflated lung. 
All the bremsstrahlung spectra showed three main characteristics: they are continuous (without 
a photopeak), they include high-energy photons (difficult to be stopped by the collimator) and 
they are of low intensity. These features confirm the challenges of imaging the pure beta 
emitters, explained in detail in section 2.3.4. 
With the knowledge and understanding of the bremsstrahlung photons production, one expects 
contribute with useful and significant information to future investigations. There are relevant 
issues regarding to the formation of the bremsstrahlung image which require particular 
attention. If the bremsstrahlung imaging is improved, a patient-specific dosimetry can be done 
and consequently a reduction in the patient dose might be achieved. It would be essential 
expand the study and use the acquired information to find the better performance parameters of 
the gamma camera in order to maximise the quality of the bremsstrahlung image.  
Due to the fact that this is an emerging area and in great development needs, further studies are 
required in order to establish and confirm the benefits of the practice, namely in the dosimetry 
field, to understand the real uptake of radionuclides in the patients treated by radionuclide 
therapy. 
 
5.1. Future work 
It would be convenient to extend the study in order to relate and adapt the bremsstrahlung 
characteristics to the gamma camera performances. Should be undertaken an investigation to 
improve quantitative bremsstrahlung image. 
Modifications in gamma camera instrumentation, on the imaging protocol or in computational 
algorithms and reconstruction, according to the bremsstrahlung features may improve imaging 
in TRT. Recent investigations shows (see Minarik et al., 2010) that adequate compensations for 
attenuation, scatter, and collimator response make 90Y bremsstrahlung imaging feasible, with a 
relatively good image quality and useful quantitative accuracy. 
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For dosimetric purposes, the information available may be of great importance for absorbed-
dose planning of high-dose radioimmunotherapy and for future improved dosimetry protocols, 
such as for present 90Y-based radionuclide therapies. New advances and developments in the 
patient-planning procedures should also be considered, as well as new protocols and 
measurements at a dosimetric level to regulate the exposure dose of the staff (mainly inside the 
gamma camera room) and general public, due to bremsstrahlung photons. 
Individualised image-based treatment promises dramatic benefits. A specific treatment plan for 
every TRT patient is an important procedure, both for the safety of the patient, as well as the 
protection of the staff and visitors, in order to measure the real absorbed dose.  
In the future, improvements in the bremsstrahlung imaging and, consequently, in the patient-
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APPENDIX 1. The COMMON Blocks (Kawrakow et al., 2011, pp. 110-119) 
Listed here are some of the COMMON blocks relevant to the user. To declare any of the 
COMMON blocks the COMIN macro need to be written. For example, 
COMIN/STACK,BOUNDS/; will automatically expand to the correct COMMON/STACK/; and 
COMMON/BOUNDS/; forms. 
COMMON BLOCK VARIABLE DESCRIPTION 
BOUNDS ECUT Array of regions’ charged particle cutoff energies(total) in MeV 
PCUT Array of regions’ photon cutoff energies in MeV 
VACDST Distance to transport in vacuum (default=1) 
EPCONT EDEP Energy deposited in MeV (Double Precision) 
TSTEP Distance to next interaction (cm) 
TUSTEP Total (curved) step length requested before check with geometry 
USTEP straight step length calculated from TUSTEP 
TVSTEP Actual total (curved) step length to be transported 
VSTEP actual straight step length after truncation by geometry 
IDISC User discard request flag (to be set in HOWFAR). IDISC>0 
means user requests immediate discard, IDISC<0 means user 
requests discard after completion of transport, and IDISC=0 
(default) means no user discard requested. IDISC=99 or −99 
means generate annihilation photons when positron is discarded 
IROLD Index of previous region 
IRNEW Index of new region 
RHOF Value of density correction (default=1) (i.e. ratio of real density to 
that of dataset 
EOLD Charged particle (total) energy at beginning of step in MeV 
ENEW Charged particle (total) energy at end of step in MeV 
IAUSFL Array(29) of flags for turning on various calls to AUSGAB. 
EKE Electron kinetic energy in MeV 
ELKE Natural logarithm of EKE (this is not available for a step in 
vacuum) 
GLE Natural logarithm of photon energy 
E_RANGE For electron IARG=0 steps, this is the range of the electron in the 
current units (see section 3.11.1) 
x[y][z]_final position at end of step 







SMAXIR Array($MXREG) defining upper limit on step 
size in each region (in whatever units defined by 
DUNIT). (default=1). 
ESTEPE Global energy loss constraint.(default=0.25). 




Distance from a boundary (in elastic MFP) at which to switch to 
one of the boundary crossing algorithms (BCAs).(default 3). If set 
0 by the user initially and BCA_ALGORITHM = 1, then the code 
assigns a value 




integer flag telling which transport algorithm to use 0) PRESTA-
II; 1) PRESTA-I.(default 0) 
BCA_ALGO
RITHM 
Integer flag telling which BCA to use. 0) use exact(single 
scattering) algorithm within SKINDEPTH FOR BCA of a 
boundary 1) use multiple scattering but with no lateral deflections 
within SKINDEPTH FOR BCA of a boundary. Default is 0 
SPIN_ 
EFFECTS 
Logical variable, .true.) use single & multiple scattering theories 
which include relativistic spin effects; .false.) use single and 
multiple scattering theories based on Rutherford scattering. 
(default .true.) 
MEDIA  MEDIA Array(24,$MXMED) of media names 
NMED Number of media being used (default=1) 
IRAYLM Array ($MXMED) of flags for turning on (=1) coherent (Rayleigh) 
scattering in various media. Set in HATCH based on values of 
IRAYLR. 
RLC Array ($MXMED) containing radiation lengths of the media in 
cm. 
RLDU Array($MXMED) containing radiation lengths of the media in 
distance units established by DUNIT. 
RHO Array($MXMED) containing density of the media in g/cm**3. 
MGE Array($MXMED) number of photon mapped energy intervals for 
a given medium 




character*16 variable holding the name of the file containing user-
supplied Compton cross section data. Full name of the file is 
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$HEN HOUSE/data/comp xsections compton.data. Only used if 
IBCMP=2 (bound Compton, no doppler effect). 
MISC MED Array($MXREG) containing medium index for each region. 
DUNIT The distance unit to be used. DUNIT=1 (default) establishes all 





currently in the 





CK) except NP, 
NPold and 
LATCHI) 
E Total energy in MeV (Double Precision). 
X,Y,Z. Position of particle in units established by DUNIT 
U,V,W Direction cosines of particle (not necessarily normalized if table 
lookups used for sines 
DNEAR A lower bound of distance from (X,Y,Z) to nearest surface of 
current region. 
WT Statistical weight of current particle (default=1.0). To be used in 
conjunction with variance reduction techniques as determined by 
user. 
IQ Integer charge of particle (+1,0,-1). 
IR Index of particle’s current region. 
NP The stack pointer (i.e., the particle currently being pointed to). 
Also, the number of particles on the stack. 
NPold Value of NP prior to an interaction (to test how many particles 
created 
LATCH An integer variable for use to track histories. 
LATCHI Initial value of LATCH(1) when shower called. 
UPHIOT  THETA Collision scattering angle (polar). 
SINTHE Sine of THETA. 
COSTHE Cosine of THETA. 
SINPHI Sine of PHI (the azimuthal scattering angle of the collision). 
COSPHI Cosine of PHI. 
PI Pi. 
TWOPI two Pi. 





APPENDIX 2. Specifications for AUSGAB (Kawrakow et al., 2011) 
The subroutine AUSGAB is called by EGS with the statement: CALL AUSGAB(IARG); 
The argument IARG indicates the situation under which AUSGAB is being called. IARG can 
take on 29 values starting from zero (i.e., IARG=0 through IARG=28), although only the first 
five are called by default in EGSnrc. The remaining 24 IARG values must be “switched-on” by 
means of the array IAUSFL, which is set by the value 1, in step 5: initialisation for AUSGAB. 
 
Table 2.1. Values of IARG which are on by default and for which energy is deposited 
IARG Situation 
0 Particle is going to be transported by distance TVSTEP 
1 
Particle is going to be discarded because its energy is below the cutoff ECUT (for charged 
particles) or PCUT (for photons)—but its energy is larger than the corresponding PEGS 
cutoff AE or AP, respectively. 
2 
Particle is going to be discarded because its energy is below both ECUT and AE (or PCUT 
and AP). 
3 
Particle is going to be discarded because the user requested it (in HOWFAR usually or by 
range rejection). 
4 
The difference between the energy of the incident particle and all of the final products is 
being deposited locally. This energy is due to sub-threshold relaxation events. 
 
 
Table 2.2. Values of IARG which are off by default 
IARG IAUSFL Situation 
5 6 Particle has been transported by distance TVSTEP. 
6 7 
A bremsstrahlung interaction is to occur and a call to BREMS is about to be made 
in ELECTR. 
7 8 Returned to ELECTR after a call to BREMS was made. 
8 9 
A Moller interaction is to occur and a call to MOLLER is about to be made in 
ELECTR. 
9 10 Returned to ELECTR after a call to MOLLER was made. 
10 11 
A Bhabha interaction is to occur and a call to BHABHA is about to be made in 
ELECTR. 
11 12 Returned to ELECTR after a call to BHABHA was made 
12 13 
An in-flight annihilation of the positron is to occur and a call to ANNIH is about 
to be made in ELECTR. 
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13 14 Returned to ELECTR after a call to ANNIH was made. 
14 15 A positron has annihilated at rest. 
15 16 
A pair production interaction is to occur and a call to PAIR is about to be made in 
PHOTON. 
16 17 Returned to PHOTON after a call to PAIR was made. 
17 18 
A Compton interaction is to occur and a call to COMPT is about to be made in 
PHOTON. 
18 19 Returned to PHOTON after a call to COMPT was made. 
19 20 
A photoelectric interaction is to occur and a call to PHOTO is about to be made in 
PHOTON. 
20 21 Returned to PHOTON after a call to PHOTO was made  
21 22 
Subroutine UPHI was just entered. Not entered in all cases now since the sampling 
is done more efficiently directly in some subroutines. 
22 23 Subroutine UPHI was just exited 
23 24 A coherent (Rayleigh) interaction is about to occur. 
24 25 A coherent (Rayleigh) interaction has just occurred. 
25 26 A fluorescent photon has just been created in RELAX. 
26 27 A Coster-Kronig electron has just been created in RELAX. 
27 28 An Auger electron has just been created in RELAX. 





APPENDIX 3. Scintillation Detector Model. EGSnrc code.  




!INDENT M4; "indent each mortran nesting level by 4" 
!INDENT F2; "indent each fortran nesting level by 2" 
 
$IMPLICIT-NONE;  
















$INTEGER ISAVE,ICOUNT,PHOTOELE,COMPTON,PAIRPROD;}  
"common block to store the data in array with  






REAL*8 ABSORBED,PHI,ITOTAL;}  
"define a common to pass information about geometry to the 
subroutine Howfar"  
 
REPLACE{$MXMED}WITH{2}      "2 medium in the problem" 
REPLACE{$MXREG}WITH{10}      "only 8 geometric regions" 
REPLACE{$MXSTACK}WITH{15}   "15 particles on stack at once" 
 
"REGIONS-CRYSTAL/GLASS" 
REPLACE {;COMIN/PLADTA/;} WITH {;COMMON/PLADTA/ 
PCOORD(3,$MXPLNS),PNORM(3,$MXPLNS);$REAL PCOORD,PNORM;} 
REPLACE{$MXPLNS}WITH{10}   "max 10 planes" 
 
REPLACE{$XTALPOSITION}WITH{5}  "thickness: position of the 
crystal back" 
REPLACE{$GLASSPOSITION}WITH{1+$XTALPOSITION}  "position of the 
glass back" 





REPLACE{$ZIN}WITH{-10}  "position of the particle: 10cm away" 
REPLACE{$ENERGYPART}WITH{2.5} "energy of the particle 100keV 
[MeV]" 
REPLACE{$CHARGEPART}WITH{0} "Charge of the particle" 
REPLACE{$MAXENERGY}WITH{3500}  "max energy of the spectra"  
 
REPLACE{$ELOWER}WITH{3.511}   "ECUT energy" 
REPLACE{$PLOWER}WITH{0.01}   "PCUT energy" 
"electron histories terminates at 0.651MeV (0.140+0.511MeV)" 
"photon histories terminates at 0.01MeV=10keV" 
 
"Num. of levels to generate random numbers" 





"The above expands into a series of COMMON statements;" 




"STEP 2 PRE-HATCH-CALL-INITIALIZATION                        " 
"------------------------------------------------------------" 
CHARACTER*4 MEDARR(24); 
DATA  MEDARR /$S'NaI_GLASS',15*' '/; 
 
CHARACTER*4 MEDARR1(24); 
DATA  MEDARR1 /$S'Glass',19*' '/; 
"two mediums used; each name store in an array;" 
"$ is a Mortran Macro to expand strings" 
 
call egs_init; "---step0---" 
 
 




"this is to avoid a DATA STATEMENT for a variable in COMMON" 
 
DO I=1,6 [MED(I)=0;] "define the regions: region0=vacuum" 
MED($CRYSTALRG)=1; "first region=NaI" 
MED(8)=2; "second region=Glass" 
 
%E  
DO I=1,$MXREG [ECUT(I)=$ELOWER;PCUT(I)=$PLOWER;]  




"STEP 3   HATCH-CALL                                         " 
"------------------------------------------------------------" 
 





CALL HATCH;   "pick up cross section data for NaI" 
              "data file must be assigned to unit 12" 
 
;OUTPUT AE(1)-0.511, AP(1); 
(/'knock-on electrons can be created and any electron followed 
down to:' 
,F8.3,'MeV kinetic energy' 
/'brem photons can be created and any photon followed down 
to:',F8.3,'MeV'); 





"STEP 4  INITIALIZATION-FOR-HOWFAR and HOWNEAR               " 
"------------------------------------------------------------" 
"define thickness of the material"  
"NaI is 1 cm thick; Glass is 1 cm thick" 
 










PCOORD(3,7)=$XTALPOSITION; "NaI with 1cm" 
PNORM(1,7)=0.0; 
PNORM(2,7)=0.0; 
PNORM(3,7)=1.0; "normal vector in z direction" 
 












PNORM(2,5)=1.0; "normal vector in y direction" 
PNORM(3,5)=0.0; 
 



















PCOORD(3,6)=$GLASSPOSITION; "Glass with 1cm" 
PNORM(1,6)=0.0; 
PNORM(2,6)=0.0; 




PCOORD(3,8)=$ZIN-1; "collimator back" 
PNORM(1,8)=0.0; 
PNORM(2,8)=0.0; 




"STEP 5  INITIALIZATION-FOR-AUSGAB                           " 
"------------------------------------------------------------" 
 
$INITIALIZE RNG USING $luxury_level AND $iseed;  
"Random number generator, with 2 luxury levels; 
"luxury levels are from 0 to 4 and a period of greater than 
10^165 
 
IAUSFL(7)=1; "a bremsstrahlung interaction is to occur" 
"and a call to BREMS is about to be made in ELECTR" 
IAUSFL(8)=1; "returned to ELECTR after a call to BREMS was made" 
 
IAUSFL(9)=1; "a Moller interaction is to occur and a call" 
"to MOLLER is about to be made in ELECTR" 
IAUSFL(10)=1; "returned to ELECTR after a call to MOLLER was 
made" 
 
IAUSFL(16)=1; "a pair production interaction is to occur and" 
"a call to PAIR is about to be made in PHOTON" 
IAUSFL(17)=1; "returned to PHOTON after a call to PAIR was made" 
 
IAUSFL(18)=1; "a Compton interaction is to occur and a call" 
"to COMPT is about to be made in PHOTON" 
IAUSFL(19)=1; "returned to PHOTON after a call to COMPT was 
made. 
 
IAUSFL(20)=1; "a photoelectric interaction is to occur and" 
"a call to PHOTO is about to be made in PHOTON" 





IAUSFL(24)=1; "a coherent (Rayleigh) interaction is about to 
occur" 
IAUSFL(25)=1; "a coherent (Rayleigh) interaction has just 
occurred" 
 
IAUSFL(26)=1; "a fluorescent photon has jsut been created in 
RELAX" 
IAUSFL(27)=1; "a  Coster-Kronig electron has just been created 
in RELAX" 




"STEP 6   DETERMINATION-OF-INICIDENT-PARTICLE-PARAMETERS     " 
"------------------------------------------------------------" 
 
IQIN=$CHARGEPART; "charge of the incident particle - photon"  
EIN=$ENERGYPART; "energy of the incident particle"       
/YIN,XIN/=0; "incident particle at origin: particle position" 






UIN=0;VIN=0;WIN=1; "particle moving along Z axis;" 
"comment in isotropic emission" 
 
IRIN=2; "start in region 7-inside crystal"               
WTIN=1; "weight = 1 since no variance reduction used"    
NCASES=100; "number of the loops for the histories" 
NHISTORIES=10000; 




"STEP 7   SHOWER-CALL                                        " 
"------------------------------------------------------------" 
"Fortran language; to write something in text files; 
"we need to place * in 5 position to change the line 
%NL 
%F 
      OPEN(UNIT=7, FILE='ENERGY_X_Y.txt', 
     *STATUS='UNKNOWN')  
C     star continuation line before 
 
      OPEN(UNIT=12, FILE='SPECTRA.txt', 













DO K=1,$MAXENERGY  [SPECT(K)=0.0;]  
"array to count the number of photons with some specific energy"  
 
"initiate the shower NCASES with NHISTORIES each time" 
DO I=1,NCASES [ "OUTPUT I;(//'START LOOP BLOCK',I5,':');" 
  DO J=1,NHISTORIES [ "OUTPUT J;(/'EMISSION',I6);" 
 
ABSORBED=0.0; "Energy absorbed by the crystal in each history; 
"place to zero each time shower is called 
 


















   ABSORBED=ABSORBED*1000; "pass energy to keV" 
   IABSORBED=INT(ABSORBED+0.5); "pass energy to integer" 
   SPECT(IABSORBED)=SPECT(IABSORBED)+1; "write an array to 
store the number of photons with some specific energy" 





"STEP 8   OUTPUT-OF-RESULTS                                  " 
"------------------------------------------------------------" 
 
"counting number of photons absorbed according its energy" 
"DO I=1,$MAXENERGY [ OUTPUT I,SPECT(I);(/,I4,T5,'KeV'," 
"T10,'NUM.ABSORBED PHOTONS:',I10);]" 
 
"total number of histories" 
OUTPUT NCASES*NHISTORIES;(/'NUMBER OF EMISSIONS:',I10); 
 
"total absorbed photons" 
DO I=1,$MAXENERGY  [ TOTALSPECT=TOTALSPECT+SPECT(I);] 




;OUTPUT PHOTOELE;(/,'NUM.PHOTOELECTRIC INTERACTIONS:',I20); 
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;OUTPUT COMPTON;(/,'NUM.COMPTON INTERACTIONS:',I20); 





      DO 90 L=1,ISAVE-1 
      WRITE(7,91)OUTDATA(L,1),OUTDATA(L,2),OUTDATA 
     *(L,3),OUTDATA(L,4),OUTDATA(L,5),OUTDATA(L,6), 
     *OUTDATA(L,7),OUTDATA(L,8),OUTDATA(L,9) 
90    CONTINUE 
91    FORMAT(9F18.3) 
      CLOSE(7) 
 
      DO 70 L=1,3500 
      WRITE(12,71)L,SPECT(L) 
70    CONTINUE 
71    FORMAT(2I14) 























"IF(IARG=6) [OUTPUT IARG;(/'BREMS OCCUR',I3);]" 
"IF(IARG=7) [OUTPUT IARG;(/'EL AFTER BREMS OCCUR',I3);]" 
"IF(IARG=8) [OUTPUT IARG;('MOLLER INT',I3);]" 
"IF(IARG=9) [OUTPUT IARG;(/'EL AFTER MOLLER INT',I3);]" 
"IF(IARG=15) [OUTPUT IARG;(/'PAIR PROD INT',I3);]" 
"IF(IARG=16) [OUTPUT IARG;(/'PHOTON AFTER PAIR PROD',I3);]" 
"IF(IARG=17) [OUTPUT IARG;(/'COMPTON INT',I3);]" 
"IF(IARG=18) [OUTPUT IARG;(/'PHOTON AFTER COMPTON INT',I3);]" 
"IF(IARG=19) [OUTPUT IARG;(/'PHOTOEL INT',I3);]" 
"IF(IARG=20) [OUTPUT IARG;(/'PHOTON AFTER PHOTOEL INT',I3);]" 
"IF(IARG=23) [OUTPUT IARG;(/'COHERENT INT',I3);]" 
"IF(IARG=24) [OUTPUT IARG;(/'AFTER COHERENT INT',I3);]" 
"IF(IARG=25) [OUTPUT IARG;(/'CHARACTERISTIC X-RAY',I3);]" 
"IF(IARG=26) [OUTPUT IARG;(/'COSTER-KRONIG ELEC',I3);]" 




IF(IARG=16) [PAIRPROD=PAIRPROD+1;] "count pair prod. events" 
IF(IARG=18) [COMPTON=COMPTON+1;] "count Compton events" 
IF(IARG=20) [PHOTOELE=PHOTOELE+1;] "count photoelec events" 
 
IF(IARG>0 & IARG<=4)[ 
 
 IRL=IR(NP); 
  IF(IR(NP)=$CRYSTALRG) [ABSORBED=ABSORBED+EDEP;] 
 "absorbed energy in the crystal in each history" 
 
 "IF(Z(NP)>2.5)[OUTPUT 

























      IF ((ISAVE.EQ.1001)) THEN 
      DO 80 ICOUNT=1,1000 
      WRITE(7,81) OUTDATA(ICOUNT,1),OUTDATA 
     *(ICOUNT,2),OUTDATA(ICOUNT,3),OUTDATA(ICOUNT,4), 
     *OUTDATA(ICOUNT,5),OUTDATA(ICOUNT,6), 
     *OUTDATA(ICOUNT,7),OUTDATA(ICOUNT,8),OUTDATA(ICOUNT,9) 
80    CONTINUE 
81    FORMAT(9F18.3) 
       ISAVE=1 
       END IF 
 
%M 



















"the arrays PCOORD and PNORM are contained in COMMON/PLADTA" 
 












$PLAN2P(2,7,1,8,9,-1); "define the collimator back" 
$PLAN2P(1,1,1,5,5,-1);  
$PLAN2P(3,3,-1,4,4,1);]   
 
ELSE [IDISC=1;] 
"Discard particles outside region 7 and 8" 
 
RETURN; 
END; "end of HOWFAR" 
 
"************************************************************" 
"                    SUBROUTINE HOWNEAR                      " 
"************************************************************" 
 
%E   
SUBROUTINE HOWNEAR(tperp, x, y, z, irl); 
$IMPLICIT-NONE; 
$REAL tperp, x, y, z; 
$INTEGER irl; 
 
tperp = 0.1; "tperp is the closest distance to any boundary;" 





END;"end of subroutine HOWNEAR" 
 
"=====================end of tutor.mortran================="  
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APPENDIX 4. Source Model. EGSnrc code.  
It is necessary take into account that the variables are changed according to the simulation. 
%L  
%E  
!INDENT M4; "indent each mortran nesting level by 4" 
!INDENT F2; "indent each fortran nesting level by 2" 
 
$IMPLICIT-NONE; 
















$INTEGER ISAVE,ICOUNT,PHOTOELE,COMPTON,PAIRPROD;}  
"common block to store the data in array with" 






















"$REAL $LGN(DL/1,2,3,4,5,6/)," "Parameter for the fit of the 
screening" 
"ALPHI,"  "Prob. for the (1-BR)/BR part in BREMS, eq. (2.7.64)" 
"BPAR, "  "Prob. for the 12*(BR-1/2)**2 part in PAIR, eq. 
(2.7.105)" 
"DELPOS, ""maximum delta, eq. (2.7.31)" 
 
Page 165 
"WA,   "  "atomic weight" 
"PZ,   "  "atomic fraction of an element in a compound" 
"ZELEM, " "Z for a given component" 
"RHOZ, " "density of an element in a compound" 
"PWR2I, " "powers of 1/2 (used for sampling (1-BR)/BR" 
"DELCM, " "136*m*exp(Zg), eq. (2.7.51)" 
"ZBRANG, ""composite factor for angular distributions"   
"LZBRANG;""-Log(ZBRANG)" 
 
"$INTEGER NNE,"   "number of elements/compound" 
"IBRDST," "flag to switch on bremsstrahlung angular 
distributions" 
"IPRDST, ""flag to switch on pair angular distributions" 
"ibr_nist, " "use the NIST bremsstrahlung cross sections" 
"itriplet, " "if set to 1, explicitely simulate triplet events" 
"pair_nrc; " "=0 => use Bethe-Heitler pair cross sections" 









$REAL smaxir,estepe,ximax,skindepth_for_bca;   
$INTEGER  transport_algorithm,bca_algorithm; 
$LOGICAL exact_bca,spin_effects;} 
 
"define a common to pass information about geometry to the 
subroutine Howfar"  
REPLACE{$MXMED}WITH{2}      "2 medium in the problem" 
REPLACE{$MXREG}WITH{8}      "only 8 geometric regions" 
REPLACE{$MXSTACK}WITH{15}   "15 particles on stack at once" 
 
"ELECTRONS TRANSPORT" 
REPLACE {$TRANSPORT-ALGORITHM-DEFAULT} WITH {$PRESTA-II} 
REPLACE {$BCA-ALGORITHM-DEFAULT} WITH {0} 
REPLACE {$SKIN-DEPTH-FOR-BCA} WITH {3}  
"value in elastic mean free paths and not in length units" 
 
"PARTICLE PARAMETERS" 
REPLACE{$ZIN}WITH{0}  "position of the particle: midle of the 
sphere" 
"REPLACE{$ENERGYPART}WITH{2.011}" "energy of the particle 
100kev+511kev [MeV]" 
REPLACE{$CHARGEPART}WITH{-1} "Charge of the particle:electrons" 
REPLACE{$MAXENERGY}WITH{3500}  "max energy of the spectra"  
 
"REGION_SPHERE" 
REPLACE{$MXSPHE}WITH{1} "Max.Number of spheres" 
REPLACE{$DELSPH}WITH{0.0001} 
 





"Num. of levels to generate random numbers" 






"The above expands into a series of COMMON statements;" 





























"STEP 3   HATCH-CALL                                         " 
"------------------------------------------------------------" 
  
;OUTPUT;('\f Start Test1'//'CALL HATCH to get cross-section 
data'/); 
 
CALL HATCH;   "pick up cross section data for NaI" 
              "data file must be assigned to unit 12" 
 
;OUTPUT AE(1)-0.511, AP(1); 
(/'knock-on electrons can be created and any electron followed 
down to:' 
,F8.3,'MeV kinetic energy' 
/'brem photons can be created and any photon followed down 
to:',F8.3,'MeV'); 
 






"STEP 4  INITIALIZATION-FOR-HOWFAR and HOWNEAR               " 
"------------------------------------------------------------" 
 





"STEP 5  INITIALIZATION-FOR-AUSGAB                           " 
"------------------------------------------------------------" 
 
$INITIALIZE RNG USING $luxury_level AND $iseed;  
"Random number generator, with 2 luxury levels" 
"luxury levels are from 0 to 4 and a period of greater than 
10^165" 
 
IAUSFL(7)=1; "a bremsstrahlung interaction is to occur" 
"and a call to BREMS is about to be made in ELECTR" 
 
IAUSFL(8)=1; "returned to ELECTR after a call to BREMS was made" 
 
IAUSFL(16)=1; "a pair production interaction is to occur and" 
"a call to PAIR is about to be made in PHOTON" 
IAUSFL(17)=1; "returned to PHOTON after a call to PAIR was made" 
 
IAUSFL(18)=1; "a Compton interaction is to occur and a call" 
"to COMPT is about to be made in PHOTON" 
IAUSFL(19)=1; "returned to PHOTON after a call to COMPT was 
made. 
 
IAUSFL(20)=1; "a photoelectric interaction is to occur and" 
"a call to PHOTO is about to be made in PHOTON" 





"STEP 6   DETERMINATION-OF-INICIDENT-PARTICLE-PARAMETERS     " 
"------------------------------------------------------------" 
 
IQIN=$CHARGEPART; "charge of the incident particle - electron"                
 
"MONOENERGETIC: energy of the incident particle"  
"EIN=$ENERGYPART;" "energy of the particle"      
 
/YIN,XIN/=0; "incident particle at origin: particle position" 
ZIN=$ZIN; "be sure that we start inside the region 7" 
"our particle is inside of the cube - middle of the cube"  
 
"/UIN,VIN/=0; WIN=1;" 
"particle moving along Z axis;" 
"we won't need if we use isotropic emission" 
 
IRIN=1; "start in the middle of the cube"               
WTIN=1; "weight = 1 since no variance reduction used"    
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NCASES=100; "number of the loops for the histories" 
NHISTORIES=100000; 
"number of the histories inside each loop-more nºquickly"   
 













 SPECTNUMYT(I)=SPECTNUMYT(I)+0.03522; ] 
 




















 "SPECTNUMPH(I)=SPECTNUMPH(I)+0.02385; ]" 
 
"32Phosphorous cumulative probability" 








"STEP 7   SHOWER-CALL                                        " 
"------------------------------------------------------------" 
"Fortran language; to write something in text files;" 






      OPEN(UNIT=7, FILE='BREMESCAPED_EN_X_Y.txt', 
     *STATUS='UNKNOWN')  
C     star continuation line before 
 
           
      OPEN(UNIT=12, FILE='BREMESCAPE.txt', 
     *STATUS='UNKNOWN') 
       
      OPEN(UNIT=14, FILE='EMISSIONSPECT.txt', 
     *STATUS='UNKNOWN') 
 
      OPEN(UNIT=16, FILE='BREMPROD.txt', 














DO K=1,$MAXENERGY  [EMSPECT(K)=0; SPECTBREMESCAP(K)=0; 
SPECTBREMPROD(K)=0;]  
"array to count the number of photons with some specific energy"  
 
"initiate the shower NCASES with NHISTORIES each time" 
DO I=1,NCASES [ "OUTPUT I;(//'START LOOP BLOCK',I8,':');" 




"Generate random energy - polyenergetic [MeV]" 
$RANDOMSET COSTHE; 
WHILE SPECTNUMYT(ABSORBED)<COSTHE[ABSORBED=ABSORBED+1]; 
EIN=(ABSORBED*0.01)+0.511; "energy of the particles" 
 


























"STEP 8   OUTPUT-OF-RESULTS                                  " 
"------------------------------------------------------------" 
 
"total number of histories" 
OUTPUT NCASES*NHISTORIES;(/'NUMBER OF EMISSIONS:',I20); 
 
"total absorbed photons" 
DO I=1,$MAXENERGY  [ 
TOTALBREMESCAP=TOTALBREMESCAP+SPECTBREMESCAP(I);] 
 
;OUTPUT TOTALBREMESCAP;(/'TOTAL ESCAPED BREMSSTRAHLUNG:',I20); 
 
DO I=1,$MAXENERGY  [ 
TOTALBREMPROD=TOTALBREMPROD+SPECTBREMPROD(I);] 
;OUTPUT TOTALBREMPROD;(/'TOTAL PRODUCED BREMSSTRAHLUNG:',I20); 
 
;OUTPUT TOTALELEC;(/,'NUM. ELECTRON INTERACTIONS:',F20.0); 
 
;OUTPUT PHOTOELE;(/,'NUM.PHOTOELECTRIC INTERACTIONS:',I20); 
;OUTPUT COMPTON;(/,'NUM.COMPTON INTERACTIONS:',I20); 





      DO 90 L=1,ISAVE-1 
      WRITE(7,91)OUTDATA(L,1),OUTDATA(L,2), 
     *OUTDATA(L,3),OUTDATA(L,4),OUTDATA(L,5), 
     *OUTDATA(L,6),OUTDATA(L,7),OUTDATA(L,8), 
     *OUTDATA(L,9) 
90    CONTINUE 
91    FORMAT(9F15.4) 
      CLOSE(7) 
 
      DO 70 L=1,3500 
      WRITE(12,71) L,SPECTBREMESCAP(L) 
70    CONTINUE 
71    FORMAT(2I10) 
      CLOSE(12) 
 
      DO 60 L=1,3500 
      WRITE(14,61) L,EMSPECT(L) 
60    CONTINUE 
61    FORMAT(2I10) 




      DO 50 L=1,3500 
      WRITE(16,51) L,SPECTBREMPROD(L) 
50    CONTINUE 
51    FORMAT(2I10) 























IF (IARG=16) [PAIRPROD=PAIRPROD+1;] 
IF (IARG=18) [COMPTON=COMPTON+1;] 
IF (IARG=20) [PHOTOELE=PHOTOELE+1;] 
 
IF(IR(NP)=1 & IQ(NP)=-1) [TOTALELEC=TOTALELEC+1;]  
"number of electron interactions" 
 










































      IF ((ISAVE.EQ.1001)) THEN 
      DO 80 ICOUNT=1,1000 
      WRITE(7,81) OUTDATA(ICOUNT,1),OUTDATA 
     *(ICOUNT,2),OUTDATA(ICOUNT,3),OUTDATA(ICOUNT,4), 
     *OUTDATA(ICOUNT,5),OUTDATA(ICOUNT,5), 
     *OUTDATA(ICOUNT,7),OUTDATA(ICOUNT,8), 
     *OUTDATA(ICOUNT,9) 
80    CONTINUE 
81    FORMAT(9F15.4) 
      ISAVE=1 
      END IF 
 
%M 


















"the arrays PCOORD and PNORM are contained in COMMON/PLADTA" 
 
IF(IR(NP).NE.1) [IDISC=1;]"Discard particles outside the cube" 
 
ELSE[ 
 $SPHERE(1,1,IHIT,TVALS);  
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"First: number of sphere; second: inside/outside; third:ihit; 
fourth:distance" 
 "OUTPUT TVALS; ('TVAL', F20.3);" 
 
 IF(IHIT.EQ.1) [$CHGTR(TVALS,2); ] 









"                    SUBROUTINE HOWNEAR                      " 
"************************************************************" 
 
%E   
SUBROUTINE HOWNEAR(tperp, a, b, c, irl); 
 
$IMPLICIT-NONE; 
$REAL tperp,a, b, c,ASPH,BSPH,CSPH,ARGSP,ROOTSP,TVALS; 
$INTEGER  irl,IHIT; 
COMIN/ET-Control,SPHDTA,STACK/; 
 
IF(irl = 2) [RETURN;] 
ELSEIF(irl = 1)[ $SPHERE(1,1,IHIT,tperp);] 
 
"tperp is the closest distance to any boundary;" 
"we defined it as zero to avoid that EGS condense some" 
"histories after the boundary" 
 
"SKIN-DEPTH-FOR-BCA: specify the distance from a boundary" 
"distance from a boundary (in elastic MFP) at which to" 




END;"end of subroutine HOWNEAR" 
 




APPENDIX 5. Matlab code to create a binary image from the list mode data (processed 
list-mode data obtained from the decoding program) 
It is necessary take into account that the text name and the title changed according to the 
measurement name. 
 
%"FRAMING UP" LIST MODE DATA 
  
en_peak=140.5; 
en_window=0.2; %20% of energy window 
en_low=en_peak-((en_peak*en_window)/2); %126.5keV of minimum energy 
en_high=en_peak+((en_peak*en_window)/2); %154.5keV of maximum energy 
matrix_size=257; %matrix with 256x256 pixels after remove first row 
and column 
FOV=565.347; %[mm] values based in the GE NM/CT 670 
pix_size=FOV/matrix_size; %[mm] 2.2mm pixel size 
  
A=dlmread('99mTc_1EnerWind_09032012_SPLIT.txt'); %read the text files 
[m,n]=size(A); 
  








    if (energy(i)>=en_low && energy(i)<=en_high) 
        x_pixel(i)=uint16(x_pos(i)/pix_size)+0.5; 
        y_pixel(i)=uint16(y_pos(i)/pix_size)+0.5; 
    else 
        x_pixel(i)=1; 
        y_pixel(i)=1; 








    if (x_pixel(i)<=matrix_size && y_pixel(i)<=matrix_size) 
        image(x_pixel(i),y_pixel(i))=image(x_pixel(i),y_pixel(i))+1; 
    end 
end 
  
image=uint16(image); %converts the elements of the array into unsigned 




imshow(image,[]); %without uniformity correction 
title ('LIST MODE: 99mTc CENTRE (140.5keV +/-10%)'); 
 
